e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended March
31, 2007
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Commission file number:
000-33477
GENESIS MICROCHIP
INC.
(Exact name of registrant as
specified in its charter)
|
|
|
DELAWARE
|
|
77-0584301
|
(State or other jurisdiction
of incorporation)
|
|
(IRS Employer
Identification Number)
|
2525 AUGUSTINE DRIVE
SANTA CLARA, CALIFORNIA
|
|
95054
|
(Address of principal executive
offices)
|
|
(Zip Code)
|
(408) 919-8400
(Registrants telephone
number, including area code)
Securities registered pursuant to section 12(b) of the
Act:
None.
Securities registered pursuant to section 12(g) of the
Act:
Shares of Common Stock, $0.001 par value
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act (Check one):
Large accelerated
filer o Accelerated
Filer
þ Non-accelerated
filer o
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
The aggregate market value of the voting stock held by
non-affiliates of the registrant as of September 30, 2006
was approximately $429,856,395 based on the number of shares
held by non-affiliates of the registrant as of
September 30, 2006, and based on the reported last sale
price of common stock on September 30, 2006, which was the
last business day of the registrants most recently
completed second fiscal quarter. This calculation does not
reflect a determination that persons are affiliates for any
other purposes. Shares of stock held by five percent
stockholders have been excluded from this calculation as they
may be deemed affiliates.
The number of shares outstanding of the registrants common
stock as of June 1, 2007 was 37,179,849.
DOCUMENTS
INCORPORATED BY REFERENCE
None.
STATEMENT
REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on
Form 10-K
contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements relate to expectations concerning
matters that are not historical facts. Words such as
projects, believes,
anticipates, plans, expects,
intends and similar words and expressions are
intended to identify forward-looking statements. We believe that
the expectations reflected in the forward-looking statements are
reasonable but we cannot assure you that those expectations will
prove to be correct. Important factors that could cause our
actual results to differ materially from those expectations are
disclosed in this report, including, without limitation, in the
Risk Factors described in Part I, Item 1A.
All forward-looking statements are expressly qualified in their
entirety by these factors and all related cautionary statements.
We do not undertake any obligation to update any forward-looking
statements.
TRADEMARKS
Genesis®,
Genesis Display
Perfection®,
Faroudja®,
DCDi®
by Faroudja, Faroudja Picture
Plus®,
Faroudja DCDi
Cinema®,
Faroudja DCDi
Edge®,
Nuon®,
SmartSCAN®,
RealColor®,
Real
Recoverytm,
Ultra-Reliable
DVI®,
Energy Spectrum
Management®,
ESM®,
PurVIEW
HDtm
and
MCTitm
by Faroudja are our trademarks or registered trademarks. This
report also refers to the trademarks of other companies.
AVAILABLE
INFORMATION
Our Internet address is www.gnss.com. On our Internet website,
we make publicly available free of charge our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of
1934 as soon as reasonably practicable after we electronically
file such material with, or furnish it to, the Securities and
Exchange Commission.
In addition, the public may read and copy any materials we file
with the SEC at the SECs Public Reference Room at
100 F Street, N.E., Washington, D.C. 20549. You
may obtain information on the operation of the Public Reference
Room by calling the SEC at
1-800-SEC-0330.
The SEC maintains an Internet site that contains reports, proxy
and information statements, and other information regarding
issuers that file electronically with the SEC at
http://www.sec.gov.
3
PART I
OVERVIEW
We design, develop and market integrated circuits called display
controllers that receive and process analog and digital video
and graphic images for viewing on a flat-panel display. Our
display controllers are typically located inside a flat-panel
display device, such as a flat-panel television or computer
monitor. We are currently addressing established display
applications such as flat-panel computer monitor, and display
applications such as liquid crystal display
(LCD) television, plasma television, digital cathode ray
tube television, digital television and other display devices
for the consumer electronics market. We are also pioneering with
other industry leaders a new interconnect standard called
DisplayPort through the Video Electronics Standard Association
(VESA). DisplayPort is an open digital standard designed to
enable a common, open source, royalty-free, scalable interface
between any flat-panel display and video or data source.
The transition from analog display systems, such as most
televisions and computer monitors that use cathode ray tubes
(CRT), to digital display systems that use a fixed-matrix of
pixels to represent an image, requires sophisticated digital
image-processing solutions. Our products solve input,
resolution, format and frame refresh rate conversion problems
while maintaining critical image information and improving
perceived image quality. Our display controller products utilize
patented algorithms and integrated circuit architectures, as
well as advanced integrated circuit design and system design
expertise.
We began business as a Canadian company in 1987, and changed our
domicile to become a Delaware, U.S. corporation in February
2002. In May 1999, we acquired Paradise Electronics, Inc., in
February 2002, we acquired Sage, Inc. and in March 2002, we
acquired the technology assets of VM Labs, Inc. These
acquisitions improved our product offerings for the flat-panel
monitor market, and our ability to diversify our business into
other emerging display markets, such as flat-panel television.
In March 2003, we entered into an agreement to merge with
Pixelworks, Inc., but in August 2003, we and Pixelworks agreed
to terminate the proposed merger. Under the terms of the
agreement, the parties agreed to a mutual release of claims, and
Pixelworks paid us $5.5 million as a reimbursement for our
expenses.
We operate through subsidiaries and offices in the United
States, Canada, China, Germany, India, Japan, Singapore, South
Korea, Taiwan and Turkey. Our business is conducted globally,
with the majority of our suppliers and customers located in
China, Europe, Japan, South Korea and Taiwan. For a geographical
breakdown of our revenues and long-lived assets, see
Note 14 to our consolidated financial statements included
in Item 8 of this report.
MARKETS
AND APPLICATIONS
Our targeted applications include the following:
|
|
|
|
|
Flat-Panel Computer Monitors. Flat-panel
computer monitors using liquid crystal displays, or LCDs, are
increasingly replacing monitors that use CRTs. For the year
ended March 31, 2007, applications sold into the flat-panel
computer monitor market represented an estimated 40% of our
total revenues. Companies whose flat-panel computer monitors
incorporate our products include AOC, BenQ, Dell, Fujitsu,
Gateway, HP, Innolux, Lenovo, Legend, Lite-On, NEC, Philips,
Samsung, Sony, ViewSonic, and many other leading brands.
|
|
|
|
Television & Video. We are
leveraging our technologies in video image processing to produce
products for fast-growing flat-panel television and high
definition digital television applications. These technologies,
which include products containing analog video image processing,
digital/MPEG video image processing, timing controllers and
other technologies, may also be designed into other applications
such as Digital
CRT-TVs,
home theaters, video projectors, audio/video receivers and DVD
players. Companies whose televisions incorporate our products
include leading TV manufacturers, including Changhong, Dell,
Eizo, Fujitsu, Haier, Hisense, Konka, LG, NEC, Philips, Samsung,
Sharp, Skyworth, Sony, Toshiba, TTE, Westinghouse and Zenith.
For the year ended March 31, 2007, revenue from
applications serving these markets represented an estimated 60%
of our total revenues.
|
4
PRODUCTS
The following table shows our principal integrated circuit
product families as of March 31, 2007:
|
|
|
|
|
Product Family
|
|
Description
|
|
Markets
|
|
FLI23xx
|
|
Video format conversion and image
enhancement processors
|
|
CRT TVs, flat-panel TVs, DVD
players, video projectors
|
gm15xx/gm16xx
|
|
Graphics/TV video processors for
SXGA-WUXGA resolutions
|
|
Flat-panel monitors, flat-panel
TVs, video projectors
|
gm22xx/gm52xx
|
|
Integrated LCD monitor controllers
supporting resolutions up to SXGA
|
|
Multi-function monitors and
entry-level LCD TVs
|
gm23xx/gm53xx
|
|
Integrated LCD monitor controllers
supporting resolutions up to SXGA
|
|
Flat-panel monitors
|
gmZAN3xx
|
|
Analog interface LCD monitor
controllers (for XGA and SXGA- resolution monitors)
|
|
LCD monitors and other
fixed-resolution pixilated displays
|
gm56xx/57xx/26xx/27xx (Phoenix)
|
|
Pin/firmware compatible family of
analog & dual input LCD monitor controllers for XGA,
SXGA and UXGA resolutions
|
|
Mainstream LCD monitors using LVDS
or RSDS LCD panels
|
FLI812x (Hudson)
|
|
Single-chip flat-panel TV
controller for cost-sensitive applications with 2D NTSC/PAL
decoder and Faroudja DCDi Edge video processing
|
|
Entry to mid-level flat panel and
digital CRT TVs
|
FLI85xx (Cortez, Cortez Plus,
Cortez Lite)
|
|
Single-chip high-end flat panel TV
controller with 3D NTSC/PAL decoder and high-end Faroudja DCDi
Cinema video processing with optional HDMI receiver
|
|
Entry-level, Mid-range and
high-end flat panel TVs
|
FLI86xx (Cortez Advanced)
|
|
Premium TV video controller with
10-bit Faroudja DCDi Cinema video processing and two 3D comb
filters
|
|
LCD/PDP TVs, premium AVR, high
definition DVD players, premium LCD TV monitors
|
FLI59xx (Oak)
|
|
Single-chip highly integrated,
mixed-signal LCD controller for multi-function monitors
supporting resolutions up to WUXGA
|
|
Multi-function monitors and LCD TVs
|
gm10500 (PurVIEW
HDtm)
|
|
Digital TV audio and video decoder
|
|
ATSC/DVB/OpenCabletm
compliant integrated Digital TVs
|
RESEARCH
AND DEVELOPMENT
Our research and development efforts are performed within the
following specialized groups:
|
|
|
|
|
Algorithm Development Group: focuses on
developing high-quality image processing technologies and their
implementation in silicon.
|
|
|
|
Product Development Group: focuses on
developing standard semiconductor components to service our
television, monitor and computer original equipment manufacturer
(OEM) customers. In addition, we develop semiconductor
components to serve customers who are designing products for new
market applications, such as flat-panel television and other
potential mass markets.
|
5
|
|
|
|
|
Software Engineering Group: develops the
software environment required for our products to work within
target systems. Software is now embedded in many of our
products. The other major role of software engineering is tool
development. We provide sophisticated software tools to help our
customers develop their applications and customize their
software to improve the productivity of those engineers involved
in the process of getting their products into production.
|
|
|
|
Systems Engineering Group: develops reference
design hardware and software applications, validates chips,
validates intellectual property, system performance tuning and
competitive analysis, and provides regional application
engineers to support our field application engineers.
|
As of March 31, 2007, we had 342 full-time employees
engaged in research and development. Expenditures for research
and development, including non-cash stock-based compensation,
were $64.5 million for the year ended March 31, 2007,
$48.7 million for the year ended March 31, 2006, and
$41.5 million for the year ended March 31, 2005.
See Managements Discussion and Analysis of Financial
Condition and Results of Operations Research And
Development for further discussion of research and
development activities.
CUSTOMERS,
SALES AND MARKETING
Our sales and marketing personnel work closely with customers,
industry leaders, sales representatives and our distributors to
define features, performance, price and market timing of our
products. We focus on developing long-term customer
relationships with both system manufacturers and equipment
manufacturers. Our marketing group includes applications
engineers who support customer designs as well as producing
evaluation boards and reference designs for LCD monitors,
thereby providing system on a chip (SOC) solutions that
facilitate the integration of our products into the end products
manufactured by our customers.
We sell and market our products directly to customers and
through regional sales representatives and distributors. Prior
to selling our products, we provide our customers with technical
support, design assistance and customer service at their
facilities and through our various offices throughout the world.
Our sales representatives and distributors also provide ongoing
support and service on our behalf. We generally provide a
one-year limited warranty for our products.
We derive a substantial portion of our revenues from a limited
number of products. For the year ended March 31, 2007, our
top five products contributed 49% of our total revenues. For the
years ended March 31, 2006 and 2005, our top five products
contributed 55% and 51% of our total revenues, respectively.
Our sales are also derived from a limited number of customers,
with our largest five customers accounting for 52% of total
revenues in fiscal 2007, 51% of total revenues in fiscal 2006
and 52% of total revenues in fiscal 2005.
For the year ended March 31, 2007, three customers, LG
Electronics, Inc., BenQ Inc., and Royal Philips Electronics N.V.
each accounted for more than 10% of our total revenues. For the
year ended March 31, 2006, three customers, LG Electronics,
Inc., BenQ Inc., and Royal Philips Electronics N.V., each
accounted for more than 10% of our total revenues. For the year
ended March 31, 2005, two customers, Samsung Electronics
Co. and LG Electronics., each accounted for more than 10% of our
total revenues. At March 31, 2007 two customers represented
more than 10% of accounts receivable trade. At March 31,
2006, four customers represented more than 10% of accounts
receivable trade. The loss of any significant customer could
have a material adverse impact on our business.
We sell our products primarily outside of the United States. For
the years ended March 31, 2007 and 2006, 99% of our
revenues were from sales to China, Japan, South Korea, Taiwan,
Europe, as well as other countries located in Asia and 1% of our
revenues were from customers in the United States. Risks
associated with our foreign operations are also discussed under
the Risk Factor, We are subject to risks associated with
international operations, which may harm our business.
Additional information on the concentration of our revenues by
geography, customers and markets can be found in Note 14 to
our consolidated financial statements included in Item 8 of
this report.
6
As of March 31, 2007, our sales and marketing force totaled
140 people. This number includes sales field application
engineers whose role is to create reference designs and assist
our customers to incorporate our integrated circuits into their
products.
MANUFACTURING
Third parties with
state-of-the-art
fabrication equipment and technology manufacture our products.
This approach enables us to focus on product design and
development, minimizes capital expenditures and provides us with
access to advanced manufacturing facilities. Currently, our
products are primarily being fabricated, assembled or tested by
Taiwan Semiconductor Manufacturing Corporation, Advanced
Semiconductor Engineering, International Semiconductor
Engineering Labs, Global Advanced Packaging Technology Co. Ltd.,
STATS ChipPAC Ltd., and Siliconware Precision Industries Ltd.
These manufacturers assemble and test our products based on the
design and test specifications we have provided. After this
process has been completed, our manufacturers ship the finished
products to our third party logistics subcontractors in Asia.
Through these subcontractors, we then ship our finished products
to OEMs or system integrators for integration into their final
products. As semiconductor manufacturing technologies advance,
manufacturers typically retire their older manufacturing
processes in favor of newer processes. When this occurs, the
manufacturer generally provides notice to its customers of its
intent to discontinue a process, and its customers will either
retire the affected part or design a newer version of the part
that can be manufactured with the more advanced process.
Consequently, our products may become unavailable from their
current manufacturers if the processes on which they are
produced are discontinued. Our devices are produced using 0.25,
0.18, 0.16 and 0.13 micron process technologies, which we expect
to be available for the next two to three years. We must manage
the transition to new parts from existing parts. We have
commitments from our suppliers to provide notice of any
discontinuance of their manufacturing processes in order to
assist us in managing these types of product transitions.
All of our products are currently sourced such that we have only
one foundry for any one semiconductor die. If required, we would
secure sufficient fabrication capacity and diversify our sources
of supply. Any inability of a current supplier to provide
adequate capacity would require us to obtain products from
alternate sources. There is a considerable amount of time
required to change wafer fabrication suppliers for any single
product, as well as substantial costs to bring that supplier
into volume production. Should a source of a product cease to be
available, we believe that this would have a material adverse
effect on our business, financial condition and results of
operations. We have no guarantees of minimum capacity from our
suppliers and are not liable for any significant minimum
purchase commitments.
QUALITY
ASSURANCE
Genesis strives for continuous quality improvement and
consistent delivery of high quality outputs at all stages of
product development, manufacturing and delivery. We are an ISO
9001 certified company. We aim to provide reliable, high quality
products and services by assigning stringent checks and controls
at all stages of product creation and delivery.
Our business model requires use of manufacturing subcontractors.
Since we depend heavily on our subcontractors ability to
meet our requirements and provide quality products, we must
carefully select our subcontractors. We employ detailed
processes for supplier qualification, monitoring and review to
help ensure quality of our subcontractors deliverables.
All our primary manufacturing subcontractors are ISO 9000
certified.
We also focus on continuous process improvement. This
improvement is not limited to manufacturing and testing
processes. We review our development and product planning
processes in an effort to design quality into our products from
the start. We also have demanding criteria for various stages of
product release. Product is usually considered fit for release
to mass production only when compliance to these criteria is
considered satisfactory upon formal reviews.
We use data provided by subcontractors as well as our own
qualification testing in an effort to ensure that our products
are reliable. This testing includes accelerated stress testing
at elevated temperatures and voltages, environment testing and
many other types of testing using methods which are recognized
industry standards. The need for failure analysis may arise
during product development or during use by a customer. We
perform failure
7
analysis of our devices using in-house and subcontracted
facilities. Depending on the failure we use both non-destructive
and destructive failure analysis techniques to ensure that any
decisions made as a result of the failure are informed and based
on quantifiable information and data.
We have also taken steps towards addressing environmental
concerns. For example, we have qualified Restriction on
Hazardous Substances (RoHS) compliant packaging for our products
to provide our customers the option of ordering such products.
In addition, we have obtained ISO 14001 (Environmental
Management System) certification for our Santa Clara,
California site.
INTELLECTUAL
PROPERTY AND LICENSES
We protect our technology through a combination of patents,
copyrights, trade secret laws, trademark registrations,
confidentiality procedures and licensing arrangements. We have
over 210 United States and foreign patents with additional
patent applications pending. In addition to the United States,
we apply for and have been granted numerous patents in other
jurisdictions, including Europe, China, Singapore, Japan, Taiwan
and South Korea. Our patents relate to various aspects of
algorithms, product design or architectures. To supplement our
proprietary technology, we also license technology from third
parties.
COMPETITION
The market in which we operate is intensely competitive and is
characterized by technological change, evolving industry
standards and rapidly declining average selling prices. We face
competition from both large and small companies, including AMD
(ATI Technologies), Broadcom Corporation, LSI Corporation,
Micronas Semiconductor Holding AG, Mediatek Inc., MStar
Semiconductor, Inc., National Semiconductor Corporation, Novatek
Microelectronics Corp., NXP Seminconductors, Pixelworks, Inc.,
Realtek Semiconductor Corp., Renesas Technology Corp., Silicon
Image, Inc., ST Microelectronics, N.V., Trident Microsystems,
Inc., and Zoran Corporation. In addition, many our of current
and potential customers have their own internally developed
integrated circuit solutions, and may choose not to purchase
solutions from third party suppliers like Genesis. We anticipate
that as the market for our products develops, our current
customers may develop their own products and competition from
diversified electronic and semiconductor companies will
intensify. Some competitors are likely to include companies with
greater financial and other resources than us. Increased
competition could harm our business, by, for example, increasing
pressure on our profit margins or causing us to lose customers.
We believe that the principal competitive factors in our markets
are:
|
|
|
|
|
image quality,
|
|
|
|
product design features and performance,
|
|
|
|
product price,
|
|
|
|
the time to market of our products, and
|
|
|
|
the quality and speed of customer support.
|
BACKLOG
Our customers typically order products by way of purchase orders
that may be canceled or rescheduled without significant penalty.
These purchase orders are subject to price negotiations and to
changes in quantities of products and delivery schedules in
order to reflect changes in customer requirements and
manufacturing availability. Further, some of our customers are
required to post a letter of credit or pay for the goods in
advance of shipment. If the customer does not provide this type
of security on a timely basis, the backlog may be rescheduled or
may never result in a shipped order. Historically, most of our
sales have been made pursuant to short lead-time orders and
delivery schedules. In addition, our actual shipments depend on
the manufacturing capability of our suppliers and the
availability of products from those suppliers. As a result, we
operate with a modest amount of backlog for any given quarter at
any given time. Therefore, we do not believe that backlog is
always a meaningful indicator of our future revenues. We do,
however, track revenue and backlog trends on a
quarter-to-quarter
basis as a means of comparing revenue at a particular date in a
quarter to revenue at comparable dates in past quarters.
8
EMPLOYEES
As of March 31, 2007, we employed a total of
595 full-time employees, including 342 in research and
development, 140 in sales and marketing, 34 in manufacturing
operations and quality assurance, and 79 in finance, information
technology, human resources and administration. We employ a
number of temporary and part-time employees and consultants on a
contract basis. Our employees are not represented by a
collective bargaining organization. We believe that relations
with our employees are satisfactory.
Our business involves risks and uncertainties. You should
carefully consider the risks described below, together with all
of the other information in this Annual Report on
Form 10-K
and other filings with the Securities and Exchange Commission in
evaluating our business. If any of the following risks actually
occur, our business, financial condition, operating results and
growth prospects would likely be adversely affected. In such an
event, the trading price of our common stock could decline, and
you could lose all or part of your investment in our common
stock. Our past financial performance should not be considered
to be a reliable indicator of future performance, and investors
should not use historical trends to anticipate results or trends
in future periods. These risks involve forward-looking
statements and our actual results may differ substantially from
those discussed in these forward-looking statements.
Our
quarterly revenues and operating results fluctuate significantly
due to a variety of factors, which may result in volatility or a
decline in our stock price.
Our historical revenues and operating results have varied
significantly from quarter to quarter. Moreover, our actual or
projected operating results for some quarters may not meet the
expectations of stock market analysts and investors, which may
cause our stock price to decline. In addition to the factors
discussed elsewhere in this Risk Factors section, a
number of factors may cause our revenue to fall short of our
expectations or cause fluctuations in our operating results,
including:
|
|
|
|
|
Our ability to gain and maintain design wins with
our customers and ramp up new designs into production volumes;
|
|
|
|
Customer inventory levels and market share;
|
|
|
|
Growth rate of the flat-panel TV and LCD monitor markets;
|
|
|
|
Seasonal consumer demand for flat-panel TV, high definition TV
(HDTV) and LCD monitors into which our products are
incorporated;
|
|
|
|
Changes in the mix of products we sell, especially between our
higher-priced TV/video products and our lower-priced monitor
products;
|
|
|
|
Increased competition and competitive pricing pressures;
|
|
|
|
The timing of new product introductions by us and our
competitors;
|
|
|
|
Availability and pricing of panels and other components for
flat-panel TVs and LCD monitors;
|
|
|
|
Wafer costs and other product fabrication costs;
|
|
|
|
Foreign exchange rate fluctuations, research and development tax
credits and other factors that impact tax rates; and
|
|
|
|
Changes in product costs or manufacturing yields or available
production capacity at our fabrication facilities.
|
As a result of the fluctuation in our revenues and operating
results, our stock price can be volatile, especially if our
actual financial performance in a quarter deviates from the
financial targets we set at the beginning of that quarter, or
from market expectations.
9
We
have had significant senior management and key employee
turnover, and may not be able to attract, retain and motivate
the personnel we need to succeed.
In order to compete, we must attract, retain and motivate
executives and other key employees, including those in
managerial, technical, sales and marketing positions. We have
recently experienced significant turnover in our senior
management team. Several executives and other key employees have
left the company, while others have joined or have been
appointed to senior management roles, including the following:
|
|
|
|
|
In May 2006, Tzoyao Chan, our Senior Vice President, Product
Development, resigned and Behrooz Yadegar joined the company as
his successor.
|
|
|
|
In July 2006, Ken Murray, our Vice President, Human Resources,
resigned and we appointed a successor.
|
|
|
|
In August 2006, Mohammad Tafazzoli, our Senior Vice President,
Operations, resigned and we appointed a successor.
|
|
|
|
In September 2006, Hildy Shandell, our Senior Vice President,
Corporate Development, joined the company.
|
|
|
|
In October 2006, Raphael Mehrbians, our Senior Vice President,
Product Marketing, resigned and we appointed two Vice Presidents
of Marketing, but have not yet appointed a Senior Vice President.
|
|
|
|
In May 2007, Michael Healy, our Chief Financial Officer,
resigned and we have not yet appointed a successor.
|
|
|
|
In June 2007, Anders Frisk, our Executive Vice President,
resigned and we have not yet appointed a successor.
|
In addition, we have lost key technical personnel. We have
experienced, and may continue to experience, difficulty in
hiring and retaining candidates with appropriate qualifications.
We may not be able to attract and retain the senior management
or other key employees that we need. Competition for experienced
employees in the semiconductor industry can be intense. If we
cannot attract and retain the employees we need, our business
could be harmed, particularly if the departure of any executive
or key employee results in a business interruption or if we are
not successful in preserving material knowledge of our departing
employees.
We
must increase our revenues and reduce our operating expenses in
order to return to profitability and we may not be able to
achieve profitability on a quarterly or annual
basis.
We were not profitable in the fiscal year ended March 31,
2007. Our net loss for the fiscal year ended March 31, 2007
was approximately $144.3 million. As of March 31,
2007, we had an accumulated deficit of approximately
$141.5 million. Returning to profitability will depend in
large part on our ability to generate and sustain increased
revenue levels in future periods. We also need to reduce
operating expenses to a level commensurate with our revenues,
while successfully executing our product development strategy.
As a result, we have and expect that we may continue to
implement cost reductions through
reductions-in-force,
outsourcing, and the like. These efforts may be more costly than
we expect and we may not be able to increase our revenue enough
to offset our operating expenses. We may not succeed in
returning to profitability and could incur losses in future
periods and, even if we do return to profitability, we may not
be able to maintain or increase our level of profitability. If
we cannot increase our revenue at a greater rate than our
expenses, we will not become profitable.
We
face intense competition in our market, especially from larger,
better-known companies, and we may lack sufficient financial or
other resources to maintain or improve our competitive
position.
The markets in which we operate are intensely competitive and
are characterized by technological change, changes in customer
requirements, frequent new product introductions and
improvements, evolving industry standards and rapidly declining
average selling prices. We expect the level of competition to
increase in the future. If we are unable to respond quickly and
successfully to these developments, our competitive position
will be harmed, and our products or technologies may become
uncompetitive or obsolete.
10
Our chief competitors include both large and small companies,
such as AMD (ATI Technologies), Broadcom Corporation, LSI
Corporation, Micronas Semiconductor Holding AG, Mediatek Inc.,
MStar Semiconductor, Inc., National Semiconductor Corporation,
Novatek Microelectronics Corp., NXP Seminconductors, Pixelworks,
Inc., Realtek Semiconductor Corp., Renesas Technology Corp.,
Silicon Image, Inc., ST Microelectronics,N.V., Trident
Microsystems, Inc., and Zoran Corporation. In addition, many of
our current and potential customers have their own internally
developed integrated circuit solutions, and may choose not to
purchase solutions from third party merchant suppliers like
Genesis. We may also face competition from
start-up
companies.
Some of our competitors, who may include our own customers, also
include companies with greater financial and other resources
than we have. Large companies may have advantages over us
because of their longer operating histories, greater brand name
recognition, larger customer bases or greater financial,
technical and marketing resources. As a result, they may be able
to adapt more quickly to new or emerging technologies and
changes in customer requirements. They also have greater
resources to devote to the promotion and sale of their products
than we have. In addition, our overseas competitors have reduced
cost structures that enable them to compete aggressively on
price. Increased competition could harm our business, by, for
example, increasing pressure on our profit margins or causing us
to lose customers. Also, we have received a license from Silicon
Image, Inc. for certain of their digital visual interface
(DVI) patents and high definition multimedia interface
(HDMI) patents, and must pay Silicon Image royalties on all of
our DVI and HDMI products. This agreement, and other royalty
obligations we may have, could hinder our ability to compete
with unlicensed competitors that are not required to pay
royalties on competing products. We may not be able to compete
successfully against our current or potential competitors,
especially those with significantly greater financial resources
or brand name recognition.
Our
failure to respond quickly to customer demand for technological
improvements and integrate new features could have an adverse
effect on our ability to compete.
To compete successfully, we must develop new products and
improve our existing products at the same pace or ahead of our
competitors. For example, in order to compete successfully in
the digital television market, consumer electronics
manufacturers must first select our products for incorporation
into their digital televisions (giving us a so-called
design win), and then we must be able to deliver
those products in high volumes in a timely fashion.
Manufacturers may not choose our digital television solution
over our competitors solutions. We often incur significant
expenditures on the development of a new product without any
assurance that our product will be selected for a design win.
Even if we are chosen, the design win may not result in any
significant revenues to us, since sales of our products largely
depend on the commercial success of our customers display
products, and whether our customers are relying on us merely as
a second source.
In addition, we need to design products for customers that
continually require higher functionality at lower costs. We
must, therefore, continue to add features to our products and to
include these features on a single chip. The development process
for these advancements is lengthy and will require us to
accurately anticipate technological innovations and market
trends. Developing and enhancing these products is
time-consuming, costly and complex.
There is a risk that these developments and enhancements will be
late, fail to meet customer or market specifications, and will
not be competitive with other products using alternative
technologies that offer comparable functionality. These types of
events could continue have a variety of negative effects on our
competitive position and our financial results, such as reducing
our revenue, increasing our costs, lowering our gross margin
percentage, and requiring us to recognize and record impairments
of our assets.
We do
not have long-term commitments from our customers, so it is
difficult for us to forecast our revenues, and could result in
excess inventory.
Our sales are made on the basis of purchase orders rather than
long-term purchase commitments. In addition, our customers may
cancel or defer purchase orders. We provide revenue guidance and
manufacture our products according to our estimates of customer
demand and we have limited visibility of such demand beyond one
quarter. This process requires us to make multiple demand
forecast assumptions, each of which may introduce errors into
our estimates. If we overestimate customer demand, we may miss
our revenue guidance, which could cause our stock price to
decline. In addition, the timing and correction of this
overestimation, could cause us to manufacture
11
products that we may not be able to sell. As a result, we could
have excess inventory, which could increase our losses.
Conversely, if we underestimate customer demand or if sufficient
manufacturing capacity were unavailable, we could forego revenue
opportunities, lose market share and damage our customer
relationships.
A
limited number of our customers comprise a significant portion
of our revenues and any decrease in revenue from these customers
could have an adverse effect on our net revenues and operating
results.
The markets for our products are highly concentrated. Our
revenues are derived from a limited number of customers.
Revenues from our largest five customers accounted for 52% of
our revenues, with 16% of our revenues coming from our largest
customer, for the fiscal year ended March 31, 2007. This
customer concentration increases the risk of quarterly
fluctuations in our revenues and operating results. Any downturn
in the business of our key customers or potential new customers
could have a negative impact on our sales to such customers,
which could adversely affect our net revenues and results of
operations. We expect that a small number of customers will
continue to account for a large amount of our revenues. The
decision by any large customer to decrease or cease using our
products would harm our business. For example, during fiscal
year 2007, we lost significant TV designs with one of our
largest customers. This loss is expected to negatively impact
our revenue until we are able to regain designs with that
customer or other customers.
In addition, several of our customers sell to a limited number
of original equipment manufacturers (OEMs). The decision by any
large OEM to decrease or cease using our customers
products could, in turn, cause our customer to decrease or cease
buying from us. Most of our sales are made on the basis of
purchase orders rather than long-term agreements so that any
customer could cease purchasing products at any time without
penalty.
Our
success will depend on the growth of the market for flat-panel
televisions and LCD monitors, and our customers commercial
success in those markets.
Our ability to generate revenues depends on the growth of the
market for flat-panel televisions, digital televisions and LCD
computer monitors. Since we do not sell to every manufacturer in
those markets, our revenues also depend on how well our
customers perform in those markets. To the extent that our
customers share of the flat panel television, LCD monitor
or digital television markets declines or does not grow, the
sales of our products will be negatively impacted. In addition,
our growth will also depend upon emerging markets for consumer
electronics such as HDTV. The potential size of these markets
and the timing of their development are uncertain and will
depend in particular upon:
|
|
|
|
|
A continued reduction in the costs of products in the respective
markets;
|
|
|
|
The availability, at a reasonable price, of components required
by such products (such as LCD panels); and
|
|
|
|
The emergence of competing technologies and standards.
|
These and other potential markets may not develop as expected,
which would harm our business.
Our
success may depend in part on market adoption of the DisplayPort
digital interface standard.
The DisplayPort digital display interface, which is based on
technology developed by Genesis and is expected to be used in
our products, is a new interface standard that has yet to
achieve widespread adoption. DisplayPort is an alternative to
older, established interconnect standards such as DVI, and
therefore could face significant obstacles to adoption. In
addition, other new standards may be introduced which could
impact DisplayPorts success. If DisplayPort does not
achieve market adoption in the computer
and/or
consumer electronics industry, our ability to generate revenue
from DisplayPort-based products would be limited.
Our
customers experience fluctuating product cycles and seasonality,
which causes their sales to fluctuate.
Our products are incorporated into flat-panel and CRT displays.
Because the market for flat-panel displays is characterized by
numerous new product introductions, our operating results may
vary significantly from quarter to quarter. Our customers also
experience seasonality in the sales of their products, which
affects their orders of our
12
products. Typically, the second half of the calendar year
represents a disproportionate percentage of sales for our
customers due to the holiday shopping period for consumer
electronics products, and therefore, a disproportionate
percentage of our sales. Also, our sales in the first quarter of
the calendar year may be lower as a result of the Chinese New
Year holiday in Asia. We expect these sales fluctuations to
continue for the foreseeable future.
We
must sell our current products in greater volumes, or introduce
new products with improved margins.
Average selling prices for our products have declined in the
past, in many cases significantly, and we expect them to
continue to decline in the future. When average selling prices
decline, our revenues decline unless we are able to sell more
units, and our gross margin dollars decline unless we are able
to reduce our manufacturing
and/or other
supply chain costs by a commensurate amount. We, therefore, need
to sell our current products in greater volumes to offset the
decline in their ASPs, and introduce new products that have
improved gross margins.
Our
semiconductor products are complex and are difficult to
manufacture cost-effectively.
Manufacturing semiconductor products is a complex process. It is
often difficult for semiconductor foundries to achieve
acceptable product yields. Product yields depend on both our
product design and the manufacturing process technology unique
to the semiconductor foundry. Since low yields may result from
either design or process difficulties, identifying yield
problems may occur well into the production cycle, when a
product exists which can be physically analyzed and tested. Low
yields negatively impact our gross margins and our financial
results.
Product
quality problems could increase our costs, cause customer
claims, and delay our product shipments.
Although we test our products, they are complex and may contain
defects and errors. In the past, we have encountered defects and
errors in our products. Delivery of products with defects or
reliability, quality or compatibility problems may damage our
reputation and our ability to retain existing customers and
attract new customers. In addition, product defects and errors
could result in additional development costs, diversion of
technical resources, delayed product shipments, increased
product returns, and product liability claims against us which
may not be covered by insurance. Any of these could harm our
business.
We
rely on distribution partners to sell our products, and
disruptions to or our failure to effectively develop these
channels could adversely affect our ability to generate revenues
from the sale of our products.
We derive a substantial percentage of our total revenues from
sales by distributors of our products. During the fiscal year
ended March 31, 2007, revenues and sales through
distributors represented approximately 22% of our total revenue.
We expect that our revenues will continue to depend, in part, on
the performance of these distributors. We do not expect to have
any long-term contracts or minimum purchase commitments with any
of our distributors. In addition, our distributors may sell
products that are competitive with ours, may devote more
resources to those competitive products and may cease selling
our products altogether. The distributors through whom we sell
our products may not be successful in selling our products for
reasons beyond our control. If any of the foregoing occurs, our
operating results will suffer.
We
subcontract our manufacturing, assembly and test
operations.
We do not have our own fabrication facilities, assembly or
testing operations. Instead, we rely on others to fabricate,
assemble and test all of our products. We do not have any
long-term supply contracts with any of these suppliers. Most of
our products use silicon wafers manufactured by Taiwan
Semiconductor Manufacturing Corporation. If we were required to
obtain silicon wafers from other manufacturers, we could
experience a material increase in the price we must pay for
silicon wafers. There are many risks associated with our
dependence upon outside manufacturing, including:
|
|
|
|
|
Lack of adequate capacity during periods of excess demand;
|
13
|
|
|
|
|
Increased manufacturing cost or the unavailability of product in
the event that manufacturing capacity becomes constrained;
|
|
|
|
Reduced control over manufacturing and delivery schedules of
products;
|
|
|
|
Reduced control over quality assurance and reliability;
|
|
|
|
Difficulty of managing manufacturing costs and quantities;
|
|
|
|
Potential misappropriation of intellectual property; and
|
|
|
|
Political or environmental risks (including earthquake and other
natural disasters) in Taiwan, where the manufacturing facilities
are located.
|
We depend upon outside manufacturers to fabricate silicon wafers
on which our integrated circuits are imprinted. These wafers
must be of acceptable quality and in sufficient quantity and the
manufacturers must deliver them to assembly and testing
subcontractors on time for packaging into final products. We
have, at times, experienced delivery delays, long manufacturing
lead times and product quality issues. These manufacturers
fabricate, test and assemble products for other companies. We
cannot be sure that our manufacturers will devote adequate
resources to the production of our products or deliver
sufficient quantities of finished products to us on time or at
an acceptable cost. The lead-time necessary to establish
strategic relationships with new manufacturing partners is
considerable. We would be unable to readily obtain an
alternative source of supply for any of our products if this
proves necessary. Any occurrence of these manufacturing
difficulties could harm our business or cause us to incur costs
to obtain adequate and timely supply of products.
Our
products require licenses of third-party technology that may not
be available to us on reasonable terms, or at all.
We license technology from third parties that is incorporated
into our products. Future products or product enhancements may
require additional third-party licenses, which may not be
available to us on commercially reasonable terms, or at all.
Third-party licenses may impact our gross margins. We also
license third-party intellectual property in order to comply
with display technology standards. For example, we signed the
DVI Adopters Agreement and the HDMI Adopters Agreement in order
to obtain a license to those standards. However, even though we
licensed the DVI technology, Silicon Image, Inc., one of the
promoters of the DVI standard, sued us for allegedly infringing
certain DVI patents. In December 2006, we entered into a
royalty-bearing Settlement and License Agreement with Silicon
Image. If we are unable to obtain third-party licenses required
to develop new products and product enhancements, or to comply
with applicable standards, we could be at competitive
disadvantage.
Because
of the lengthy sales cycles for our products and the fixed
nature of a significant portion of our expenses, we may incur
substantial expenses before we earn associated revenue and may
not ultimately achieve our forecasted sales for our
products.
Because our products are based on new technology and standards,
a lengthy sales process, typically requiring several months or
more, is often required before potential customers begin the
technical evaluation of our products. This technical evaluation
can then exceed nine months and it may take an additional nine
months before a customer commences volume shipments of systems
that incorporate our products. However, even when a manufacturer
decides to design our products into its systems, the
manufacturer may never ship systems incorporating our products.
Given our lengthy sales cycle, we experience a delay between the
time we increase expenditures for research and development,
sales and marketing efforts and inventory and the time we
generate revenues, if any, from these expenditures. These long
cycles, as well as our expectation that customers will tend to
sporadically place large orders with short lead times, may cause
revenues and operating results to vary significantly and
unexpectedly from quarter to quarter. As a result, our business
could be harmed if a significant customer reduces or delays its
orders or chooses not to release products incorporating our
products. Given our customer concentration and our lengthy sales
cycle, the loss or decline in volume of one or several key
customers could have a material impact on our revenue for a
sustained period of time.
14
We are
subject to risks associated with international operations, which
may harm our business.
We depend on product design groups located outside of the United
States, primarily in Canada and India. We also rely on foreign
third-party manufacturing, assembly and testing operations.
These foreign operations subject us to a number of risks
associated with conducting business outside of the United
States, including the following:
|
|
|
|
|
Unexpected changes in, or impositions of, legislative or
regulatory requirements;
|
|
|
|
Delays resulting from difficulty in obtaining export licenses
for certain technology, tariffs, quotas and other trade barriers
and restrictions;
|
|
|
|
Imposition of additional taxes and penalties;
|
|
|
|
The burdens of complying with a variety of foreign laws; and
|
|
|
|
Other factors beyond our control, including acts of terrorism,
which may delay the shipment of our products, impair our ability
to travel or our ability to communicate with foreign locations.
|
In addition, the laws of certain foreign countries in which our
products are or may be designed, manufactured or sold may not
protect our products or intellectual property rights to the same
extent as the laws of the United States. This increases the
possibility of piracy of our technology and products.
Our
multi-jurisdictional tax structure is complex and we could be
subject to increased taxation.
We conduct business operations in a number of countries and are
subject to taxation in those jurisdictions. We develop our tax
position based upon the anticipated nature and structure of our
business and the tax laws, administrative practices and judicial
decisions now in effect in the countries in which we have assets
or conduct business, all of which are subject to change or
differing interpretations. We are also subject to audit by local
tax authorities which could result in additional tax expense in
future periods. Any increase in our income tax expense could
adversely impact on our future earnings and cash flows.
In addition, some of our subsidiaries provide products and
services to, and may undertake significant transactions with,
our other subsidiaries that are incorporated in different
jurisdictions. Some of these jurisdictions have tax laws with
detailed transfer pricing rules which require that all
transactions with non-resident related parties be priced using
arms-length pricing principles. International transfer
pricing is a complex area of taxation and generally involves a
significant degree of judgment. If international taxation
authorities successfully challenge our transfer pricing
policies, our income tax expense may be adversely affected.
Most
of our revenues will come from sales to customers outside of the
United States, which creates additional business
risks.
Most of our revenues come from sales to customers outside of the
United States, particularly to equipment manufacturers located
in South Korea, China, Europe, Japan and Taiwan. For the fiscal
year ended March 31, 2007, sales to regions outside of the
United States represented 99% of revenues. For that same period,
sales to China and South Korea alone constituted 39% and 25%,
respectively. These sales are subject to numerous risks,
including:
|
|
|
|
|
Fluctuations in currency exchange rates, tariffs, import
restrictions and other trade barriers;
|
|
|
|
Unexpected changes in regulatory requirements;
|
|
|
|
Political and economic instability;
|
|
|
|
Exposure to litigation or government investigations in these
countries;
|
|
|
|
Longer payment periods;
|
|
|
|
Ability to enforce contracts or payment terms;
|
|
|
|
Potentially adverse tax consequences;
|
15
|
|
|
|
|
Export license requirements; and
|
|
|
|
Unexpected changes in diplomatic and trade relationships.
|
Because our sales are denominated in U.S. dollars,
increases in the value of the U.S. dollar could increase
the price of our products in
non-U.S. markets
and may make our products more expensive than competitors
products denominated in local currencies.
The
cyclical nature of the semiconductor industry may lead to
significant variances in the demand for our
products.
In the past, significant downturns and wide fluctuations in
supply and demand have characterized the semiconductor industry.
Also, the industry has experienced significant fluctuations in
anticipation of changes in general economic conditions,
including economic conditions in Asia. These cycles have led to
significant variances in product demand and production capacity.
They have also accelerated the erosion of average selling prices
per unit. We may experience periodic fluctuations in our future
financial results because of changes in industry-wide conditions.
We
have in the past and may in the future engage in acquisitions of
companies, products or technologies, which involve numerous
risks and the anticipated benefits of any acquisitions we make
may never be realized.
Our growth is dependent upon our ability to enhance our existing
products and introduce new products on a timely basis. One of
the ways we may address the need to develop new products is
through acquisitions of other companies or technologies, such as
our prior acquisitions of Sage and the assets of VM Labs. These
acquisitions and potential future acquisitions involve numerous
risks, including the following:
|
|
|
|
|
We may experience difficulty in assimilating the acquired
operations and employees;
|
|
|
|
We may be unable to retain the key employees of the acquired
operations;
|
|
|
|
The acquisitions may disrupt our ongoing business;
|
|
|
|
We may not be able to incorporate successfully the acquired
technologies and operations into our business and maintain
uniform standards, controls, policies and procedures;
|
|
|
|
We may lack the experience to enter into new markets, products
or technologies; and
|
|
|
|
An acquisition we choose to pursue may require a significant
amount of capital, which limits our ability to pursue other
strategic opportunities.
|
Acquisitions of high-technology companies are inherently risky,
and recent or potential future acquisitions may not be
successful and may adversely affect our business, operating
results or financial condition. We must also maintain our
ability to manage growth effectively. Failure to manage growth
effectively and successfully integrate acquisitions made by us
could materially harm our business and operating results.
Intellectual
property infringement suits brought against us or our customers
may significantly harm our business.
We defended and settled claims brought against us by Silicon
Image, Inc., alleging that certain of our products that contain
digital receivers infringe various Silicon Image patent claims.
In addition, IP Innovation LLC has sued Toshiba Corporation and
other companies that incorporate our products into their
displays, alleging patent infringement by certain consumer and
professional electronics products, including some that contain
our display controller products. These lawsuits, or any future
patent infringement lawsuits, could subject us to permanent
injunctions preventing us from selling the accused products
and/or cause
us to incur significant costs, including defense costs,
settlements and judgments. In addition, as a result of this
lawsuit or any future patent infringement lawsuits, our existing
customers may decide to stop buying our products, and
prospective customers may be unwilling to buy our products.
16
Intellectual property lawsuits, regardless of their success, are
time-consuming and expensive to resolve and divert management
time and attention.
In addition, if we are unsuccessful and our products (or our
customers monitors or televisions that contain our
products) are found to infringe the intellectual property rights
of others, we could be forced to do one or more of the following:
|
|
|
|
|
Stop selling the products or using the technology that are
allegedly infringing;
|
|
|
|
Attempt to obtain a license to the relevant intellectual
property, which license may not be available on commercially
reasonable terms or at all;
|
|
|
|
Incur substantial costs including defense costs, settlements
and/or
judgments; and
|
|
|
|
Attempt to redesign those products that are allegedly infringing.
|
As a result, intellectual property litigation could have a
material adverse effect on our revenues, financial results and
market share.
We may
be required to indemnify our customers against claims of
intellectual property infringement.
From time to time, we enter into agreements with our customers
that contain indemnification provisions for claims based on
infringement of third party intellectual property rights. As a
result, if such a claim based on our products is made against an
indemnified customer, we may be required under our
indemnification obligations to defend or settle the litigation,
and/or to
reimburse that customer for its costs, including defense costs,
settlements and judgments. From time to time, we receive
requests for indemnification from customers with whom we do not
have indemnification agreements. We may also be subject to
claims for indemnification under statutory or common law. Patent
litigation and any indemnification obligations we may have could
have a material adverse effect on our revenues, financial
results and market share, and could result in significant
payments by us that could have a material adverse effect on our
financial position.
We may
be unable to adequately protect our intellectual property. We
rely on a combination of patent, copyright, trademark and trade
secret laws, as well as non-disclosure agreements and other
methods to protect our proprietary technologies.
We have been issued patents and have pending United States and
foreign patent applications. Our patents may be subject to
challenges, may not be broad enough to protect our technology,
or could be invalidated or circumvented. If we are not
successful in obtaining the patent protection we need, our
competitors may be able to replicate our technology and compete
more effectively against us. The legal protections described
above afford only limited protection. It is possible that we may
also have to resort to litigation to enforce and protect our
copyrights, trademarks, patents and trade secrets, which
litigation could be costly and a diversion of management
resources. In addition, it is possible that existing or future
patents, or even court rulings in our favor regarding our
patents, may be challenged, invalidated or circumvented. Despite
our efforts to protect our proprietary rights, unauthorized
parties may attempt to copy aspects of our products, or
otherwise attempt to obtain and use our intellectual property or
develop similar technology independently or design around our
patents. Monitoring unauthorized use of our products is
difficult, and the steps we have taken may not prevent
unauthorized use of our technology, particularly in foreign
countries where effective patent, copyright, trademark and trade
secret protection may be unavailable or may not protect our
proprietary rights as fully as in the United States.
We
need to continually evaluate internal financial controls against
evolving standards.
The Sarbanes-Oxley Act of 2002 and other rules and regulations
of the Securities and Exchange Commission and the National
Association of Securities Dealers impose duties on us and our
executives, directors, attorneys and independent registered
public accountants. In order to comply with the Sarbanes-Oxley
Act and other rules and regulations, we have evaluated our
internal controls systems that require management to report on,
and our independent auditors to attest to, our internal
controls. As a result, we have incurred additional expenses for
internal and outside legal, accounting and advisory services,
which have increased our operating expenses and accordingly
17
reduced our net income or increased our net losses. In addition,
our Chief Financial Officer resigned in May 2007 and we have
otherwise experienced significant turnover in our senior
management as more fully described under the risk factor
entitled We have had significant senior management and key
employee turnover, and may not be able to attract, retain and
motivate the personnel we need to succeed. If we are not
able to maintain internal controls over financial reporting in
light of the significant senior management and key employee
turnover, we may not be able to meet the requirements of
Section 404. While we have met the requirements of
Section 404 including the evaluation, documentation and
testing of internal controls for the year ended March 31,
2007, we cannot be certain as to the future outcome of our
testing and resulting remediation actions or the impact of the
same on our operations. We have an ongoing program to perform
the system and process evaluation and testing necessary to
comply with these requirements and we expect to continue to
incur significant expenses in connection with this process. In
the event that our Chief Executive Officer, Principal Accounting
Officer or independent registered public accounting firm
determine in the future that our internal controls over
financial reporting are not effective as defined under
Section 404, investor perceptions may be adversely affected
and could cause a decline in the market price of our stock. In
addition, current regulatory standards are subject to change,
and additional standards may be imposed.
We may
become subject to judgments for securities class action
suits.
We have been a defendant in a securities class action suit. In
March 2006, Genesis and the plaintiff signed an agreement to
settle the lawsuit, and in December 2006, the court issued a
final judgment approving the settlement and dismissing the case
with prejudice. However, we may be subject to future securities
class action suits, which could subject us to judgments in
excess of our insurance coverage and could harm our business. In
addition, this kind of lawsuit, regardless of its outcome, is
likely to be time-consuming and expensive to resolve and may
divert management time and resources.
A
breakdown in our information technology systems could cause a
business interruption, impair our ability to manage our business
or report results, or result in the unauthorized disclosure of
our confidential and proprietary information.
Our information technology systems could suffer a sudden
breakdown as a result of factors beyond our control, such as
earthquakes, insecure connections or problems with our outside
consultants who provide information technology services to us.
If our information technology systems were to fail and we were
not able to gain timely access to adequate alternative systems
or back-up
information, this could have a negative impact on our ability to
operate and manage our business and to report results in a
timely manner. Also, any breach of our information systems by an
unauthorized third party could result in our confidential
information being made public or being used by a competitor,
which could have a material adverse effect on our ability to
realize the potential of our proprietary rights.
General
economic conditions may reduce our revenues and harm our
business.
As our business has grown, we have become increasingly subject
to the risks arising from adverse changes in domestic and global
economic conditions. During times of economic slowdown, many
industries may delay or reduce technology purchases. As a
result, if economic conditions in the United States, Asia or
Europe worsen, or if a wider or global economic slowdown occurs,
reduced orders and shipments may cause us to fall short of our
revenue expectations for any given period and may result in us
carrying increased inventory. These conditions would negatively
affect our business and results of operations. If our inventory
builds up as a result of order postponement, we would carry
excess inventory that is either unusable or that must be sold at
reduced prices which will harm our revenues and gross margins.
In addition, weakness in the technology market could negatively
affect the cash flow of our customers who could, in turn, delay
paying their obligations to us. This would increase our credit
risk exposure, which could harm our financial condition.
18
|
|
ITEM 1B.
|
UNRESOLVED
STAFF COMMENTS
|
None.
We lease offices in Santa Clara and San Jose,
California; Thornhill, Ontario, Canada; Bangalore, India;
Taipei, Taiwan; Seoul, South Korea; Singapore; Shenzhen, China;
Tokyo, Japan and Izmir, Turkey. We believe our existing
facilities are adequate to meet our needs for the immediate
future and that future growth can be accomplished by leasing
additional or alternative space on commercially reasonable
terms. Further information on our lease commitments can be found
in Note 13 to our consolidated financial statements
included in Item 8 of this report.
|
|
ITEM 3.
|
LEGAL
PROCEEDINGS
|
We are not a party to any material legal proceedings.
|
|
ITEM 4.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
No matters were submitted to a vote of security holders during
the fourth quarter of fiscal 2007.
19
PART II
|
|
ITEM 5.
|
MARKET
FOR OUR COMMON STOCK AND RELATED STOCKHOLDER
MATTERS
|
MARKET
INFORMATION
Our common stock trades on the Nasdaq Global Market under the
symbol GNSS. We have not listed our stock on any
other markets or exchanges. The following table shows the high
and low closing prices for our common stock as reported by the
Nasdaq Global Market:
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal 2006
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
19.25
|
|
|
$
|
13.32
|
|
Second Quarter
|
|
$
|
27.16
|
|
|
$
|
18.15
|
|
Third Quarter
|
|
$
|
23.13
|
|
|
$
|
17.07
|
|
Fourth Quarter
|
|
$
|
22.40
|
|
|
$
|
17.04
|
|
Fiscal 2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
17.37
|
|
|
$
|
11.10
|
|
Second Quarter
|
|
$
|
14.78
|
|
|
$
|
9.89
|
|
Third Quarter
|
|
$
|
12.15
|
|
|
$
|
9.69
|
|
Fourth Quarter
|
|
$
|
10.11
|
|
|
$
|
7.67
|
|
As of June 1, 2007, we had approximately 164 common
stockholders of record. Many of our shares of common stock are
held by brokers and other institutions on behalf of our
stockholders. Based on our proxy mailing from 2006, we estimate
the total number of stockholders represented by these record
holders to be at approximately 12,800.
DIVIDEND
POLICY
We have never declared or paid dividends on our common stock. We
intend to retain our earnings for use in our business and
therefore we do not anticipate declaring or paying any cash
dividends in the foreseeable future.
20
STOCK
PERFORMANCE GRAPH
The following performance graph compares the percentage change
in the cumulative total stockholder return on shares of our
common stock with the cumulative total return for:
|
|
|
|
|
a group of our peer corporations, comprising the Nasdaq
Electronic Components Stocks; and
|
|
|
|
the Total Return Index for The Nasdaq Stock Market (US and
Foreign).
|
This comparison covers the period from March 31, 2002 to
March 31, 2007, the last trading date in our 2007 fiscal
year. It assumes $100 was invested on March 31, 2002 in
shares of our common stock, our peer corporations and The Nasdaq
Stock Market, and assumes reinvestment of dividends, if any.
The Nasdaq Electronic Components Stocks consists of all
corporations traded on The Nasdaq Stock Market with 367 as their
primary standard industrial classification number. The Total
Return Index for The Nasdaq Stock Market (US and Foreign)
comprises all ADRs, domestic shares, and foreign common shares
traded on The Nasdaq Global Market and The Nasdaq Small Cap
Market, excluding preferred shares, rights and warrants.
Comparative
chart
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Nasdaq
|
Date
|
|
|
Genesis
|
|
|
Peer Group
|
|
|
Return
|
March 31, 2002
|
|
|
|
100.00
|
|
|
|
|
100.00
|
|
|
|
|
100.00
|
|
March 31, 2003
|
|
|
|
48.00
|
|
|
|
|
57.68
|
|
|
|
|
73.00
|
|
March 31, 2004
|
|
|
|
64.42
|
|
|
|
|
100.59
|
|
|
|
|
108.68
|
|
March 31, 2005
|
|
|
|
55.58
|
|
|
|
|
80.46
|
|
|
|
|
109.67
|
|
March 31, 2006
|
|
|
|
65.54
|
|
|
|
|
91.41
|
|
|
|
|
129.54
|
|
March 31, 2007
|
|
|
|
35.73
|
|
|
|
|
89.54
|
|
|
|
|
134.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information used on this graph was obtained from Nasdaq.
Although we believe the information to be accurate, we are not
responsible for any errors or omissions. This chart is not
soliciting material. It is not deemed filed with the
Securities and Exchange Commission and it is not to be
incorporated by reference in any of our filings under the
Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended.
SALES OF
UNREGISTERED SECURITIES
None.
21
|
|
ITEM 6.
|
SELECTED
CONSOLIDATED FINANCIAL DATA
|
Selected consolidated financial data for the last five fiscal
years appears below (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
STATEMENTS OF OPERATIONS DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
214,617
|
|
|
$
|
269,506
|
|
|
$
|
204,115
|
|
|
$
|
213,420
|
|
|
$
|
194,325
|
|
Cost of revenues(2)
|
|
|
126,281
|
|
|
|
153,039
|
|
|
|
125,394
|
|
|
|
134,735
|
|
|
|
127,110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
88,336
|
|
|
|
116,467
|
|
|
|
78,721
|
|
|
|
78,685
|
|
|
|
67,215
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development(2)
|
|
|
64,497
|
|
|
|
48,700
|
|
|
|
41,534
|
|
|
|
38,552
|
|
|
|
39,895
|
|
Selling, general and
administrative(2)
|
|
|
65,223
|
|
|
|
48,698
|
|
|
|
45,619
|
|
|
|
47,126
|
|
|
|
47,042
|
|
Impairment of goodwill and
intangible assets(1)
|
|
|
101,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
230,721
|
|
|
|
97,398
|
|
|
|
87,153
|
|
|
|
85,678
|
|
|
|
86,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
(142,385
|
)
|
|
|
19,069
|
|
|
|
(8,432
|
)
|
|
|
(6,993
|
)
|
|
|
(19,722
|
)
|
Interest and other income, net
|
|
|
12,259
|
|
|
|
5,403
|
|
|
|
1,939
|
|
|
|
1,725
|
|
|
|
946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(130,126
|
)
|
|
|
24,472
|
|
|
|
(6,493
|
)
|
|
|
(5,268
|
)
|
|
|
(18,776
|
)
|
Provision for (recovery of) income
taxes
|
|
|
14,215
|
|
|
|
6,082
|
|
|
|
2,954
|
|
|
|
(1,063
|
)
|
|
|
(4,140
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(144,341
|
)
|
|
$
|
18,390
|
|
|
$
|
(9,447
|
)
|
|
$
|
(4,205
|
)
|
|
$
|
(14,636
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(3.95
|
)
|
|
$
|
0.53
|
|
|
$
|
(0.29
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.47
|
)
|
Diluted
|
|
$
|
(3.95
|
)
|
|
$
|
0.50
|
|
|
$
|
(0.29
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.47
|
)
|
Weighted average number of common
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
36,514
|
|
|
|
34,909
|
|
|
|
33,084
|
|
|
|
31,876
|
|
|
|
31,248
|
|
Diluted
|
|
|
36,514
|
|
|
|
36,877
|
|
|
|
33,084
|
|
|
|
31,876
|
|
|
|
31,248
|
|
|
|
|
(1) |
|
See Notes 5 & 6 to our consolidated financial
statements included in Item 8 of this report. |
|
(2) |
|
Effective April 1, 2006 we adopted statement of Financial
Accounting Standards No. 123 (Revised 2004), Share-Based
Payment. See Note 9 to our consolidated financial
statements in Item 8 of this report. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
BALANCE SHEETS DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and
short-term investments
|
|
$
|
188,250
|
|
|
$
|
185,379
|
|
|
$
|
129,757
|
|
|
$
|
118,222
|
|
|
$
|
113,138
|
|
Working capital
|
|
|
202,108
|
|
|
|
204,518
|
|
|
|
156,411
|
|
|
|
147,651
|
|
|
|
130,831
|
|
Total assets
|
|
|
351,714
|
|
|
|
479,677
|
|
|
|
416,292
|
|
|
|
410,726
|
|
|
|
402,654
|
|
Stockholders equity
|
|
|
323,369
|
|
|
|
439,423
|
|
|
|
389,496
|
|
|
|
386,855
|
|
|
|
373,833
|
|
22
|
|
ITEM 7.
|
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The following discussion contains forward-looking statements
within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, including statements regarding
anticipated revenues, gross margins, operating expenses,
amortization of intangibles and stock-based compensation,
liquidity and cash flow, business strategy, demand for our
products, average selling prices, regional market growth, amount
of sales to distributors and future competition. Words such as
anticipates, expects,
intends, plans, believes,
seeks, estimates and similar expressions
identify such forward-looking statements. These forward-looking
statements are subject to risks and uncertainties that could
cause actual results to differ materially from those indicated
in the forward-looking statements. Factors which could cause
actual results to differ materially include those set forth in
the following discussion, and, in particular, the risks
discussed below under the subheading Risk Factors
and in other documents we file with the Securities and Exchange
Commission. Unless required by law, we undertake no obligation
to update publicly any forward-looking statements.
We begin Managements Discussion and Analysis of Financial
Condition and Results of Operations (MD&A) with a general
discussion of our target markets, the nature of our products,
and some of the business issues we are facing as a company.
Next, we address the Critical Accounting Policies and Estimates
that we believe are important to understanding the assumptions
and judgments incorporated in our reported financial results. We
then discuss our Results of Operations for the year ended
March 31, 2007, or fiscal 2007, compared to fiscal 2006 and
2005, and corresponding quarterly information for fiscal 2007
and 2006 as viewed through the eyes of Management. Lastly, we
provide an analysis of changes in our balance sheet and cash
flows, and discuss our financial commitments. This MD&A
should be read in conjunction with the other sections of this
Annual Report on
Form 10-K.
Dollars are in thousands unless otherwise noted.
OVERVIEW
We develop and market image-processing and image enhancing
solutions. We design, develop and market integrated circuits
that receive and process digital video and graphic images. We
also supply reference boards and designs that incorporate our
software and proprietary integrated circuits, or chips. Our
products are primarily used in large-area liquid crystal
displays (LCDs). These displays may be used in
desktop monitor applications or other types of display devices,
including LCD TVs, Plasma TVs, Rear Projection TVs, Digital CRT
TVs, DVD players and AVRs (Audio/Video Receivers).
We generate the majority of our revenue by selling our
image-processing solutions to the manufacturers of LCD monitors,
flat panel displays and television sets. We outsource the
manufacturing of our products to large semiconductor
manufacturers, thereby eliminating the need for
capital-intensive plant and equipment. Our most significant cash
operating expense is labor, with our workforce employed in
research and development of new products and technologies and in
marketing, sales, customer support, and distribution of our
products.
Our primary target end-markets are LCD computer monitors and
flat panel televisions. We also design products that serve both
applications, so-called multi-function monitors, and it is
difficult to distinguish between a monitor with television
capability and a television with a PC input. Both of these
display devices could use the same Genesis chip. Similarly, we
supply certain customers with chips originally designed for an
LCD computer monitor that the customer may use in flat panel
televisions. We assist customers in developing their designs.
Typically, a TV design will take substantially more time and
support from our software application and field application
engineers than a monitor design, increasing our costs during a
customers pre-production period.
The growth in our target markets is limited by the
industrys capacity to supply LCD panels or other digital
displays. Furthermore, the availability of LCD panels from time
to time has been constrained, causing unexpected increases in
the cost of LCD panels to our customers, thus resulting in
customers rapidly changing their demand expectations for our
products. Our products usually represent less than two percent
of the average retail cost of a standard flat panel TV today,
while the cost of the LCD panel within a LCD computer monitor or
flat panel TV represents the majority of the cost of the
finished product. The increase in production volumes of larger
size LCD panels in new fabrication facilities coming on line
over the next few years is expected to result in lower-cost
panels
23
and hence lower average selling prices of the end product. We
believe retail prices for televisions will continue to decline
and we expect this trend to lead to an increase in demand for
display controllers.
The LCD computer monitor and flat panel TV industries are very
competitive and growth industries like ours tend to attract new
entrants. The average selling prices of monitor display
controllers, in spite of increased functionality, have declined
by more than 40% over the past two fiscal years. Our strategy is
to lead the market by integrating new features and functions and
by providing the highest image quality at a cost-effective
price. Our goal is to deliver the desired feature-rich image
quality through relationships with customers, patented
technologies, effective chip design, software capabilities, and
customer support. We also strive to generate profitability by
reducing product cost through efficient chip design and driving
costs down throughout our supply chain.
Sales to distributors comprised approximately 22% of revenue for
the year ended March 31, 2007. We are also using
distributor relationships to enable us to increase our market
penetration of smaller customers with minimal incremental direct
customer support.
Average selling prices and product margins of our products are
typically highest during the initial periods following product
introduction and decline over time and as volume increases.
Part of our overall strategy is to develop intellectual property
that is used in our integrated circuits. We have and will
continue to defend our intellectual property rights against
those companies that may use our technology without the proper
authorization. At times we may enter into agreements that allow
customers or other companies to license our patented technology.
Revenue
Recognition
Genesis recognizes revenue primarily from semiconductor product
sales to customers when a contract is established, the price is
determined, shipment is made and collectibility is reasonably
assured. Genesis has also periodically entered into license
agreements and recognizes royalty revenue. Product sales to
distributors may be subject to agreements having a right of
return on termination of the distributor relationship. Revenue,
and related cost of revenues from sales to distributors, is
deferred until the distributors resell the product, verified by
point-of-sale
reports. At the time of shipment to distributors, we record a
trade receivable for the selling price, relieve inventory of the
value of the product shipped and record the gross margin as
deferred revenue, a component of accrued liabilities on our
consolidated balance sheet. In certain circumstances, where
orders are placed with non-cancelable/non-return terms, we
recognize revenue upon shipment. Reserves for sales returns and
allowances are recorded at the time of recognizing revenue. To
date, we have not experienced significant product returns.
Manufacturing
and Supply
We generally need to place purchase orders for products before
we receive purchase orders from our customers. This is because
production lead times for silicon wafers and substrates, from
which our products are manufactured, can be as long as three to
four months, while many of our customers place orders only one
month or less in advance of their requested delivery date. We
have agreements with suppliers in Asia such that we are
dependent on the suppliers manufacturing yields. We
continue to review and, where feasible, establish alternative
sources of supply to reduce our reliance on individual key
suppliers and reduce lead times, though dual sourcing for
specific products sometimes is more costly due to initial
set-up costs
and lower initial yields as each new manufacturing supplier
ramps up production. While we have frequent communication with
significant customers to review their requirements, we are
restricted in our ability to react to fluctuations in demand for
our products, which exposes us to the risk of having either too
much or not enough of a particular product. We regularly
evaluate the carrying value of inventory held. For the year
ended March 31, 2007, we recorded reserves totaling $2,293
for inventory for which we did not foresee sufficient demand to
support the carrying value or where the market price was less
than our actual cost.
Global
Operations
We operate through subsidiaries and offices in several countries
throughout the world. Our head office is located in
Santa Clara (Silicon Valley), California. Our research and
development resources are located in the
24
United States, Canada and India. The majority of our customers
are located in Asia, supported by our sales offices in China,
Germany, Japan, Singapore, South Korea, Taiwan and Turkey. Our
third party suppliers are located primarily in Taiwan. Although
all of our revenues and virtually all of our costs of revenues
are denominated in U.S. dollars, portions of our operating
expenses are denominated in foreign currencies. Accordingly, our
operating results are affected by changes in the exchange rate
between the U.S. dollar and those currencies. Any future
strengthening of those currencies against the U.S. dollar
could negatively impact our operating results by increasing our
operating expenses as measured in U.S. dollars.
We do not currently engage in any hedging or other transactions
intended to manage the risks relating to foreign currency
exchange rate fluctuations, other than natural hedges that occur
as a result of holding both assets and liabilities denominated
in foreign currencies. Our operating expenses are also affected
by changes in the rate of inflation in the various countries in
which we operate.
Critical
Accounting Policies and Estimates
The preparation of financial statements in conformity with
generally accepted accounting principles requires us to make
estimates and assumptions that affect the reported amounts of
assets and liabilities, the disclosure of contingent assets and
liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting
periods. As described below, significant estimates are used in
determining the allowance for doubtful accounts, inventory
obsolescence provision, deferred tax asset valuation, potential
settlements and costs associated with patent litigation, royalty
obligations to third parties and the useful lives of intangible
assets. We evaluate our estimates on an on-going basis,
including those related to product returns, bad debts,
inventories, investments, intangible assets, income taxes,
warranty and royalty obligations, litigation and other
contingencies. We base our estimates on historical experience
and on various other assumptions that are believed to be
reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates under
different assumptions or conditions.
We believe the following critical accounting policies affect our
more significant judgments and estimates used in the preparation
of our financial statements:
|
|
|
|
|
We record estimated reductions to revenue for customer returns
based on historical experience. A customer has a right to return
products only if the product is faulty or upon termination of a
distributor agreement, although in certain circumstances we
agree to accept returns if replacement orders are placed for
other products or to maintain our business relationship. If
actual customer returns increase, we may be required to
recognize additional reductions to revenue.
|
|
|
|
We record the estimated future cost of replacing faulty product
as an increase to cost of revenues. To date we have not
experienced significant returns related to quality. If returns
increase as a result of changes in product quality, we may be
required to recognize additional warranty expense.
|
|
|
|
We maintain allowances for estimated losses resulting from the
inability of our customers to make required payments and other
disputes. If the financial condition of our customers were to
deteriorate, resulting in an impairment of their ability to make
payments, additional allowances may be required. We have not
suffered any significant loss in this area.
|
|
|
|
We provide for inventory obsolescence reserves against our
inventory for estimated obsolete or unmarketable inventory equal
to the difference between the cost of inventory and the
estimated market value based upon assumptions about future
demand and market conditions. If actual market conditions are
less favorable than those we project, additional inventory
valuation reserves may be required.
|
|
|
|
Commencing April 1, 2006, we account for stock-based
compensation in accordance with Statement of Financial
Accounting Standards (SFAS) No. 123R, Share-Based
Payment. Under the provisions of SFAS No. 123R,
stock based compensation is estimated at the grant date based on
the awards fair-value as calculated by the Black-Scholes
option-pricing model and is recognized as expense ratably over
the requisite service period. The Black-Scholes model requires
various judgmental assumptions including volatility, and
expected option life. In addition, share-based compensation
expense is adjusted to reflect
|
25
|
|
|
|
|
estimated forfeiture rates. If any of the assumptions change
significantly, stock-based compensation expense may differ
materially in the future from that recorded in the current
period.
|
|
|
|
|
|
We provide for costs associated with settling litigation when we
believe that we have a reasonable basis for estimating those
costs. If actual costs associated with settling litigation
differ from our estimates, we may be required to recognize
additional costs.
|
|
|
|
Goodwill, which represents the excess of cost over the fair
value of net assets acquired in business combinations, is tested
annually for impairment or more frequently whenever events or
changes in circumstances indicate that the carrying amount may
not be recoverable. The impairment tests are performed in
accordance with FASB Statement of Financial Accounting Standards
No. 142, Goodwill and Other Intangible Assets.
Accordingly, an impairment loss is recognized to the extent that
the carrying amount of goodwill exceeds its implied fair value.
This determination is made at the reporting unit level. We have
assigned all goodwill to a single, enterprise-level reporting
unit. The impairment test consists of two steps. First, we
determine the fair value of the reporting unit. The fair value
is then compared to its carrying amount. Second, if the carrying
amount of the reporting unit exceeds its fair value, an
impairment loss is recognized for any excess of the carrying
amount of the reporting units goodwill over the implied
fair value of that goodwill. The implied fair value of goodwill
would be determined by allocating the fair value of the
reporting unit in a manner similar to a purchase price
allocation in accordance with FASB Statement of Financial
Accounting Standards No. 141, Business
Combinations. The residual fair value after this
allocation is the implied fair value of the reporting unit
goodwill. We perform our annual impairment test on
January 1st of each year.
|
As a result of an impairment review that was performed in
December 2006, the Company recorded a goodwill impairment charge
of $97,576 in fiscal 2007. We did not record any goodwill
impairment charges in fiscal 2006 or 2005. Goodwill balances may
also be affected by changes in other estimates, for example,
related to the ability to utilize acquired tax benefits, made at
the time of acquisitions.
|
|
|
|
|
We record a valuation allowance to reduce our deferred tax
assets to the amount that we believe is more likely than not to
be realized. The Company has, and expects to continue to provide
a valuation allowance on future tax benefits in certain
jurisdictions until it can demonstrate a sustained level of
profitability that establishes its ability to utilize the assets
in the jurisdictions that the assets relate.
|
|
|
|
From time to time, we incur costs related to potential merger
activities. When we assess that we will be the acquirer for
accounting purposes in such transactions and we expect to
complete the transaction, direct costs associated with the
acquisition are deferred and form part of the final purchase
price. In the event these assessments change, any such deferred
costs would be expensed. Costs associated with other merger
activities are expensed as incurred.
|
Recent
Accounting Pronouncements
Please refer to Note 2 of the consolidated financial
statements in Item 8 of this report.
26
RESULTS
OF OPERATIONS
Revenue
and Gross Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Total revenue
|
|
$
|
214,617
|
|
|
$
|
269,506
|
|
|
$
|
204,115
|
|
Gross profit
|
|
|
88,336
|
|
|
|
116,467
|
|
|
|
78,721
|
|
Gross profit percentage
|
|
|
41.2
|
%
|
|
|
43.2
|
%
|
|
|
38.6
|
%
|
Revenue by geography:
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
1,180
|
|
|
$
|
3,493
|
|
|
$
|
8,803
|
|
China
|
|
|
83,707
|
|
|
|
115,016
|
|
|
|
78,167
|
|
Japan
|
|
|
24,005
|
|
|
|
27,356
|
|
|
|
15,289
|
|
South Korea
|
|
|
53,256
|
|
|
|
51,487
|
|
|
|
52,871
|
|
Taiwan
|
|
|
20,307
|
|
|
|
28,704
|
|
|
|
28,824
|
|
Europe
|
|
|
24,705
|
|
|
|
31,131
|
|
|
|
13,334
|
|
Rest of world
|
|
|
7,457
|
|
|
|
12,319
|
|
|
|
6,827
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
$
|
214,617
|
|
|
$
|
269,506
|
|
|
$
|
204,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Total revenue for the year ended March 31, 2007 decreased
by 20% to $214,617 from $269,506 for the year ended
March 31, 2006, which in turn represented an increase of
5.1% from $204,115 for the year ended March 31, 2005. The
revenue decline in fiscal 2007 is attributable to a decrease in
unit shipments of 10% to 56.1 million units from
62.6 million units in fiscal 2006, as well as the declining
average selling prices (ASPs) of 11%.
Our products are designed for multiple applications. Therefore,
we must estimate whether the chips we have sold are used in LCD
monitors or flat-panel televisions. Estimated revenue from
monitor controllers and licensing decreased to $85,904 for the
year ended March 31, 2007 compared to $117,277 for the
fiscal year 2006, due to lower unit shipments and ASP declines
of 17%. Our estimate of unit shipments into digital televisions
and other related video devices decreased by 7% year over year,
and estimated revenue from this market decreased 15% to
$128,713. During the year ended March 31, 2007, we estimate
that approximately 60% of total revenue was from TV and video
products, compared with 57% for the year ended March 31,
2006.
During fiscal 2007, we lost significant designs with some of our
largest customers. These losses are expected to negatively
impact our revenue until we are able to regain designs with
those customers or other customers. We continue to ship the
majority of our product to customers located in Asia, and we
expect most of our revenue to come from this region in the
future, especially China.
Gross
Profit
Gross profit for the year ended March 31, 2007 was $88,336,
representing a decrease of approximately 24% compared with the
year ended March 31, 2006 gross profit of $116,467, which
in turn represented an increase of 48% from $78,721 for the year
ended March 31, 2005. Gross profit represented 41.2% of
revenue for the fiscal year 2007, compared with 43.2% for the
fiscal year 2006 and 38.6% for fiscal year 2005. The decrease in
gross profit percentage is mainly due to increased pricing
pressures on our products, an increase in inventory reserves for
fiscal 2007 and the impact of the fixed component of cost of
sales at lower levels of revenue, partially offset by royalty
revenue received in the current year and no amortization of
acquired developed product technology in fiscal 2007. We expect
continued pressure on our gross margins , due to ongoing pricing
pressures and changes in the revenue mix to lower margin
products.
27
OPERATING
EXPENSES
Research
and Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Research and development
|
|
$
|
64,497
|
|
|
$
|
48,700
|
|
|
$
|
41,534
|
|
Research and development as a
percentage of revenue
|
|
|
30.0
|
%
|
|
|
18.1
|
%
|
|
|
20.3
|
%
|
Research and development expenses include costs associated with
research and development personnel, application engineers,
development tools, hardware and software licenses, prototyping
and the amortization of acquired intangibles.
Research and development expenses for the year ended
March 31, 2007 were $64,497, compared with $48,700 in
fiscal 2006 and $41,534 in fiscal 2005. These annual increases
are a reflection of the continued investment in the research and
development of technologies addressing the television and video
markets, especially the digital TV market and other related
technologies, such as DisplayPort, a new digital interconnect
standard,
MCTitm
by Faroudja, our motion compensation technology, and our
universal demodulator technology for our DTV products. In
addition, the mix of spending has changed, as we devote
increasing resources to improving performance and integration of
the more complex multimedia and video applications, especially
digital TV technologies, while the focus within the monitor
applications has moved more towards technologies supporting
multi-function monitors. Genesiss move towards lower
geometry processes, including 0.13 micron and lower, for its
highly integrated SOC digital TV chips has also increased
research and development spending.
The increase in research and development expenses is also due to
an increase in stock-based compensation charges primarily due to
the adoption of FAS 123R in fiscal 2007, higher
labor-related costs due to increased headcount and increased IP
consulting costs, partially offset by a decrease in the
amortization of acquired intangibles. Research and development
expenses include stock-based compensation charges of $8,454 in
fiscal 2007, $421 in fiscal 2006 and $1,941 in fiscal 2005.
Selling,
General and Administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Selling, general and
administrative expenses
|
|
$
|
65,223
|
|
|
$
|
48,698
|
|
|
$
|
45,619
|
|
Selling, general and
administrative expenses as a percentage of revenue
|
|
|
30.4
|
%
|
|
|
18.1
|
%
|
|
|
22.3
|
%
|
Selling, general and administrative expenses consist of
personnel and related overhead costs for selling, including
field application engineers, product marketing, marketing
communications, customer support, finance, human resources,
legal costs (including settlement fees), IT, public company
costs related, but not limited to, our compliance with the
Sarbanes Oxley Act of 2002, general management functions and
commissions paid to sales representatives.
Selling, general and administrative expenses for the year ended
March 31, 2007 were $65,223, compared with $48,698 in
fiscal 2006 and $45,619 in fiscal 2005. The increase of 34% in
fiscal 2007 from fiscal 2006 is mainly due to an increase in
stock-based compensation of $9,213 primarily due to the adoption
of FAS 123R in fiscal 2007 and a legal settlement of $4,500
that was recorded in the third quarter of fiscal 2007. Selling,
general and administrative expenses include stock-based
compensation charges of $9,790 in fiscal 2007, $577 in fiscal
2006 and $2,553 in fiscal 2005.
28
Impairment
of goodwill and intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Impairment of goodwill and
intangibles
|
|
$
|
101,001
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We are required to evaluate goodwill annually or whenever events
or changes in circumstances indicate that the carrying amount
may not be recoverable. Due to a sustained reduction in our
market capitalization plus the decline in current and projected
revenue from certain customers, we determined a triggering event
occurred in the third quarter of fiscal 2007 requiring
management to assess the recoverability of goodwill. Impairment
is tested at the reporting unit level by comparing the reporting
units carrying amount to its fair value. Where the
carrying amount of the reporting unit exceeds its fair value, an
impairment loss is recognized for the amount by which the
carrying amount of the reporting units goodwill exceeds
the implied fair value of that goodwill.
We have determined that the Company has one reporting unit for
purposes of goodwill impairment review under SFAS 142. Upon
performing the impairment test, it was found that the carrying
value of goodwill exceeded its implied fair value of $84,405 and
therefore an impairment charge of $97,576 was recorded in the
third quarter of fiscal 2007. We engaged an independent
valuation professional to assist with our measurement of fair
value as part of the goodwill and intangible asset impairment
tests. The fair value of the reporting unit was estimated using
a combination of the market approach and a discounted cash flows
approach.
Due to a decline in projected revenue for products which
incorporate technology acquired from VM Labs in fiscal 2002, we
determined a triggering event occurred in the third quarter of
fiscal 2007 which required us to reassess the underlying value
of the acquired technology. Management assessed the
recoverability of this asset by comparing its carrying amount
with its estimated fair value using a discounted cash flow
approach. An impairment was identified for which we recorded a
non-cash impairment charge of $3,425 prior to performing the
goodwill impairment analysis.
NON
OPERATING INCOME AND EXPENSES
Interest
and Other Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Interest income
|
|
$
|
9,042
|
|
|
$
|
5,403
|
|
|
$
|
1,939
|
|
Gain on sale of investment
|
|
|
3,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
12,259
|
|
|
$
|
5,403
|
|
|
$
|
1,939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income includes interest earned on cash, cash
equivalents and short-term investments.
Interest income earned in fiscal 2007 increased by $3,639 to
$9,042 compared to $5,403 in fiscal 2006 due to the combined
effects of higher average cash, cash equivalents and short-term
investments and higher average interest rates during fiscal 2007
as compared to fiscal 2006. Interest income earned in fiscal
2006 increased by $3,464 from $1,939 to $5,403 also due to the
combined effects of higher average cash, cash equivalents and
short-term investments and higher average interest rates during
fiscal 2006 as compared to fiscal 2005.
Other income includes a gain of $3,217 on the disposal of our
entire investment in the shares of Techwell, Inc. in conjunction
with their initial public offering.
29
Provision
for Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Current income tax expense
|
|
$
|
3,316
|
|
|
$
|
3,177
|
|
|
$
|
6,386
|
|
Deferred income tax expense
(recovery)
|
|
|
10,899
|
|
|
|
2,905
|
|
|
|
(3,432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
14,215
|
|
|
$
|
6,082
|
|
|
$
|
2,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We recorded income tax expense of $14,215 for the year ended
March 31, 2007, compared with expense of $6,082 for the
year ended March 31, 2006 and an expense of $2,954 for the
year ended March 31, 2005.
Our accounting effective tax rate typically differs from the
expected statutory rates due to several permanent differences
including, but not limited to, research and experimental
development tax credits, stock-based compensation expense for
which no tax benefits can be recognized, foreign exchange
fluctuations on the U.S. dollar working capital balances of
foreign subsidiaries, and differences in tax rates in foreign
jurisdictions. Any net tax benefit of these items is partially
offset by changes in the valuation allowance against net
operating loss carry forwards. In assessing the realization of
deferred tax assets, management considers whether it is more
likely than not that some portion or all of our deferred tax
assets will not be realized. The ultimate realization of
deferred tax assets is dependent upon the generation of future
taxable income during the periods in which those temporary
differences become deductible in the appropriate jurisdiction.
Management considers projected future taxable income,
uncertainties related to the industry in which Genesis operates
and tax planning strategies in making this assessment.
Historically, we have recorded the majority of our valuation
allowance against the tax attributes in the United States. FASB
Statement No. 109, Accounting for Income Taxes, states that
forming a conclusion that a valuation allowance is not needed is
difficult when there is negative evidence, such as losses in the
jurisdictions to which the deferred tax asset relate. As a
result of the review of goodwill and intangible assets
undertaken in the third quarter of fiscal 2007, we concluded
that it was appropriate to establish a full valuation allowance
in the financial statements against the tax attributes in Canada
and recorded a valuation allowance in the third and fourth
quarter of fiscal 2007. In addition, we expect to provide a full
valuation allowance on future tax benefits in both the United
States and Canada until we can demonstrate a sustained level of
profitability that establishes our ability to utilize the assets
in the jurisdictions to which the assets relate.
The increase in tax expense for fiscal 2006 compared to fiscal
2005, resulted primarily from much higher profitability. Income
tax expense in fiscal 2005 also included a charge of
approximately $3,700 as a result of a repatriation of
approximately $73,000 of funds by our Canadian subsidiary which
was treated as a dividend for U.S. tax purposes. Certain
provisions of the American Jobs Creation Act of 2004 (AJCA),
which was signed into law on October 22, 2004, allow for
only 15% of this dividend to be taxable, but this may not be
sheltered by net operating losses. This charge in fiscal 2005
also increased our effective tax rate for the year. We do not
expect to repatriate any more earnings from international
affiliates in the foreseeable future as we consider the
investments to be permanent in nature. The Company has not
recognized a deferred tax liability of approximately $19,600 for
the unremitted earnings of its foreign affiliates.
As of March 31, 2007, we had generated deductible temporary
differences and operating loss and tax credit carry forwards. We
have approximately $155 million and $38 million of
operating loss carry forwards in the United States and Canada,
respectively, to offset future taxable income. A portion of the
carry forwards expire on various dates through 2027, if not
used. Utilization of a portion of net operating losses is
subject to an annual limitation due to the ownership change
provisions of the Internal Revenue Code of 1986 and similar
state provisions.
We have established a valuation allowance for deferred tax
assets related to certain loss carry forwards. At March 31,
2007, the valuation allowance totaled $103,248 and we have $252
of net deferred tax assets on our balance sheet. Based upon the
level of historical taxable income and projections for future
taxable income over the periods which the deferred tax assets
are deductible, management believes it is more likely than not
the Company will realize the benefits of these deductible
differences, net of the existing valuation allowance. We may
record additional valuation allowances in the future. The
benefit of $90 million of operating loss carryforwards,
which
30
relate to acquired entities or deductions associated with the
exercise of certain stock options, if utilized, will result in
an increase to equity
and/or a
reduction of goodwill.
Future income tax provision amounts will depend on our effective
tax rates, the distribution of taxable income between taxation
jurisdictions, foreign exchange rate fluctuations, the amount of
research and development performed in Canada, other variables,
and the likelihood of being able to utilize available tax
credits or losses.
QUARTERLY
RESULTS OF OPERATIONS
The following table shows our unaudited quarterly statement of
operations data for the most recent eight quarters reported.
This unaudited data has been prepared on the same basis as our
audited consolidated financial statements that are included in
Item 8 of this report, and includes all adjustments,
consisting only of normal recurring adjustments, necessary for a
fair presentation of such information for the periods presented.
The statement of operations data should be read in conjunction
with our consolidated financial statements and their related
Notes. Amounts in this table are in thousands, except per share
data.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Mar.
|
|
|
Dec.
|
|
|
Sep.
|
|
|
Jun.
|
|
|
Mar.
|
|
|
Dec.
|
|
|
Sep.
|
|
|
Jun.
|
|
|
|
2007
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2005
|
|
|
|
(Unaudited)
|
|
|
Revenues
|
|
$
|
38,592
|
|
|
$
|
51,117
|
|
|
$
|
69,009
|
|
|
$
|
55,899
|
|
|
$
|
60,862
|
|
|
$
|
73,965
|
|
|
$
|
74,854
|
|
|
$
|
59,825
|
|
Cost of revenues(2)
|
|
|
24,555
|
|
|
|
30,261
|
|
|
|
38,225
|
|
|
|
33,240
|
|
|
|
35,684
|
|
|
|
39,762
|
|
|
|
41,974
|
|
|
|
35,619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
14,037
|
|
|
|
20,856
|
|
|
|
30,784
|
|
|
|
22,659
|
|
|
|
25,178
|
|
|
|
34,203
|
|
|
|
32,880
|
|
|
|
24,206
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development(2)
|
|
|
16,558
|
|
|
|
15,621
|
|
|
|
17,401
|
|
|
|
14,917
|
|
|
|
13,655
|
|
|
|
12,541
|
|
|
|
11,542
|
|
|
|
10,962
|
|
Selling, general and
administrative(2)
|
|
|
15,301
|
|
|
|
19,786
|
|
|
|
15,314
|
|
|
|
14,822
|
|
|
|
13,658
|
|
|
|
12,195
|
|
|
|
12,092
|
|
|
|
10,753
|
|
Impairment of goodwill and
intangibles(1)
|
|
|
|
|
|
|
101,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
31,859
|
|
|
|
136,408
|
|
|
|
32,715
|
|
|
|
29,739
|
|
|
|
27,313
|
|
|
|
24,736
|
|
|
|
23,634
|
|
|
|
21,715
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
(17,822
|
)
|
|
|
(115,552
|
)
|
|
|
(1,931
|
)
|
|
|
(7,080
|
)
|
|
|
(2,135
|
)
|
|
|
9,467
|
|
|
|
9,246
|
|
|
|
2,491
|
|
Interest and other income, net
|
|
|
2,342
|
|
|
|
2,324
|
|
|
|
2,212
|
|
|
|
5,381
|
|
|
|
1,907
|
|
|
|
1,519
|
|
|
|
1,067
|
|
|
|
910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(15,480
|
)
|
|
|
(113,228
|
)
|
|
|
281
|
|
|
|
(1,699
|
)
|
|
|
(228
|
)
|
|
|
10,986
|
|
|
|
10,313
|
|
|
|
3,401
|
|
Provision for (recovery of) income
taxes
|
|
|
(28
|
)
|
|
|
17,209
|
|
|
|
173
|
|
|
|
(3,139
|
)
|
|
|
89
|
|
|
|
3,621
|
|
|
|
1,032
|
|
|
|
1,340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(15,452
|
)
|
|
$
|
(130,437
|
)
|
|
$
|
108
|
|
|
$
|
1,440
|
|
|
$
|
(317
|
)
|
|
$
|
7,365
|
|
|
$
|
9,281
|
|
|
$
|
2,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.42
|
)
|
|
$
|
(3.57
|
)
|
|
$
|
0.00
|
|
|
$
|
0.04
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.21
|
|
|
$
|
0.27
|
|
|
$
|
0.06
|
|
Diluted
|
|
$
|
(0.42
|
)
|
|
$
|
(3.57
|
)
|
|
$
|
0.00
|
|
|
$
|
0.04
|
|
|
$
|
(0.01
|
)
|
|
$
|
0.20
|
|
|
$
|
0.25
|
|
|
$
|
0.06
|
|
Weighted average number of shares
of common stock outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
37,030
|
|
|
|
36,585
|
|
|
|
36,437
|
|
|
|
36,001
|
|
|
|
35,760
|
|
|
|
35,413
|
|
|
|
34,826
|
|
|
|
33,624
|
|
Diluted
|
|
|
37,030
|
|
|
|
36,585
|
|
|
|
36,840
|
|
|
|
36,518
|
|
|
|
35,760
|
|
|
|
37,295
|
|
|
|
37,534
|
|
|
|
35,060
|
|
|
|
|
(1) |
|
See Notes 5 & 6 to our consolidated financial
statements included in Item 8 of this report. |
|
(2) |
|
Effective April 1, 2006 we adopted statement of Financial
Accounting Standards No. 123 (Revised 2004), Share-based
Payment. See Note 9 to our consolidated financial
statements in Item 8 of this report. |
31
Most of our revenues come from sales of semiconductors to
manufacturers of flat-panel displays, including televisions and
LCD monitors. Revenue fluctuates from quarter to quarter
depending on a number of factors, including, but not limited to
the relative growth in our target markets, changes in our market
share, changes in our customers market share, the rate of
decline in ASPs, the price of LCD panels, which often impacts
demand for our products, and inventory levels of display
controllers and finished goods at our customers locations.
The revenue decrease in the later part of fiscal year 2007 is
primarily due to the change in our market share and our
customers market share and the decline in ASPs. Gross margins
have varied from quarter to quarter depending on changes in
product mix, levels of inventory reserves required, level of
product yields in the manufacturing process, prices charged by
our manufacturing vendors, and the difference in rates of
decline of ASPs compared to average product costs.
Research and development expenses have varied from quarter to
quarter primarily due to changes in staff levels, the purchase
of technology and licenses needed for digital TV development,
and the timing of non-recurring engineering charges related to
new product development. Selling, general and administrative
expenses have varied from quarter to quarter primarily due to
changes in staff levels for sales and customer support
activities, costs associated with compliance of the
Sarbanes-Oxley Act of 2002, sales and marketing promotional
events, and sales commissions.
Income tax expense (recovery) has varied from quarter to
quarter, depending primarily on the levels of taxable income,
the distribution of taxable income between jurisdictions,
foreign exchange fluctuations, and the likelihood of being able
to utilize available tax credits or losses.
Our results of operations have fluctuated significantly in the
past and may continue to fluctuate in the future as a result of
a number of factors, many of which are beyond our control. These
factors include those described under the caption Risk
Factors, among others. Any one or more of these factors
could result in our failure to achieve our expectations as to
future operating results. Our expenditures for research and
development, selling, general and administrative functions are
based in part on future revenue projections. We may be unable to
adjust spending in a timely manner in response to any
unanticipated declines in revenues as a large portion of our
expenses are relatively fixed as they are dependent on the
number of employees, which may have a material adverse effect on
our business, financial condition and results of operations. We
may be required to reduce our selling prices in response to
competitive pressure or other factors, or to increase spending
to pursue new market opportunities or to defend ourselves
against lawsuits that may be brought against us. Any decline in
average selling prices of a particular product that is not
offset by a reduction in product costs or by sales of other
products with higher gross margins, would decrease our overall
gross profit and adversely affect our business, financial
condition and results of operations.
LIQUIDITY
AND CAPITAL RESOURCES
Since inception we have satisfied our liquidity needs primarily
through cash generated from operations and sales of equity
securities, initially by way of a public offering, and
subsequently under our stock option and employee stock purchase
plans. We believe that our existing cash balances together with
any cash generated from our operations will be sufficient to
meet our capital and operating requirements for the foreseeable
future.
Periodically, we may be required to use a portion of our cash
balances to increase investment in operating assets such as
prepaid assets or inventory to assist in the growth of our
business, or for property and equipment. Furthermore, because we
do not have our own semiconductor manufacturing facility, we may
be required to make deposits to secure supply in the event there
is a shortage of manufacturing capacity in the future. While we
currently have no plans to raise additional funds for such uses,
we could be required or could elect to seek to raise additional
capital in the future.
32
From time to time we evaluate acquisitions and investments in
businesses, products or technologies that are complimentary or
strategic to our business. Any such transactions, if
consummated, may use a portion of our working capital or require
the issuance of equity securities that may result in further
dilution to our existing stockholders.
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(Dollars in thousands)
|
|
|
Cash and cash equivalents
|
|
$
|
123,701
|
|
|
$
|
154,630
|
|
Short-term investments
|
|
|
64,549
|
|
|
|
30,749
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and
short-term Investments
|
|
|
188,250
|
|
|
|
185,379
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
$
|
202,108
|
|
|
$
|
204,518
|
|
Current ratio
|
|
|
8.13
|
|
|
|
6.08
|
|
Days Sales Outstanding
|
|
|
46
|
|
|
|
54
|
|
Inventory days
|
|
|
61
|
|
|
|
45
|
|
At March 31, 2007, cash and short-term investments totaled
$188,250 compared with $185,379 at March 31, 2006. Our
current ratio was 8.13 at March 31, 2007 compared to 6.08
at March 31, 2006. Net cash generated from operating
activities was $2,244 in fiscal year 2007 compared with $49,055
in fiscal 2006.
Working capital generation of cash related primarily to the
decrease in accounts receivable and the increase in income taxes
payable, partially offset by a decrease in accounts payable and
accrued liabilities. Accounts receivable decreased by $16,729
from March 31, 2006 to March 31, 2007 primarily due to
a decrease in revenue in fiscal 2007. Days sales outstanding
(DSO) decreased at March 31, 2007 to
46 days, compared to 54 days at March 31, 2006.
Our credit policy is to offer credit to customers only after
examination of their creditworthiness. Our payment terms range
from cash in advance of shipment, to payment ninety days after
shipment. For fiscal 2007, our three largest customers accounted
for 36% of revenue, compared with 35% in fiscal 2006 and 34% in
fiscal 2005. Additionally, these top three customers accounted
for 49% of accounts receivable at March 31, 2007 and 34% at
March 31, 2006. Inventory levels decreased by 4% from
March 31, 2006 to $16,424 from $17,175. Average days of
inventory on hand at March 31, 2007 increased to 61days
compared to 45 days at March 31, 2006. The average
inventory levels and inventory turns is impacted by a number of
dynamic activities including the accuracy of customer forecasts,
expected panel supplies, and pricing considerations. These
activities are not necessarily an indication of what inventory
turns might be in the future.
Net cash used in investing activities was $41,878 during the
year ended March 31, 2007, net cash of $54,659 was used
during the year ended March 31, 2006. Net cash generated
from investing activities was $90,068 during the year ended
March 31, 2005. The decrease in cash used, year over year,
was primarily due to an increase in net proceeds received on the
maturity of short-term investments and the sale of an investment
during the fiscal year 2007.
Net cash provided by financing activities was $8,705 in the year
ended March 31, 2007, $30,477 in the year ended
March 31, 2006, and $7,594 in the year ended March 31,
2005. These represent funds received for the purchase of shares
under the terms of our stock option and employee stock purchase
plans.
Contractual
Obligations
As of March 31, 2007, our principal commitments consisted
of obligations outstanding under operating leases. These
commitments include a lease for our new corporate headquarters
in Santa Clara, California, which was signed in September
2006. This new lease commenced on January 1, 2007, expires
in January 2012, and is non-cancelable. The aggregate minimum
annual payments required under our lease obligations, excluding
sub-lease income, by fiscal year are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due By Fiscal Year
|
|
|
|
Total
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
Operating Leases
|
|
$
|
14,879
|
|
|
$
|
4,958
|
|
|
$
|
4,464
|
|
|
$
|
2,529
|
|
|
$
|
1,863
|
|
|
$
|
1,065
|
|
Our lease agreements expire at various dates through calendar
2012.
33
Further information on lease obligations and commitments can be
found in Note 13 to our consolidated financial statements.
Off-Balance
Sheet Arrangements
We do not have any off-balance sheet arrangements that have or
are reasonably likely to have a material current or future
effect on our financial condition, revenue or expenses, results
of operations, liquidity, capital expenditures or capital
resources.
Capital
commitments
We do not have any capital commitments that will have a material
future effect on our financial condition.
|
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
We are exposed to financial market risks including changes in
interest rates and foreign currency exchange rates.
The fair value of our investment portfolio or related income
would not be significantly impacted by either a 10% increase or
decrease in interest rates due mainly to the short-term nature
of the major portion of our investment portfolio.
We carry out a significant portion of our operations outside of
the United States, primarily in Canada and in India and to a
lesser extent China, Japan, South Korea, Singapore and Taiwan.
Although virtually all of our revenues and costs of revenues are
denominated in U.S. dollars, portions of our operating
revenue and expenses are denominated in foreign currencies.
Accordingly, our operating results are affected by changes in
the exchange rate between the U.S. dollar and those
currencies. Any future strengthening of those currencies against
the U.S. dollar could negatively impact our operating
results by increasing our operating expenses as measured in
U.S. dollars. The maximum potential exposure on a near-term
10% depreciation in the U.S. dollar is estimated to be
approximately $4 million annually. We do not currently
engage in any hedging or other transactions intended to manage
the risks relating to foreign currency exchange rate
fluctuations, other than natural hedges that occur as a result
of holding both assets and liabilities denominated in foreign
currencies. We may, in the future, undertake hedging or other
such transactions, if we determine it is necessary to offset
exchange rate risks. Based on our overall currency rate exposure
at March 31, 2007 and March 31, 2006, a near-term 10%
appreciation or depreciation in the U.S. dollar relative to
a pool of our foreign currencies would not have a material
effect on our operating expenses or financial condition.
|
|
ITEM 8.
|
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA
|
Managements
Annual Report on Internal Control Over Financial
Reporting
Management of Genesis Microchip is responsible for establishing
and maintaining adequate internal control over financial
reporting as defined in
Rules 13a-15(f)
and
15d-15(f)
under the Securities Exchange Act of 1934. Genesis
Microchips internal control over financial reporting is
designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. Internal control over
financial reporting includes those policies and procedures that:
|
|
|
|
|
pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company;
|
|
|
|
provide reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and
that receipts and expenditures
|
34
|
|
|
|
|
of the company are being made only in accordance with
authorizations of management and directors of the
company; and
|
|
|
|
|
|
provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition of the
companys assets that could have a material effect on the
financial statements.
|
Management assessed the effectiveness of Genesis
Microchips internal control over financial reporting as of
March 31, 2007. In making this assessment, management used
the criteria set forth in Internal Control- Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO). Based on its assessment of internal
controls over financial reporting, management has concluded
that, as of March 31, 2007, Genesis Microchips
internal control over financial reporting was effective to
provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted
accounting principles. Genesis Microchips independent
registered public accounting firm, KPMG LLP, have issued an
audit report on our assessment of Genesis Microchips
internal control of financial reporting. This report appears on
page F-3.
35
FINANCIAL
STATEMENTS TABLE OF CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
Number
|
|
|
|
|
F-2
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
|
|
|
F-8
|
|
F-1
Report of
Independent Registered Public Accounting Firm
The Board of Directors and Stockholders
Genesis Microchip Inc.
We have audited the accompanying consolidated balance sheets of
Genesis Microchip Inc. as of March 31, 2007 and 2006, and
the related consolidated statements of operations,
stockholders equity, and cash flows for each of the years
in the three-year period ended March 31, 2007. These
consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of Genesis Microchip Inc. as of March 31, 2007 and
2006, and the results of its operations and its cash flows for
each of the years in the three-year period ended March 31,
2007, in conformity with U.S. generally accepted accounting
principles.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of Genesis Microchip Inc.s internal control
over financial reporting as of March 31, 2007, based on
criteria established in Internal Control Integrated
Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission (COSO), and our report dated
June 7, 2007 expressed an unqualified opinion on
managements assessment of, and the effective operation of,
internal control over financial reporting.
/s/ KPMG
Chartered Accountants, Licensed Public Accountants
Toronto, Canada
June 7, 2007
F-2
Report of
Independent Registered Public Accounting Firm
The Board of Directors and Stockholders
Genesis Microchip Inc.
We have audited managements assessment, included in the
accompanying Managements Report on Internal Control over
Financial Reporting, that Genesis Microchip Inc. maintained
effective internal control over financial reporting as of
March 31, 2007, based on criteria established in Internal
Control Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO).
Genesis Microchip Inc.s management is responsible for
maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control
over financial reporting. Our responsibility is to express an
opinion on managements assessment and an opinion on the
effectiveness of the Companys internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, managements assessment that Genesis
Microchip Inc. maintained effective internal control over
financial reporting as of March 31, 2007, is fairly stated,
in all material respects, based on criteria established in
Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission
(COSO). Also, in our opinion, Genesis Microchip Inc. maintained,
in all material respects, effective internal control over
financial reporting as of March 31, 2007, based on criteria
established in Internal Control Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO).
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Genesis Microchip Inc. as of
March 31, 2007 and 2006, and the related consolidated
statements of operations, stockholders equity and cash
flows for each of the years in the three-year period ended
March 31, 2007, and our report dated June 7, 2007
expressed an unqualified opinion on those consolidated financial
statements.
/s/ KPMG
Chartered Accountants, Licensed Public Accountants
Toronto, Canada
June 7, 2007
F-3
Genesis
Microchip Inc.
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands, except
|
|
|
|
per share amounts)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
123,701
|
|
|
$
|
154,630
|
|
Short-term investments
|
|
|
64,549
|
|
|
|
30,749
|
|
Accounts receivable trade, net of
allowance for doubtful accounts of nil in 2007 and $401 in 2006
|
|
|
19,455
|
|
|
|
36,184
|
|
Inventories (Note 3)
|
|
|
16,424
|
|
|
|
17,175
|
|
Prepaids and other
|
|
|
6,324
|
|
|
|
6,034
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
230,453
|
|
|
|
244,772
|
|
Property and equipment, net
(Note 4)
|
|
|
16,238
|
|
|
|
16,459
|
|
Intangible assets, net
(Note 5)
|
|
|
5,006
|
|
|
|
9,055
|
|
Goodwill (Note 6)
|
|
|
84,405
|
|
|
|
181,981
|
|
Deferred income taxes
(Note 10)
|
|
|
252
|
|
|
|
11,151
|
|
Other long-term assets
(Note 7)
|
|
|
15,360
|
|
|
|
16,259
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
351,714
|
|
|
$
|
479,677
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
6,759
|
|
|
$
|
14,911
|
|
Accrued liabilities
|
|
|
14,888
|
|
|
|
21,778
|
|
Income taxes payable
|
|
|
6,698
|
|
|
|
3,565
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
28,345
|
|
|
|
40,254
|
|
Stockholders equity
(Notes 8 and 9):
|
|
|
|
|
|
|
|
|
Capital stock:
|
|
|
|
|
|
|
|
|
Preferred stock:
|
|
|
|
|
|
|
|
|
Authorized 5,000
preferred shares, $0.001 par value issued and
outstanding none at March 31, 2007 and at
March 31, 2006
|
|
|
|
|
|
|
|
|
Common stock:
|
|
|
|
|
|
|
|
|
Authorized 100,000
common shares, $0.001 par value issued and
outstanding 37,097 shares at March 31,
2007 and 35,899 shares at March 31, 2006
|
|
|
37
|
|
|
|
36
|
|
Additional paid-in capital
|
|
|
465,744
|
|
|
|
441,197
|
|
Cumulative other comprehensive loss
|
|
|
(94
|
)
|
|
|
(94
|
)
|
Treasury shares
|
|
|
(833
|
)
|
|
|
|
|
Deferred stock-based compensation
|
|
|
|
|
|
|
(4,572
|
)
|
Retained Earnings (deficit)
|
|
|
(141,485
|
)
|
|
|
2,856
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
323,369
|
|
|
|
439,423
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
351,714
|
|
|
$
|
479,677
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
(Note 13)
|
|
|
|
|
|
|
|
|
See accompanying Notes to consolidated financial statements.
F-4
Genesis
Microchip Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands, except per share amounts)
|
|
Revenues
|
|
$
|
214,617
|
|
|
$
|
269,506
|
|
|
$
|
204,115
|
|
Cost of revenues(1)(2)
|
|
|
126,281
|
|
|
|
153,039
|
|
|
|
125,394
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
88,336
|
|
|
|
116,467
|
|
|
|
78,721
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development(3)(5)
|
|
|
64,497
|
|
|
|
48,700
|
|
|
|
41,534
|
|
Selling, general and
administrative(4)
|
|
|
65,223
|
|
|
|
48,698
|
|
|
|
45,619
|
|
Impairment of goodwill and
intangible assets (Notes 5 and 6)
|
|
|
101,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
230,721
|
|
|
|
97,398
|
|
|
|
87,153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
(142,385
|
)
|
|
|
19,069
|
|
|
|
(8,432
|
)
|
Interest and other income, net:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
9,042
|
|
|
|
5,403
|
|
|
|
1,939
|
|
Gain on sale of investment
|
|
|
3,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income, net
|
|
|
12,259
|
|
|
|
5,403
|
|
|
|
1,939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(130,126
|
)
|
|
|
24,472
|
|
|
|
(6,493
|
)
|
Provision for income taxes
(Note 10)
|
|
|
14,215
|
|
|
|
6,082
|
|
|
|
2,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(144,341
|
)
|
|
$
|
18,390
|
|
|
$
|
(9,447
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share
(Note 12):
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(3.95
|
)
|
|
$
|
0.53
|
|
|
$
|
(0.29
|
)
|
Diluted
|
|
$
|
(3.95
|
)
|
|
$
|
0.50
|
|
|
$
|
(0.29
|
)
|
Weighted average number of common
shares outstanding (Note 12):
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
36,514
|
|
|
|
34,909
|
|
|
|
33,084
|
|
Diluted
|
|
|
36,514
|
|
|
|
36,877
|
|
|
|
33,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Amount includes
amortization of acquired developed product technology
|
|
$
|
|
|
|
$
|
6,835
|
|
|
$
|
7,700
|
|
(2) Amount includes stock-based
compensation
|
|
$
|
1,338
|
|
|
$
|
63
|
|
|
$
|
|
|
(3) Amount includes stock-based
compensation
|
|
$
|
8,454
|
|
|
$
|
421
|
|
|
$
|
1,941
|
|
(4) Amount includes stock-based
compensation
|
|
$
|
9,790
|
|
|
$
|
577
|
|
|
$
|
2,553
|
|
(5) Amount includes
amortization of acquired developed product technology
|
|
$
|
1,552
|
|
|
$
|
2,809
|
|
|
$
|
2,916
|
|
See accompanying Notes to consolidated financial statements.
F-5
Genesis
Microchip Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Other
|
|
|
Deferred
|
|
|
Retained
|
|
|
Total
|
|
|
|
Common Shares
|
|
|
Paid-In
|
|
|
Treasury
|
|
|
Comprehensive
|
|
|
Stock-Based
|
|
|
Earnings/
|
|
|
Stockholders
|
|
|
|
Number
|
|
|
Amount
|
|
|
Capital
|
|
|
Shares
|
|
|
Loss
|
|
|
Compensation
|
|
|
(Deficit)
|
|
|
Equity
|
|
|
|
(In thousands)
|
|
|
Balances, March 31, 2004
|
|
|
32,653
|
|
|
|
32
|
|
|
|
395,837
|
|
|
|
|
|
|
|
(94
|
)
|
|
|
(2,833
|
)
|
|
|
(6,087
|
)
|
|
|
386,855
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9,447
|
)
|
|
|
(9,447
|
)
|
Issued under stock option and
stock purchase plans
|
|
|
826
|
|
|
|
1
|
|
|
|
7,593
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,594
|
|
Stock-based compensation related
to acceleration of vesting in terminations
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
(2,000
|
)
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,494
|
|
|
|
|
|
|
|
4,494
|
|
Reversal of stock-based
compensation related to terminations
|
|
|
|
|
|
|
|
|
|
|
(107
|
)
|
|
|
|
|
|
|
|
|
|
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2005
|
|
|
33,479
|
|
|
|
33
|
|
|
|
405,323
|
|
|
|
|
|
|
|
(94
|
)
|
|
|
(232
|
)
|
|
|
(15,534
|
)
|
|
|
389,496
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,390
|
|
|
|
18,390
|
|
Issued under stock option and
stock purchase plans
|
|
|
2,420
|
|
|
|
3
|
|
|
|
30,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,476
|
|
Stock-based compensation related
to acceleration of vesting in terminations
|
|
|
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
|
|
Unamortized portion of restricted
stock units
|
|
|
|
|
|
|
|
|
|
|
5,342
|
|
|
|
|
|
|
|
|
|
|
|
(5,342
|
)
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,061
|
|
|
|
|
|
|
|
1,061
|
|
Unrealized portion of stock-based
compensation related to terminations
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2006
|
|
|
35,899
|
|
|
|
36
|
|
|
|
441,197
|
|
|
|
|
|
|
|
(94
|
)
|
|
|
(4,572
|
)
|
|
|
2,856
|
|
|
|
439,423
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(144,341
|
)
|
|
|
(144,341
|
)
|
Issued under stock option and
stock purchase plans
|
|
|
1,198
|
|
|
|
1
|
|
|
|
9,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,538
|
|
Treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(833
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(833
|
)
|
Reversal of unamortized portion of
restricted stock units
|
|
|
|
|
|
|
|
|
|
|
(4,572
|
)
|
|
|
|
|
|
|
|
|
|
|
4,572
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
19,582
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,582
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2007
|
|
|
37,097
|
|
|
$
|
37
|
|
|
$
|
465,744
|
|
|
$
|
(833
|
)
|
|
$
|
(94
|
)
|
|
$
|
|
|
|
$
|
(141,485
|
)
|
|
$
|
323,369
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to consolidated financial statements.
F-6
Genesis
Microchip Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (loss)
|
|
$
|
(144,341
|
)
|
|
$
|
18,390
|
|
|
$
|
(9,447
|
)
|
Adjustments to reconcile net loss
to cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
11,313
|
|
|
|
8,742
|
|
|
|
6,729
|
|
Amortization of intangible assets
|
|
|
2,477
|
|
|
|
9,946
|
|
|
|
10,857
|
|
Impairment of intangible assets
|
|
|
3,425
|
|
|
|
|
|
|
|
|
|
Goodwill impairment
|
|
|
97,576
|
|
|
|
|
|
|
|
|
|
Non-cash stock-based compensation
|
|
|
19,582
|
|
|
|
1,061
|
|
|
|
4,494
|
|
Deferred income taxes
|
|
|
10,899
|
|
|
|
2,905
|
|
|
|
(2,773
|
)
|
Gain on sale of investment
|
|
|
(3,217
|
)
|
|
|
|
|
|
|
|
|
Other
|
|
|
360
|
|
|
|
496
|
|
|
|
224
|
|
Change in operating assets and
liabilities, net of amounts acquired:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable trade
|
|
|
16,729
|
|
|
|
(5,874
|
)
|
|
|
(1,985
|
)
|
Inventories
|
|
|
751
|
|
|
|
382
|
|
|
|
1,216
|
|
Prepaids and other
|
|
|
(290
|
)
|
|
|
(451
|
)
|
|
|
614
|
|
Accounts payable
|
|
|
(8,152
|
)
|
|
|
2,867
|
|
|
|
2,196
|
|
Accrued liabilities
|
|
|
(8,001
|
)
|
|
|
10,144
|
|
|
|
131
|
|
Income taxes payable
|
|
|
3,133
|
|
|
|
447
|
|
|
|
598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
2,244
|
|
|
|
49,055
|
|
|
|
12,854
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of short-term investments
|
|
|
(109,493
|
)
|
|
|
(102,482
|
)
|
|
|
(174,683
|
)
|
Proceeds on sales and maturities
of short-term investments
|
|
|
75,693
|
|
|
|
71,733
|
|
|
|
273,664
|
|
Additions to property and equipment
|
|
|
(7,452
|
)
|
|
|
(8,597
|
)
|
|
|
(4,712
|
)
|
Proceeds on sale of investment
|
|
|
3,919
|
|
|
|
|
|
|
|
|
|
Investments
|
|
|
|
|
|
|
(10,190
|
)
|
|
|
|
|
Additions to mask sets
|
|
|
(2,753
|
)
|
|
|
(3,673
|
)
|
|
|
(2,082
|
)
|
Additions to intangible assets
|
|
|
(1,853
|
)
|
|
|
(1,736
|
)
|
|
|
(1,391
|
)
|
Other
|
|
|
61
|
|
|
|
286
|
|
|
|
(728
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
investing activities
|
|
|
(41,878
|
)
|
|
|
(54,659
|
)
|
|
|
90,068
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issue of common stock
|
|
|
8,705
|
|
|
|
30,477
|
|
|
|
7,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing
activities
|
|
|
8,705
|
|
|
|
30,477
|
|
|
|
7,594
|
|
Increase (decrease) in cash and
cash equivalents
|
|
|
(30,929
|
)
|
|
|
24,873
|
|
|
|
110,516
|
|
Cash and cash equivalents,
beginning of year
|
|
|
154,630
|
|
|
|
129,757
|
|
|
|
19,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
year
|
|
$
|
123,701
|
|
|
$
|
154,630
|
|
|
$
|
129,757
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash received for interest
|
|
$
|
8,879
|
|
|
$
|
5,365
|
|
|
$
|
1,994
|
|
Cash paid for income taxes
|
|
$
|
121
|
|
|
$
|
3,218
|
|
|
$
|
5,687
|
|
Supplemental disclosure of
non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
$
|
|
|
|
$
|
(3
|
)
|
|
$
|
(107
|
)
|
Additional paid-in capital
|
|
$
|
|
|
|
$
|
62
|
|
|
$
|
2,000
|
|
See accompanying Notes to consolidated financial statements.
F-7
Genesis
Microchip Inc.
(dollars in thousands, except per share amounts)
Genesis Microchip Inc. (Genesis or the
Company) designs, develops and markets integrated
circuits that manipulate and process digital video and graphic
images.
|
|
2.
|
SIGNIFICANT
ACCOUNTING POLICIES
|
Basis
of consolidation
These consolidated financial statements include the accounts of
Genesis and its subsidiaries. All material inter-company
transactions and balances have been eliminated.
Critical
accounting policies and estimates
The preparation of consolidated financial statements in
conformity with accounting principles generally accepted in the
United States (GAAP) requires management to make
estimates and assumptions that affect the amounts reported in
the consolidated financial statements and accompanying notes. On
an on-going basis, the Company evaluates its estimates,
including those related to product returns, bad debts,
inventories, investments, intangible assets, goodwill, income
taxes, warranty and royalty obligations, litigation and other
contingencies. Genesis bases its estimates on historical
experience and on various other assumptions that are believed to
be reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates under
different assumptions or conditions
Genesis believes the following critical accounting policies
affect its more significant judgments and estimates used in the
preparation of its consolidated financial statements. The
Company records estimated reductions to revenue for customer
returns based on historical experience. If actual customer
returns increase, the Company may be required to recognize
additional reductions to revenue. Genesis records the estimated
future cost of replacing faulty product as a warranty expense in
cost of sales. If warranty returns increase as a result of
changes in product quality, Genesis may be required to recognize
additional warranty expense. The Company maintains allowances
for doubtful accounts for estimated losses resulting from the
inability of its customers to make required payments and other
disputes. If the financial condition of Genesis customers
were to deteriorate, resulting in an impairment of their ability
to make payments, additional allowances may be required. The
Company provides for valuation reserves against its inventory
for estimated obsolescence or unmarketable inventory equal to
the difference between the cost of inventory and the estimated
market value based upon assumptions about future demand and
market conditions. If actual market conditions change from those
projected by management, an adjustment of inventory valuation
reserves may be required. Genesis provides for costs associated
with patent litigation and other litigation when management
believes there is a reasonable basis for estimating those costs.
If actual costs associated with litigation differ from
estimates, additional provision may be required. Genesis
performs impairment tests on the carrying value of intangible
assets and goodwill. These tests are based on numerous
assumptions as to potential future results of the business that
are considered to be reasonable at the time those assumptions
are made. If any of these assumptions later prove to be
incorrect or if management changes its assessment as to their
reasonability because of changing business conditions, an
impairment charge may be required. Genesis records a valuation
allowance to reduce its deferred tax assets to the amount that
is more likely than not to be realized. Should Genesis determine
that it would not be able to realize all or part of its net
deferred tax asset in the future, an adjustment to the deferred
tax asset would be recorded to income tax expense in the period
such determination was made.
F-8
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Cash
and cash equivalents
All highly liquid investments with an original maturity of three
months or less at the date of acquisition are classified as cash
equivalents. Cash and cash equivalents of $123,701 and $154,630
as of March 31, 2007 and 2006, respectively, consist
primarily of government securities, corporate bonds and
commercial paper.
Short-term
investments
All of our short-term investments are categorized as
available-for-sale at the balance sheet date, and have been
presented at fair value, which approximates amortized cost. If
material, any temporary difference between the cost and fair
value of an investment would be presented as a separate
component of stockholders equity. Short-term investments
at March 31, 2007 consist entirely of government and
corporate notes and bonds.
Accounts
receivable
Accounts receivable are recorded based on the selling price of
the item sold and are recorded at the time of shipment. An
allowance for doubtful accounts is determined based on a review
of our customers past due balances. The following table
presents a roll forward of the allowance for doubtful accounts
for the indicated periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Balance as of beginning of year
|
|
$
|
401
|
|
|
$
|
282
|
|
|
$
|
422
|
|
Provision (recovery)
|
|
|
(401
|
)
|
|
|
259
|
|
|
|
(75
|
)
|
Write offs
|
|
|
|
|
|
|
(140
|
)
|
|
|
(65
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of end of year
|
|
$
|
|
|
|
$
|
401
|
|
|
$
|
282
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Genesis records a recovery of a provision when amounts have
subsequently been collected.
Inventories
Inventories consist of finished goods and
work-in-process
and are stated at the lower of standard cost (approximates
actual cost on
first-in,
first-out basis) or market value, being net realizable value. A
reserve against inventories for obsolescence or unmarketable
inventories is estimated based upon assumptions about future
demand and market conditions.
The following table presents a roll forward of the inventories
obsolescence reserve for the indicated periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Balance as of beginning of year
|
|
$
|
3,665
|
|
|
$
|
2,954
|
|
|
$
|
3,243
|
|
Increase to provision
|
|
|
2,293
|
|
|
|
1,080
|
|
|
|
883
|
|
Write offs
|
|
|
(2,029
|
)
|
|
|
(369
|
)
|
|
|
(1,172
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of end of year
|
|
$
|
3,929
|
|
|
$
|
3,665
|
|
|
$
|
2,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-9
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Property
and equipment
Property and equipment are stated at cost or fair value at the
date of acquisition. Amortization is recorded using the
following methods and annual rates over the estimated useful
lives of the assets:
|
|
|
Property and equipment
|
|
10% to 30% declining balance
|
Software
|
|
1 to 5 years straight-line
|
Leasehold improvements
|
|
Straight line over the term of the
lease
|
Genesis regularly reviews the carrying values of its property
and equipment by comparing the carrying amount of the asset to
the expected future cash flows to be generated by the asset. If
the carrying value exceeds the estimated amount recoverable, a
write-down equal to the excess of the carrying value over the
assets fair value is charged to the consolidated
statements of operations.
Intangible
assets
Intangible assets are comprised of acquired technology, patents,
trademarks and trade names. Patents are amortized on a
declining-balance basis at a rate of 10% while all other
intangible assets are amortized on a straight-line basis over
four to seven years. The Company continually evaluates the
remaining estimated useful life of intangible assets that are
being amortized to determine whether events or circumstances
warrant a revision to the remaining period of amortization.
As a result of an impairment review that was performed in
December 2006, the Company recorded an impairment of intangible
assets of $3,425 in the quarter ended December 31, 2006
(Note 5).
Goodwill
Goodwill represents the excess purchase price over the fair
value of acquired net assets and is tested for impairment during
the fourth quarter of each fiscal year or more frequently if
events and circumstances indicate that the asset might be
impaired. Impairment is tested at the reporting unit level by
comparing the reporting units carrying amount to its fair
value. If the carrying amount of the reporting unit exceeds its
fair value, an impairment loss is recognized for the amount by
which the carrying amount of the reporting units goodwill
exceeds the implied fair value of that goodwill.
As a result of an impairment review that was performed in
December 2006, the Company recorded an impairment of goodwill of
$97,576 in the quarter ended December 31, 2006
(Note 6). The Company did not record any goodwill
impairment charges in fiscal 2006 or 2005.
Asset
impairments
Management reviews long-lived assets, such as capital assets and
definite lived intangible assets, for impairment whenever events
or changes in circumstances indicate the carrying amount of the
assets may not be recoverable. Recoverability of these assets is
determined by comparing the forecasted undiscounted net cash
flows of the operation to which the assets relate, to the
carrying amount including associated intangible assets of the
operation.
An impairment loss is recognized if the operation is determined
to be unable to recover the carrying amount of its assets.
Intangible assets are written down first, followed by the other
long-lived assets of the operation, to fair value. Fair value is
determined based on discounted cash flows or appraised values,
depending upon the nature of the assets. Assets to be disposed
of would be separately presented in the consolidated balance
sheet and reported at the lower of carrying amount or fair value
less costs to sell, and are no longer depreciated. The assets
and liabilities of a disposed group classified as held for sale
would be presented in the appropriate asset and liability
sections of the balance sheets.
F-10
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Revenue
recognition
Genesis recognizes revenue primarily from semiconductor product
sales to customers when a contract is established, the price is
determined, shipment is made and collectibility is reasonably
assured. Genesis has also periodically entered into license
agreements and recognizes royalty revenue. Distributor
agreements, which may be canceled by either party upon specified
notice, generally contain a provision for the return of the
Companys products in the event the agreement with the
distributor is terminated, and the distributors products
have not been sold. Accordingly, revenue and related cost of
revenues from sales to distributors are deferred until the
distributors resell the product, which is verified by
point-of-sale reports. At the time of shipment to distributors,
we record a trade receivable for the selling price, relieve
inventory of the value of the product shipped and record the
gross margin as deferred revenue, a component of accrued
liabilities on our consolidated balance sheets. In certain
circumstances, where orders are placed with
non-cancelable/non-returnable terms, we recognize revenue upon
shipment. Sales to distributors were 22% of revenue for fiscal
year 2007, 21% of revenue for fiscal year 2006 and 13% for
fiscal year 2005. There have been no significant product returns.
Warranty
program
Genesis accrues the estimated future cost of replacing faulty
product under the provisions of its warranty agreements as an
increase to cost of sales. Product warranties typically cover a
one-year period from the date of delivery to the customer.
Management estimates the accrual based on known product failures
(if any), historical experience, and other available evidence.
The following table presents a roll forward of the reserve for
warranty returns for the indicated periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Balance as of beginning of year
|
|
$
|
164
|
|
|
$
|
230
|
|
|
$
|
200
|
|
Increase to provision
|
|
|
442
|
|
|
|
157
|
|
|
|
288
|
|
Write offs
|
|
|
(396
|
)
|
|
|
(223
|
)
|
|
|
(258
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of end of year
|
|
$
|
210
|
|
|
$
|
164
|
|
|
$
|
230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties
From time to time, Genesis enters into agreements to license
certain technology from third parties. These agreements often
contain provisions for payment of
per-unit
royalties, based either on the number of products sold or
manufactured, or on the net sales price of the product
containing the licensed technology. Royalty expenses pursuant to
these license agreements are recorded in cost of revenues.
Currency
translation
The U.S. dollar is the functional currency of Genesis and
of its subsidiaries. Transactions originating in foreign
currencies are translated into U.S. dollars at exchange
rates approximating those at the date of the transaction.
Monetary assets and liabilities denominated in foreign
currencies are translated at the period-end rate of exchange and
non-monetary items are translated at historical exchange rates.
Exchange gains and losses are included in the consolidated
statements of operations and did not have a material effect in
the years ended March 31, 2007, March 31, 2006, and
March 31, 2005.
Research
and development expenses
Research and development costs are expensed as incurred other
than acquired technology which has alternative future use
(Note 5). Research and development costs include costs
associated with algorithm and semiconductor development
including the costs of developing software used within our
semiconductor devices.
F-11
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Costs of production mask sets related to products are deferred
once technological feasibility has been achieved, included in
other long-term assets, and then amortized as product costs to
cost of revenues over the estimated remaining life of the
product on a straight-line basis.
Financial
instruments and concentration of credit risk
Financial instruments consist of cash and cash equivalents,
short-term investments, accounts receivable trade, accounts
payable and accrued liabilities. Genesis determines the fair
value of its financial instruments based on quoted market values
or discounted cash flow analyses. Unless otherwise indicated,
the fair values of financial assets and financial liabilities
approximate their recorded amounts.
Financial instruments that potentially subject Genesis to
concentrations of credit risk consist primarily of cash
equivalents, short-term investments and accounts receivable
trade. Cash equivalents consist of deposits with or guaranteed
by major commercial banks, the maturities of which are three
months or less from the date of purchase. Short-term investments
consist entirely of government and corporate debt securities.
With respect to trade accounts receivable, Genesis performs
periodic credit evaluations of the financial condition of its
customers and typically does not require collateral from them.
Allowances are maintained for potential credit losses consistent
with the credit risk of specific customers, historical trends
and other information. Credit losses have been within
managements range of expectations.
Earnings
(loss) per share
Basic earnings (loss) per share has been calculated by dividing
the net income (loss) for the year available to common
stockholders by the weighted average number of common shares
outstanding during that year. Basic earnings (loss) per share
excludes the dilutive effect of potential common shares such as
those issuable on exercise of stock options. Diluted earnings
(loss) per share gives effect to all potential common shares
outstanding during the year. The weighted average number of
diluted shares outstanding is calculated assuming that the
proceeds from potential common shares are used to repurchase
common shares at the average closing share price in the year.
Stock-based
compensation
On April 1, 2006, the Company adopted Statement of
Financial Accounting Standards (SFAS) No. 123
(revised 2004), Share-Based Payment
(SFAS 123R), which requires the measurement and
recognition of compensation expense for all share-based payment
awards based on the grant date fair value of the awards.
Prior to the adoption of SFAS 123R, the Company followed
Accounting Principles Board Opinion No. 25 (APB
25), Accounting for Stock Issued to Employees
and related interpretations, in accounting for employee stock
options and restricted stock units. Under APB 25, deferred
stock-based compensation was recorded at the grant date in an
amount equal to the excess of the market value of a share of
common stock over the exercise price of the option or restricted
stock unit and was amortized over the vesting period of the
individual options or stock units, generally two to four years,
in accordance with Financial Accounting Standards Boards
(FASB) Interpretation No. 44.
The Company adopted SFAS 123R using the modified
prospective transition method, which requires the recognition of
compensation expense for awards granted after April 1, 2006
that are expected to vest and for unvested awards granted prior
to adoption that are expected to vest after the adoption date.
The compensation expense related to the awards granted prior to
adoption is based on the grant date fair value estimated in
accordance with SFAS 123 for prior year pro forma
disclosure purposes, adjusted to reflect estimated forfeitures.
In accordance with the modified prospective transition method,
prior period results have not been adjusted to reflect the
adoption of SFAS 123R. No modifications were made to the
terms of the Companys outstanding stock options in
anticipation of the adoption of SFAS 123R. See Note 9.
F-12
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Comprehensive
income
Comprehensive income is defined as the change in equity of a
company during a period resulting from transactions and other
events and circumstances from non-owner sources. For the fiscal
years ended March 31, 2007, 2006, and 2005, there was no
difference between the Companys net income (loss) and
comprehensive income (loss).
Income
taxes
Genesis applies the asset and liability method of SFAS 109
Accounting for Income Taxes, under which deferred
tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities
and their respective tax bases and for operating loss and tax
credits carry forwards. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are
expected to be recovered or settled. Under SFAS 109, the
effect on deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes the
enactment date. To the extent that it is not considered to be
more likely than not that a deferred tax asset will be realized,
a valuation allowance is provided.
Genesis is entitled to Canadian federal and provincial research
and development investment tax credits which are earned as a
percentage of eligible current and capital research and
development expenditures incurred in each taxation year.
Investment tax credits are available to be applied against
future income tax liabilities, subject to a ten year carry
forward period. Investment tax credits are classified as a
reduction of income tax expense for items of a current nature
and a reduction of the related asset cost for items of a long-
term nature, provided that Genesis has reasonable assurance that
the tax credits will be realized.
Recent
accounting pronouncements
Standards
adopted in 2007:
In September 2006, the staff of the U.S. Securities and
Exchange Commission (SEC) issued Staff Accounting
Bulletin No. 108, Considering the Effects of
Prior Year Misstatements when Quantifying Misstatements in
Current Year Financial Statements
(SAB 108). SAB 108 provides interpretive
guidance on how the effects of the carryover or reversal of
prior year misstatements should be considered in quantifying a
current year misstatement. SAB 108 requires SEC registrants
to quantify misstatements using both the balance sheet and
income statement approaches and to evaluate whether either
approach results in quantifying an error that is material in
light of relevant quantitative and qualitative factors.
SAB 108 does not change the staffs previous guidance
in SAB 99 on evaluating the materiality of misstatements.
When the effect of initial adoption is determined to be
material, SAB 108 allows registrants to record that effect
as a cumulative-effect adjustment to beginning-of-year retained
earnings under U.S. GAAP. SAB 108 is effective for the
Companys annual financial statements for the current
fiscal year. The adoption of SAB 108 did not impact the
Companys financial statements for the year ended
March 31, 2007.
In May 2005, the FASB issued SFAS No. 154,
Accounting Changes and Error Corrections
(SFAS 154), which replaces Accounting
Principles Board Opinion No. 20, Accounting
Changes, and SFAS No. 3, Reporting
Accounting Changes in Interim Financial Statements.
SFAS 154 provides guidance on the accounting for, and
reporting of, changes in accounting principles and error
corrections. SFAS 154 requires retrospective application to
prior periods financial statements of voluntary changes in
accounting principles and changes required by new accounting
standards when the standard does not include specific transition
provisions, unless it is impracticable to do so. Certain
disclosures are also required for restatements due to correction
of an error. SFAS 154 is effective for accounting changes
and corrections of errors made in fiscal years beginning after
December 15, 2005, and has been adopted by the Company for
the year ended March 31, 2007. The adoption of
SFAS 154 did not impact the Companys financial
statements for the year ended March 31, 2007.
F-13
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Subsequent to year end the Company has undertaken a review of
amortization methods applied to property and equipment and
intangible assets. As a result of the review, the Company has
concluded that the pattern of consumption for property and
equipment and patents has changed, and that the straight line
amortization method better matches the consumption pattern of
these assets. As provided by SFAS 154, the Company will
apply this change prospectively as of April 1, 2007. The
Company estimates that the change in depreciation methods will
not have a significant impact on depreciation and amortization
expense in fiscal year 2008.
Standards
issued but not yet adopted:
In June 2006, the Financial Accounting Standards Board
(FASB) issued Interpretation No. 48,
Accounting for Uncertainty in Income Taxes, an
interpretation of FASB Statement No. 109
(FIN 48). FIN 48 requires that companies
recognize the tax benefits of uncertain tax positions only where
the position is more likely than not to be
sustained, assuming examination by tax authorities. The amount
recognized would be the amount that represents the largest
amount of tax benefit that is greater than 50% likely of being
ultimately realized. A liability would be recognized for the
taxes attributable to any benefit claimed, or expected to be
claimed, in a tax return in excess of the amount of the
uncertainty that is eligible to be recognized as a benefit in
the financial statements, along with any interest and penalty
(if applicable) on the excess. Disclosure will also be required
for those uncertain tax positions where it is reasonably
possible that the estimate of the tax benefit will change
significantly in the next 12 months. FIN 48 is
effective for the Companys fiscal year beginning on
April 1, 2007. The effect, if any, of adopting FIN 48
on the Companys consolidated financial statements is
currently being evaluated by management.
Statement of Financial Accounting Standards No. 157,
Fair Value Measurement (SFAS 157)
was issued in September 2006. SFAS 157 provides guidance
for using fair value to measure assets and liabilities.
SFAS 157 also expands disclosures about the extent to which
companies measure assets and liabilities at fair value, the
information used to measure fair value, and the effect of fair
value measurement on earnings. SFAS 157 applies under other
accounting pronouncements that require or permit fair value
measurements and does not expand the use of fair value
measurements in any new circumstances. Under SFAS 157, fair
value refers to the price that would be received to sell an
asset or paid to transfer a liability in an orderly transaction
between market participants in the market in which the entity
transacts. SFAS 157 is effective for fair value
measurements and disclosures made by the Company in its fiscal
year beginning on April 1, 2008. The Company is currently
reviewing the impact of this statement.
In February 2007, the Financial Accounting Standards Board
(FASB) issued Statement of Financial Accounting
Standards (SFAS) No. 159, The Fair Value
Option for Financial Assets and Financial
Liabilities Including an Amendment of FASB Statement
No. 115 (SFAS 159). SFAS 159
permits an entity to choose to measure many financial
instruments and certain other items at fair value. Most of the
provisions in SFAS 159 are elective; however, the amendment
to FASB Statement No. 115, Accounting for Certain
Investments in Debt and Equity Securities, applies to all
entities with available-for-sale and trading securities.
SFAS 159 is effective for the Company beginning
July 1, 2008. The Company is currently assessing the
potential impact that the adoption of SFAS 159 will have on
its financial statements.
Inventories consist of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Finished goods
|
|
$
|
11,596
|
|
|
$
|
10,717
|
|
Work-in-process
|
|
|
8,757
|
|
|
|
10,123
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,353
|
|
|
|
20,840
|
|
Less reserve for obsolescence
|
|
|
(3,929
|
)
|
|
|
(3,665
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,424
|
|
|
$
|
17,175
|
|
|
|
|
|
|
|
|
|
|
F-14
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
|
|
4.
|
PROPERTY
AND EQUIPMENT
|
Property and equipment consist of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Property and equipment
|
|
$
|
19,697
|
|
|
$
|
17,429
|
|
Software
|
|
|
24,711
|
|
|
|
21,632
|
|
Leasehold improvements
|
|
|
4,280
|
|
|
|
6,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,688
|
|
|
|
45,276
|
|
Less accumulated amortization
|
|
|
(32,450
|
)
|
|
|
(28,817
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,238
|
|
|
$
|
16,459
|
|
|
|
|
|
|
|
|
|
|
Intangible assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2007
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
Amortization
|
|
|
Impairment
|
|
|
Net
|
|
|
Acquired technology
|
|
$
|
48,792
|
|
|
$
|
44,009
|
|
|
$
|
3,425
|
|
|
$
|
1,358
|
|
Patents
|
|
|
5,132
|
|
|
|
1,484
|
|
|
|
|
|
|
|
3,648
|
|
Other
|
|
|
500
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
54,424
|
|
|
$
|
45,993
|
|
|
$
|
3,425
|
|
|
$
|
5,006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2006
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
Amortization
|
|
|
Impairment
|
|
|
Net
|
|
|
Acquired technology
|
|
$
|
47,953
|
|
|
$
|
42,029
|
|
|
$
|
|
|
|
$
|
5,924
|
|
Patents
|
|
|
4,118
|
|
|
|
987
|
|
|
|
|
|
|
|
3,131
|
|
Other
|
|
|
500
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
52,571
|
|
|
$
|
43,516
|
|
|
$
|
|
|
|
$
|
9,055
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the year ended March 31, 2007, $2,477 was amortized
(2006 $9,946; 2005 $10,857).
Due to a decline in projected revenue for products which
incorporate technology acquired from VM Labs in fiscal 2002, the
Company determined a triggering event occurred in the quarter
ending December 31, 2006 which required the Company to
reassess the underlying value of the acquired technology. The
Company engaged an independent valuation professional to assist
with its measurement of fair value as part of the intangible
asset impairment test. The recoverability of this asset was
assessed by comparing its carrying amount with its estimated
fair value using a discounted cash flow approach. An impairment
was identified for which the Company recorded a non-cash
impairment charge of $3,425 prior to performing the goodwill
impairment analysis.
F-15
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Estimated future intangible assets amortization expense, based
on current balances, as of March 31, 2007 is as follows:
|
|
|
|
|
For the Year Ended
|
|
March 31
|
|
|
2008
|
|
$
|
738
|
|
2009
|
|
|
688
|
|
2010
|
|
|
467
|
|
2011
|
|
|
257
|
|
2012
|
|
|
198
|
|
Thereafter
|
|
|
2,658
|
|
|
|
|
|
|
Total
|
|
$
|
5,006
|
|
|
|
|
|
|
The majority of the goodwill carried on the balance sheet arose
in February 2002 when the Company acquired Sage Inc. for
approximately $297,000.
The Company is required to evaluate goodwill annually or
whenever events or changes in circumstances indicate that the
carrying amount may not be recoverable. Due to a sustained
reduction in the Companys market capitalization plus the
decline in current and projected revenue from certain customers,
the Company determined a triggering event occurred in the
quarter ending December 31, 2006 requiring management to
assess the recoverability of goodwill. Impairment is tested at
the reporting unit level by comparing the reporting units
carrying amount to its fair value. Where the carrying amount of
the reporting unit exceeds its fair value, an impairment loss is
recognized for the amount by which the carrying amount of the
reporting units goodwill exceeds the implied fair value of
that goodwill.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2007
|
|
|
March 31, 2006
|
|
|
|
Cost
|
|
|
Impairment
|
|
|
Net
|
|
|
Cost
|
|
|
Impairment
|
|
|
Net
|
|
|
Goodwill
|
|
$
|
181,981
|
|
|
$
|
(97,576
|
)
|
|
$
|
84,405
|
|
|
$
|
181,981
|
|
|
$
|
|
|
|
$
|
181,981
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management has determined that the Company has one reporting
unit for purposes of goodwill impairment review under
SFAS 142. Upon performing the impairment test, it was found
that the carrying value of goodwill exceeded its implied fair
value of $84,405 and therefore an impairment charge of $97,576
was recorded in the quarter ending December 31, 2006. The
Company engaged an independent valuation professional to assist
with its measurement of fair value as part of the goodwill
impairment test. The fair value of the reporting unit was
estimated using a combination of the market approach and a
discounted cash flows approach. There was no impairment charge
for fiscal 2006.
|
|
7.
|
OTHER
LONG TERM ASSETS
|
Other long-term assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Investments (at cost)
|
|
$
|
10,190
|
|
|
$
|
11,177
|
|
Production mask sets, net of
accumulated amortization of $2,729 in fiscal 2007, $2,775 in
fiscal 2006
|
|
|
5,170
|
|
|
|
5,082
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
15,360
|
|
|
$
|
16,259
|
|
|
|
|
|
|
|
|
|
|
During the year ended March 31, 2006, the Company purchased
$10,000 of preferred shares of a private company. In conjunction
with the investment, the company also signed a Master
Development and Cross License
F-16
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Agreement giving both companies access to each others
certain technologies for select markets and enabling future
joint product development that focuses on multimedia processors
used in the mobile video market. The preferred shares are
convertible to common shares on a one for one basis.
Amortization expense of $2,700 was recognized in relation to
production mask sets during the year ended March 31, 2007
(2006 $1,343; 2005 $1,269).
Authorized
Capital Stock
Genesis certificate of incorporation authorizes the
issuance of 105,000,000 shares of capital stock, consisting
of 100,000,000 shares of common stock, $0.001 par
value per share, and 5,000,000 shares of preferred stock,
$0.001 par value per share.
Common
Stock
The holders of common stock are entitled to one vote per share
on all matters to be voted upon by stockholders. Upon the
liquidation, dissolution or winding up of Genesis, the holders
of common stock will be entitled to share ratably in the net
assets legally available for distribution to stockholders after
the payment of all debts and other liabilities of the Company,
subject to the prior rights of preferred stock, if any, then
outstanding.
Preferred
Stock
The Board of Directors of Genesis is authorized to issue shares
of preferred stock in one or more series and to fix the rights,
preferences, privileges and restrictions, qualifications and
limitations granted to or imposed upon any unissued and
undesignated shares of preferred stock and to fix the number of
shares constituting any series and the designations of such
series, without any further vote or action by the stockholders
(subject to applicable law and applicable stock exchange rules).
The Board of Directors, without stockholder approval (subject to
applicable law and applicable stock exchange rules), can issue
preferred stock with voting and conversion rights that could
adversely affect the voting power or other rights of the holders
of Genesis common stock, and the issuance of such preferred
stock may have the effect of delaying, deferring or preventing a
change in control of Genesis. No such preferred shares have been
issued or authorized.
Preferred
Stock Rights Agreement
On June 26, 2002, the Board of Directors adopted a
Preferred Stock Rights Agreement, dated as of June 27,
2002, between Genesis and Mellon Investor Services, L.L.C. (the
Rights Agreement). Under the Rights Agreement, each
share of common stock carries a right to obtain additional stock
according to the terms provided in the Rights Agreement (each, a
Right and collectively, the Rights).
The Rights will not be exercisable or separable from the common
stock until the occurrence of certain events. If a person or
group acquires or announces a tender or exchange offer that
would result in the acquisition of a certain percentage of the
common stock of Genesis while the Rights Agreement remains in
place, the Rights will become exercisable, unless redeemed, by
all Rights holders except the acquiring person or group, for
shares of Genesis or of the third party acquirer having a value
of twice the Rights then-current exercise price. Until a
right is exercised, the holder of a right, as such, will have no
rights as a stockholder of Genesis, including, without
limitation, the rights to vote as a stockholder or receive
dividends.
F-17
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
|
|
9.
|
STOCK-BASED
COMPENSATION
|
On April 1, 2006, the Company adopted Statement of
Financial Accounting Standards (SFAS) No. 123
(revised 2004), Share-Based Payment
(SFAS 123R), which requires the measurement and
recognition of compensation expense for all share-based payment
awards based on the grant date fair value of the awards.
Prior to the adoption of SFAS 123R, the Company followed
Accounting Principles Board Opinion No. 25 (APB
25), Accounting for Stock Issued to Employees
and related interpretations, in accounting for employee stock
options and restricted stock units. Under APB 25, deferred
stock-based compensation was recorded at the grant date in an
amount equal to the excess of the market value of a share of
common stock over the exercise price of the option or restricted
stock unit and was amortized over the vesting period of the
individual options or stock units, generally two to four years,
in accordance with Financial Accounting Standards Boards
(FASB) Interpretation No. 44.
The Company adopted SFAS 123R using the modified
prospective transition method, which requires the recognition of
compensation expense for awards granted after April 1, 2006
that are expected to vest and for unvested awards granted prior
to adoption that are expected to vest after the adoption date.
The compensation expense related to the awards granted prior to
adoption is based on the grant date fair value estimated in
accordance with SFAS 123 for prior year pro forma
disclosure purposes, adjusted to reflect estimated forfeitures.
In accordance with the modified prospective transition method,
prior period results have not been adjusted to reflect the
adoption of SFAS 123R. No modifications were made to the
terms of the Companys outstanding stock options in
anticipation of the adoption of SFAS 123R.
During the year ended March 31, 2007, the Company
recognized stock-based compensation expense of $19,582, related
to stock options, restricted stock units and employee stock
purchase plans granted to employees and directors. The Company
has not capitalized any stock-based compensation costs as part
of the cost of an asset. There were no tax benefits recognized
related to the compensation cost for share-based payments.
The cumulative effect of the implementation of SFAS 123R
for the year ended March 31, 2007 was to increase loss from
operations, loss before income taxes and net loss by $17,205 and
basic and fully diluted loss per share by $0.47. In addition,
$4,572 of deferred stock-based compensation recorded as a
reduction to stockholders equity as of March 31, 2006
was reversed against the Companys additional
paid-in-capital.
There was no impact on cash flows from operating and financing
activities.
The fair value of stock-based compensation was determined using
the Black-Scholes option-pricing model using a dividend yield of
0% and the assumptions noted in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Stock option plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rates
|
|
|
4.9
|
%
|
|
|
4.8
|
%
|
|
|
3.6
|
%
|
Volatility
|
|
|
66
|
%
|
|
|
78
|
%
|
|
|
90
|
%
|
Expected life (in years)
|
|
|
4.25
|
|
|
|
4.25
|
|
|
|
4.25
|
|
Employee stock purchase plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rates
|
|
|
5.1
|
%
|
|
|
4.8
|
%
|
|
|
3.1
|
%
|
Volatility
|
|
|
47
|
%
|
|
|
78
|
%
|
|
|
90
|
%
|
Expected life (in years)
|
|
|
0.75
|
|
|
|
1.25
|
|
|
|
1.25
|
|
The Company uses historical volatility as a basis for projecting
the expected volatility of the underlying stock and estimates
the expected life of its stock options based upon historical
data. The risk-free rate for periods within the contractual life
of the option is based on the U.S. Treasury yield curve in
effect at the time of grant.
F-18
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
The weighted average grant date fair values of options granted
during fiscal 2007, 2006 and 2005, were $6.23, $12.67 and
$10.12, respectively.
In accordance with SFAS 123R, the Company is required to
estimate the number of instruments for which the requisite
service is expected to be rendered. Under APB 25, forfeiture
rates were recognized as they occurred. The cumulative effect of
the change in accounting policy for the adjustment related to
the forfeitures for the prior periods was not material at
April 1, 2006.
Had the Company accounted for stock-based compensation in
accordance with SFAS 123R prior to April 1, 2006, our
net earnings would have approximated the pro forma amount for
the periods indicated as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Net income (loss) attributable to
common stockholders:
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
18,390
|
|
|
$
|
(9,447
|
)
|
Stock compensation, as reported
|
|
|
1,061
|
|
|
|
4,494
|
|
Stock compensation, under
SFAS 123
|
|
|
(22,432
|
)
|
|
|
(28,345
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
(2,981
|
)
|
|
$
|
(33,298
|
)
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
0.53
|
|
|
$
|
(0.29
|
)
|
Pro forma
|
|
$
|
(0.09
|
)
|
|
$
|
(1.01
|
)
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
0.50
|
|
|
$
|
(0.29
|
)
|
Pro forma
|
|
$
|
(0.08
|
)
|
|
$
|
(1.01
|
)
|
The pro forma stock compensation expense for the year ended
March 31, 2005 has been restated from that previously
presented to reflect changes identified in the methodology of
their revaluation.
STOCK
OPTION AND STOCK PURCHASE PLANS
1997
Employee Stock Option Plan
The 1997 Employee Stock Option Plan (1997 Employee
Plan) provided for the granting to employees of incentive
stock options, nonstatutory stock options, stock appreciation
rights, stock purchase rights and restricted stock units for up
to 800,000 shares of common stock plus an annual increase
to be added on the first day of each fiscal year equal to the
least of (i) 2,000,000 shares of common stock,
(ii) 3.5% of the outstanding shares on such date, or
(iii) an amount determined by the Board of Directors of
Genesis. The exercise price of incentive stock options granted
under the 1997 Employee Plan was not to be less than 100% (110%
in case of any options granted to a person who held more than
10% of the total combined voting power of all classes of shares
of Genesis) of the fair market value of the shares of common
stock subject to the option on the date of the grant. The term
of the options do not exceed 10 years (five years in the
case of any incentive stock options granted to an employee who
held more than 10% of the total combined voting power of all
classes of shares of Genesis) and generally vest over four years.
As of March 31, 2007, there were 1,856,000 shares
available for grant under the 1997 Employee Plan. In the quarter
ended September 30, 2005, the Company amended the 1997
Employee Plan to allow the granting of stock appreciation rights
and restricted stock units. The Company has not issued any stock
appreciation rights to date. Restricted stock units generally
vest over a period of 4 years.
F-19
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
1997
Paradise Stock Option Plan
The 1997 Paradise Stock Option Plan (Paradise Plan)
provided for the granting of incentive stock options
(ISOs) to employees of Paradise Electronics Inc.
(Paradise), a wholly owned subsidiary of Genesis and
nonstatutory stock options (NSOs) to Paradise
employees, directors, and consultants. As a result of the merger
of Paradise with Genesis in May 1999, each outstanding option or
right to purchase shares of Paradise common stock became
exercisable for Genesis shares of common stock, adjusted to
reflect the exchange ratio of Genesis shares of common stock for
Paradise common stock in the merger. No additional options will
be granted under the Paradise Plan. Upon exercise, expiration or
cancellation of all of the options granted under the Paradise
Plan, this plan will be terminated.
1997
Non-Employee Stock Option Plan
The 1997 Non-Employee Stock Option Plan (Non-Employee
Plan) provides for the granting to non-employee directors
and consultants of Genesis of options for up to
500,000 shares of common stock. The exercise price of stock
options granted under the Non-Employee Plan may not be less than
100% of the fair market value of the shares of common stock
subject to the option on the date of the grant. Options granted
under the Non-Employee Plan have a term of up to ten years and
generally vest over periods of up to two years. As of
March 31, 2007, there were 70,000 shares available for
grant under the Non-Employee Plan.
2000
Nonstatutory Stock Option Plan
The 2000 Nonstatutory Stock Option Plan (2000 Plan)
provides for the granting to employees and non-employees of
nonstatutory stock options and stock appreciation rights for up
to 1,500,000 shares of common stock plus an annual increase
to be added on the first day of each fiscal year equal to the
least of (i) 2,000,000 shares of common stock,
(ii) 3.5% of the outstanding shares on such date, or
(iii) an amount determined by the Board of Directors of
Genesis. The exercise price of stock options granted under the
2000 Plan has not been less than 100% of the fair market value
of the shares of common stock subject to the option at the date
of grant. The options generally have a term of 10 years and
vest over four years. As of March 31, 2007, there were
1,475,000 shares available for grant under the 2000
Employee Plan. In the quarter ended September 30, 2005, the
Company amended the 2000 Nonstatutory Stock Option Plan to
allow the granting of stock appreciation rights. The Company has
not issued any stock appreciation rights to date.
2001
Nonstatutory Stock Option Plan
The 2001 Nonstatutory Stock Option Plan (2001 Employee
Plan) provides for the granting to employees of
nonstatutory stock options for up to 1,000,000 shares of
common stock. The exercise price of stock options granted under
the 2001 Employee Plan are determined by the plan administrator
but have not been less than 100% of the fair market value of the
shares of common stock subject to the option at the date of
grant. The options generally have a term of 10 years and
vest over four years. As of March 31, 2007, there were
107,000 shares available for grant under the 2001 Employee
Plan.
2003
Stock Plan
The 2003 Stock Plan (2003 Stock Plan) provides for
the granting to newly hired employees of nonstatutory stock
options, stock appreciation rights, stock purchase rights,
restricted stock, performance shares and performance units for
up to 1,000,000 shares of common stock. The exercise price
of stock options granted under the 2003 Stock Plan have not
been less than 100% of the fair market value of the shares of
common stock subject to the option at the date of grant. The
options generally have a term of 10 years and vest over
four years. As of March 31, 2007, there were
119,000 shares available for grant under the 2003 Employee
Plan.
F-20
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Sage
Stock Option Plan
The Sage Stock Option Plan (Sage Plan) provided for
the granting of ISOs to employees of Sage, a wholly owned
subsidiary of Genesis and NSOs to Sage employees, directors, and
consultants. As a result of the purchase of Sage in 2002, each
outstanding option or right to purchase shares of Sage common
stock is exercisable for Genesis shares of common stock,
adjusted to reflect the exchange ratio of Genesis shares of
common stock to Sage common stock in the purchase and sale
agreement. No additional options will be granted under the Sage
Plan. Upon exercise, expiration or cancellation of all of the
options granted under the Sage Plan, this plan will be
terminated.
Employee
Stock Purchase Plan
Genesis has established an employee stock purchase plan under
which employees may authorize payroll deductions of up to 15% of
their compensation (as defined in the plan) to purchase shares
of common stock at a price equal to 85% of the lower of the fair
market values as of the beginning or the end of each six month
purchase period within an offering period. The plan provides for
the purchase of 500,000 shares of common stock plus an
annual increase to restore the number of shares available for
purchase under the plan to 500,000. As of March 31, 2007,
there were 215,000 shares available for issuance under this
plan.
Effective July 1, 2006, awards granted pursuant to the plan
may be exercised at the end of each six month purchase period
within a twelve month offering period. The offering period of
awards granted prior to July 1, 2006 was approximately
twenty-four months. On May 10, 2007, we amended the plan to
make the final offering period six months instead of twelve
months.
F-21
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Summary
of Stock Options
Details of stock option transactions are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
Number of
|
|
|
Exercise Price
|
|
|
Weighted Average
|
|
|
|
Options
|
|
|
Per Share
|
|
|
Remaining Life
|
|
|
|
(In thousands)
|
|
|
|
|
|
(Years)
|
|
|
Outstanding, March 31, 2004
|
|
|
7,272
|
|
|
$
|
15.01
|
|
|
|
7.90
|
|
Issued
|
|
|
2,729
|
|
|
|
14.93
|
|
|
|
|
|
Exercised
|
|
|
(423
|
)
|
|
|
8.79
|
|
|
|
|
|
Forfeited
|
|
|
(568
|
)
|
|
|
13.92
|
|
|
|
|
|
Expired
|
|
|
(205
|
)
|
|
|
21.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, March 31, 2005
|
|
|
8,805
|
|
|
|
15.22
|
|
|
|
7.49
|
|
Issued
|
|
|
760
|
|
|
|
19.98
|
|
|
|
|
|
Exercised
|
|
|
(2,065
|
)
|
|
|
12.66
|
|
|
|
|
|
Forfeited
|
|
|
(291
|
)
|
|
|
14.00
|
|
|
|
|
|
Expired
|
|
|
(82
|
)
|
|
|
22.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, March 31, 2006
|
|
|
7,127
|
|
|
|
16.43
|
|
|
|
6.74
|
|
Issued
|
|
|
1,276
|
|
|
|
11.17
|
|
|
|
|
|
Exercised
|
|
|
(536
|
)
|
|
|
8.36
|
|
|
|
|
|
Forfeited
|
|
|
(620
|
)
|
|
|
15.37
|
|
|
|
|
|
Expired
|
|
|
(893
|
)
|
|
|
20.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, March 31, 2007
|
|
|
6,354
|
|
|
$
|
15.61
|
|
|
|
5.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, March 31, 2005
|
|
|
4,359
|
|
|
$
|
16.10
|
|
|
|
6.34
|
|
Exercisable, March 31, 2006
|
|
|
4,267
|
|
|
$
|
16.67
|
|
|
|
6.10
|
|
Exercisable, March 31, 2007
|
|
|
4,239
|
|
|
$
|
16.52
|
|
|
|
5.72
|
|
During the year ended March 31, 2007, 1,402,452 stock
options vested.
At March 31, 2007, compensation expense of $14,806 related
to non-vested stock options has not been recognized. This cost
is expected to be recognized over a weighted average period of
1.07 years. The total intrinsic value of options
outstanding and options exercisable at March 31, 2007 was
$1,192 and $1,140, respectively. The total intrinsic value of
options exercised during the year ended March 31, 2007 was
$1,815. The total intrinsic value of options exercised during
the year ended March 31, 2006 and 2005 was $19,985 and
$2,871, respectively.
For the year ended March 31, 2007, cash in the amount of
$8,707 was received as the result of the exercise of options
granted under share-based payment arrangements which includes
$3,703 for stock options exercised and $5,004 for the sale of
shares in connection with the Employee Stock Purchase Plan.
F-22
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Summary
of Restricted Stock Units
Details of restricted stock unit transactions are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
Grant-Date
|
|
|
|
Number of RSUs
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
|
|
|
Nonvested, March 31, 2005
|
|
|
|
|
|
$
|
|
|
Granted
|
|
|
270
|
|
|
|
19.93
|
|
Forfeited
|
|
|
(4
|
)
|
|
|
19.80
|
|
|
|
|
|
|
|
|
|
|
Nonvested, March 31, 2006
|
|
|
266
|
|
|
|
19.93
|
|
Granted
|
|
|
609
|
|
|
|
11.47
|
|
Vested
|
|
|
(112
|
)
|
|
|
11.12
|
|
Forfeited
|
|
|
(74
|
)
|
|
|
15.06
|
|
|
|
|
|
|
|
|
|
|
Nonvested, March 31, 2007
|
|
|
689
|
|
|
$
|
13.15
|
|
|
|
|
|
|
|
|
|
|
At March 31, 2007, compensation expense of $5,837 related
to non-vested restricted stock units has not been recognized.
This cost is expected to be recognized over a weighted average
period of 1.48 years. The total fair value of restricted
stock units vested during the year ended March 31, 2007 was
$1,205. No restricted stock units vested during the year ended
March 31, 2006.
The Companys policy is to satisfy stock option exercises
and RSUs by issuing new shares of common stock. No cash was used
by the Company to settle equity instruments granted under
stock-based compensation arrangements.
The provision for (recovery of) income taxes consists of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Current
|
|
$
|
3,316
|
|
|
$
|
3,177
|
|
|
$
|
6,386
|
|
Deferred
|
|
|
10,899
|
|
|
|
2,905
|
|
|
|
(3,432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,215
|
|
|
$
|
6,082
|
|
|
$
|
2,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-23
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
The provision for (recovery of) income taxes differs from the
amount computed by applying the statutory federal income tax
rate to income before provision for income taxes. The sources
and tax effects of the differences are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Basic federal rate applied to
income before provision for (recovery of) income taxes
|
|
$
|
(44,244
|
)
|
|
$
|
8,320
|
|
|
$
|
(2,208
|
)
|
Adjustments resulting from:
|
|
|
|
|
|
|
|
|
|
|
|
|
State and provincial income taxes
|
|
|
(7,808
|
)
|
|
|
1,468
|
|
|
|
(390
|
)
|
Non-deductible expenses and other
permanent differences
|
|
|
5,293
|
|
|
|
324
|
|
|
|
2,672
|
|
Non-deductible impairment of
goodwill and intangible assets
|
|
|
40,400
|
|
|
|
|
|
|
|
|
|
Research and development
deductions and investment tax credits
|
|
|
(3,740
|
)
|
|
|
(3,668
|
)
|
|
|
(1,276
|
)
|
Foreign exchange and tax rate
differences
|
|
|
(7,834
|
)
|
|
|
(9,870
|
)
|
|
|
(9,371
|
)
|
Tax on repatriation from foreign
subsidiary
|
|
|
|
|
|
|
|
|
|
|
3,701
|
|
Change in valuation allowance
|
|
|
30,174
|
|
|
|
9,403
|
|
|
|
9,745
|
|
Other items
|
|
|
1,974
|
|
|
|
105
|
|
|
|
81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,215
|
|
|
$
|
6,082
|
|
|
$
|
2,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pretax income from foreign operations was $9,122, $42,979 and
$34,609 for the years ended March 31, 2007, 2006, and 2005,
respectively.
On October 22, 2004, the American Jobs Creation Act
of 2004 (AJCA) was signed into law. The AJCA
includes a deduction of 85% of certain foreign earnings that are
repatriated, as defined in the AJCA. In March 2005, the Company
repatriated $73,000 of earnings and profits in accordance with
certain provisions of the AJCA. A charge of $3,701 associated
with this repatriation is included in the provision for income
taxes for the year ended March 31, 2005. Under normal
circumstances, U.S. income and foreign withholding taxes
are not provided on certain unremitted earnings of international
affiliates which Genesis considers to be indefinitely reinvested
in the foreign jurisdiction. A deferred tax liability will be
recognized when the Company can no longer demonstrate that it
plans to indefinitely reinvest the undistributed earnings. As of
March 31, 2007, the undistributed earnings of these
affiliates were approximately $49,000. The Company has not
recognized a deferred tax liability of approximately $19,600 for
the unremitted earnings of its foreign affiliates.
Significant components of Genesis deferred tax assets are
as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Acquisition-related intangibles
|
|
$
|
(1,864
|
)
|
|
$
|
(1,864
|
)
|
Net operating loss carryforwards
|
|
|
69,563
|
|
|
|
55,616
|
|
Research tax credit carryforwards
|
|
|
23,916
|
|
|
|
20,317
|
|
Net capital loss carryforwards
|
|
|
6,157
|
|
|
|
7,137
|
|
Other
|
|
|
5,727
|
|
|
|
2,596
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
|
103,499
|
|
|
|
83,802
|
|
Less valuation allowance
|
|
|
(103,247
|
)
|
|
|
(72,651
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
252
|
|
|
$
|
11,151
|
|
|
|
|
|
|
|
|
|
|
F-24
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
The valuation allowance increased by $30,596 during the year
ended March 31, 2007 (2006 $14,825), primarily
as a result of the Company recording a full valuation allowance
against the tax attributes in both Canada and the United States.
The valuation allowance includes $13,232 (2006
$13,232) arising from acquired losses and research credits,
which, if realized, will be credited to goodwill. The valuation
allowance also includes $22,662 (2006 $22,434) of
losses arising from stock option deductions of which
subsequently recognized tax benefits will be recorded as
additional paid-in capital. No such benefit was realized during
2007, 2006 or 2005.
In assessing the realization of deferred tax assets, management
considers whether it is more likely than not that some portion
or all of its deferred tax assets will not be realized. The
ultimate realization of deferred tax assets is dependent upon
the generation of future taxable income during the periods in
which those temporary differences become deductible in the
appropriate jurisdiction. Management considers projected future
taxable income, uncertainties related to the industry in which
Genesis operates and tax planning strategies in making this
assessment. FASB Statement No. 109, Accounting for Income
Taxes, states that forming a conclusion that a valuation
allowance is not needed is difficult when there is negative
evidence, such as losses in the jurisdictions to which the
deferred tax asset relate. As a result of the review of goodwill
and intangible assets undertaken in the third quarter of fiscal
2007, the Company concluded that it was appropriate to establish
a further valuation allowance. Based upon the level of
historical taxable income and projections for future taxable
income over the periods which the deferred tax assets are
deductible, management believes it is more likely than not the
Company will realize the benefits of these deductible
differences net of the existing valuation allowance.
|
|
11.
|
RELATED
PARTY TRANSACTIONS
|
In March 2006, Genesis made an equity investment in Mobilygen
Corp, and Elias Antoun, our president and CEO, joined
Mobilygens Board of Directors.
In March 2006, we entered into a cross-licensing agreement with
Mobilygen Corp., a privately held company that is developing
H.264 and other video codec solutions for mobile devices. The
agreement will give both companies access to certain
technologies for select markets and enables them to jointly
define future products to complement existing product portfolios.
The investment in Mobilygen is recorded within other long term
assets. No financial transactions were undertaken with Mobilygen
during the year ended March 31, 2007.
F-25
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
|
|
12.
|
EARNINGS
(LOSS) PER SHARE
|
The following table reconciles the numerators and denominators
of the basic and diluted earnings (loss) per share computation
as required by SFAS 128:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Numerator for basic and diluted
earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(144,341
|
)
|
|
$
|
18,390
|
|
|
$
|
(9,447
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings
(loss) per share
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
|
|
|
36,514
|
|
|
|
34,909
|
|
|
|
33,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share
|
|
$
|
(3.95
|
)
|
|
$
|
0.53
|
|
|
$
|
(0.29
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted earnings
(loss) per share
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
|
|
|
36,514
|
|
|
|
34,909
|
|
|
|
33,084
|
|
Stock options
|
|
|
|
|
|
|
1,968
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing diluted
earnings (loss) per share
|
|
|
36,514
|
|
|
|
36,877
|
|
|
|
33,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share
|
|
$
|
(3.95
|
)
|
|
$
|
0.50
|
|
|
$
|
(0.29
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive potential common
shares excluded from above calculation (in thousands):
|
|
|
6,837
|
|
|
|
5,804
|
|
|
|
8,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Had Genesis been profitable during the year ended March 31,
2007, 313,000 shares would have been added to weighted
average shares for the purposes of calculating diluted earnings
per share (2005 1,192,000 shares).
|
|
13.
|
COMMITMENTS
AND CONTINGENCIES
|
Lease
commitments
Genesis leases premises in the United States, Canada, India,
Taiwan, Japan, South Korea, Singapore, China and Turkey under
operating leases that expire between April 2007 and January
2012. In addition, certain equipment is leased under
non-cancelable operating leases expiring in various years
through 2011. Future minimum lease payments by fiscal year are
as follows:
|
|
|
|
|
2008
|
|
$
|
4,958
|
|
2009
|
|
|
4,464
|
|
2010
|
|
|
2,529
|
|
2011
|
|
|
1,863
|
|
2012
|
|
|
1,065
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,879
|
|
|
|
|
|
|
Rental expense was $5,580 for the year ended March 31,
2007, $4,244 for the year ended March 31, 2006, and $4,249
for the year ended March 31, 2005.
F-26
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Legal
proceedings
Genesis is not a party to any material legal proceedings.
Supply
arrangements
Genesis subcontracts portions of its semiconductor manufacturing
from several suppliers and no single production process for any
single product is performed by more than one supplier. Should
our wafer supplier or any of Genesis packaging or testing
subcontractors cease to be available, management believes that
this would have a material adverse effect on Genesis
business, financial condition and results of operations. Genesis
has no guarantees of minimum capacity from its suppliers and is
not liable for any material minimum purchase commitments.
Guarantees
and indemnifications
In connection with certain agreements that we have executed in
the past, we have at times provided indemnities to cover the
indemnified party for matters such as product liability. We have
also on occasion included intellectual property indemnification
provisions in the terms of our technology related agreements
with third parties. Maximum potential future payments cannot be
estimated because many of these agreements do not have a maximum
stated liability. However, historic costs related to these
indemnification provisions have not been significant. We have
not recorded any liability in our consolidated financial
statements for such indemnities.
Genesis operates and tracks its results in one operating
segment. Genesis designs, develops and markets integrated
circuits that manipulate and process digital video and graphic
images. The target market is the advanced display market
including LCD monitors and flat-panel televisions.
Geographic
information
Geographic revenue information is based on the shipment
destination. Long-lived assets include property and equipment,
as well as intangible assets. Property and equipment information
is based on the physical location of the asset while the
intangible assets are based on the location of the owning entity.
Revenues from unaffiliated customers by geographic region were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
United States
|
|
$
|
1,180
|
|
|
$
|
3,493
|
|
|
$
|
8,803
|
|
China
|
|
|
83,707
|
|
|
|
115,016
|
|
|
|
78,167
|
|
Japan
|
|
|
24,005
|
|
|
|
27,356
|
|
|
|
15,289
|
|
South Korea
|
|
|
53,256
|
|
|
|
51,487
|
|
|
|
52,871
|
|
Taiwan
|
|
|
20,307
|
|
|
|
28,704
|
|
|
|
28,824
|
|
Europe
|
|
|
24,705
|
|
|
|
31,131
|
|
|
|
13,334
|
|
Rest of world
|
|
|
7,457
|
|
|
|
12,319
|
|
|
|
6,827
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
214,617
|
|
|
$
|
269,506
|
|
|
$
|
204,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-27
Genesis
Microchip Inc.
Notes to
Consolidated Financial
Statements (Continued)
Net long-lived assets by country were as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
United States
|
|
$
|
94,716
|
|
|
$
|
197,561
|
|
Rest of world
|
|
|
10,933
|
|
|
|
9,934
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
105,649
|
|
|
$
|
207,495
|
|
|
|
|
|
|
|
|
|
|
Concentration
information
The following table shows the percentage of our revenues in the
years ended March 31, 2007, 2006 and 2005 that was derived
from customers who individually accounted for more than 10% of
revenues in that year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Customer A
|
|
|
16
|
%
|
|
|
15
|
%
|
|
|
15
|
%
|
Customer B
|
|
|
10
|
%
|
|
|
10
|
%
|
|
|
|
|
Customer C
|
|
|
10
|
%
|
|
|
10
|
%
|
|
|
|
|
Customer D
|
|
|
|
|
|
|
|
|
|
|
10
|
%
|
The following table shows customers accounting for more than 10%
of accounts receivable trade at March 31, 2007 and
March 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Customer 1
|
|
|
36
|
%
|
|
|
22
|
%
|
Customer 2
|
|
|
13
|
%
|
|
|
12
|
%
|
Customer 3
|
|
|
|
|
|
|
12
|
%
|
Customer 4
|
|
|
|
|
|
|
11
|
%
|
We have reclassified certain prior year information to conform
to the current years presentation.
F-28
|
|
ITEM 9.
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
Not applicable.
|
|
ITEM 9A.
|
CONTROLS
AND PROCEDURES
|
(a) Evaluation of disclosure controls and
procedures. Our management evaluated, with the
participation of our Chief Executive Officer and our Principal
Accounting Officer, the effectiveness of our disclosure controls
and procedures as of the end of the period covered by this
report. Based on this evaluation, our Chief Executive Officer
and our Principal Accounting Officer have concluded that our
disclosure controls and procedures as of the end of the period
covered by this report are effective to ensure that information
we are required to disclose in reports that we file or submit
under the Securities Exchange Act of 1934 is accumulated and
communicated to our management, including our Chief Executive
Officer and Principal Accounting Officer, as appropriate, to
allow timely decisions regarding required disclosure, and that
such information is recorded, processed, summarized and reported
within the time periods specified in the Securities and Exchange
Commissions rules and forms.
Managements Report on Internal Control Over Financial
Reporting. Please see Managements Annual
Report on Internal Control over Financial Reporting under
Item 8 of this
Form 10-K,
which report is incorporated herein by reference.
(b) Changes in internal control over financial
reporting. There was no change in our internal
control over financial reporting that occurred during the fourth
quarter of 2007 that has materially affected, or is reasonably
likely to materially affect, our internal control over financial
reporting.
|
|
ITEM 9B.
|
OTHER
INFORMATION
|
Not applicable.
PART III
|
|
ITEM 10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
DIRECTORS
Currently, there are seven (7) members of our Board of
Directors. The following table sets forth certain information
concerning our current directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
Name
|
|
Age
|
|
Position
|
|
Since
|
|
Class III Directors Whose
Terms Expire at the 2007 Annual Meeting
|
|
|
|
|
|
|
|
|
|
|
Jon Castor(1)(4)
|
|
|
55
|
|
|
Director
|
|
|
2004
|
|
Chieh Chang(2)(3)
|
|
|
55
|
|
|
Director
|
|
|
2004
|
|
Jeffrey Diamond(2)(4)
|
|
|
55
|
|
|
Chairman of the Board
|
|
|
2001
|
|
Class I Directors Whose
Terms Expire at the 2008 Annual Meeting:
|
|
|
|
|
|
|
|
|
|
|
Tim Christoffersen(1)(3)
|
|
|
65
|
|
|
Director
|
|
|
2002
|
|
Robert H. Kidd(1)(4)
|
|
|
63
|
|
|
Director
|
|
|
2002
|
|
Class II Directors Whose
Terms Expire at the 2009 Annual Meeting:
|
|
|
|
|
|
|
|
|
|
|
Chandrashekar M. Reddy(2)(3)
|
|
|
47
|
|
|
Director
|
|
|
2002
|
|
Elias Antoun
|
|
|
51
|
|
|
President, Chief Executive
Officer and Director
|
|
|
2004
|
|
|
|
|
(1) |
|
Member of the Audit Committee. |
|
(2) |
|
Member of the Compensation Committee. |
36
|
|
|
(3) |
|
Member of the Corporate Governance Committee. |
|
(4) |
|
Member of the Nominating Committee. |
Jon Castor has been a director of Genesis since November
2004. From January 2004 to June 2004, Mr. Castor was an
Executive Advisor to the Chief Executive Officer of Zoran
Corporation, and from August 2003 to December 2003, he was
Senior Vice President and General Manager of Zorans DTV
Division. From October 2002 to August 2003, Mr. Castor was
the Senior Vice President and General Manager of the TeraLogic
Group at Oak Technology Inc., a developer of integrated circuits
(ICs) and software for digital televisions and printers which
was acquired by Zoran. Prior to that, Mr. Castor co-founded
TeraLogic, Inc., a developer of digital television ICs, software
and systems in June 1996 where he served in several capacities
including as its President, Chief Financial Officer and director
from June 1996 to November 2000, and as its Chief Executive
Officer and director from November 2000 to October 2002, when it
was acquired by Oak Technology. Mr. Castor also serves on
the Board of Directors of Adaptec Inc. (NASDAQ: ADPT), a data
storage solutions company, and as a member of its Audit and
Compensation Committees. Mr. Castor also serves as Chairman
of the Board of Directors of Artimi, Inc., an ultrawideband
wireless technology company, where he is also Chairman of the
Compensation Committee, and as Chairman of the Board of Omneon
Video Networks, a broadcast media server and storage company,
where he is also Chairman of the Compensation Committee and a
member of the Audit Committee. Mr. Castor received his B.A.
with distinction from Northwestern University and his M.B.A.
from Stanford Graduate School of Business.
Chieh Chang has been a director of Genesis since November
2004. Mr. Chang has been a member of the board of directors
of Oplink Communications, Inc. since September 1995. Since
February 2003, Mr. Chang has served as Vice Chairman of
Chingis Technology Corporation., a fabless semiconductor design
company, and from February 2000 to February 2003, as its Chief
Executive Officer. From April 1992 to August 1996,
Mr. Chang was the Director of Technology at Cirrus Logic,
Inc., a semiconductor company. Mr. Chang received his B.S.
in Electrical Engineering from the National Taiwan University
and his M.S. in Electrical Engineering from UCLA.
Jeffrey Diamond was appointed Chairman of the Board of
Directors in July 2003, and has served as a director since April
2001. After our acquisition of Paradise Electronics, Inc. in May
1999, Mr. Diamond also served as an executive officer and
as a consultant to Genesis through December 2000. Prior to that,
he served as a director of Paradise from its inception in 1996
and as its Chief Executive Officer from September 1998 until May
1999. Mr. Diamond held senior management positions at
Cirrus Logic, Inc. from April 1992 to March 1995.
Mr. Diamond received his B.S. in Business Administration
from the University of Illinois.
Tim Christoffersen was appointed as a director in August
2002. Mr. Christoffersen served as Chief Financial Officer
of Monolithic Power Systems, Inc. (MPS), a semiconductor
company, from June 2004 to April 2006, and served on MPSs
board of directors from March 2004 to July 2004. Since January
1999, Mr. Christoffersen has been a financial consultant to
technology companies. Prior to that, Mr. Christoffersen
served as Chief Financial Officer of NeoParadigm Labs, Inc. from
1998 to 1999 and as Chief Financial Officer of Chips &
Technologies, Inc. from 1994 until its sale to Intel Corporation
in 1998. Mr. Christoffersen was Executive Vice President,
Director and Chief Operating Officer of Resonex, Inc. from 1991
to 1992. From 1986 to 1991, Mr. Christoffersen held several
managerial positions with Ford Motor Company.
Mr. Christoffersen is a Phi Beta Kappa graduate of Stanford
University where he earned a B.A. in Economics. He also holds a
Masters degree in Divinity from Union Theological Seminary
in New York City.
Robert H. Kidd was appointed as a director in August
2002. Mr. Kidd serves as President of Location Research
Company of Canada Limited, a consulting company. Mr. Kidd
also serves as a director of Hostopia.com (TSX: H), a provider
of private-label wholesale hosting, email, and application
services, and as Vice Chairman of Appleby College Foundation.
Mr. Kidd served as Chief Financial Officer of Technology
Convergence Inc. from 2000 to 2002, of Lions Gate Entertainment
Corp. from 1997 to 1998, and of InContext Systems Inc. from 1995
to 1996. He served as Senior Vice President, Chief Financial
Officer and Director of George Weston Limited from 1981 to 1995,
as a partner of Thome Riddell, Chartered Accountants, a
predecessor firm of KPMG LLP, from 1973 to 1981 and as a
Lecturer in Finance, Faculty of Management Studies, University
of Toronto, from 1971 to 1981. Mr. Kidd has served on
several professional committees, including the Toronto Stock
Exchange Investors & Issuers Advisory Committee from
1993 to 1998, the Canadian Institute of Chartered Accountants
Emerging Issues Committee from 1992 to 1997 and the Canadian
Securities Administrators Committee on Conflicts of Interest in
Underwriting from
37
1994 to 1996. Mr. Kidd has a B. Commerce from the
University of Toronto and an M.B.A. from York University.
Mr. Kidd is a Fellow of the Institute of Chartered
Accountants of Ontario.
Chandrashekar M. Reddy joined Genesis as a director upon
its acquisition of Sage, Inc. in February 2002. He served as
Vice Chairman and as Executive Vice President, Engineering of
Genesis from February 2002 to November 2002. He served as
Chairman of the Board of Directors and Chief Executive Officer
of Sage from its inception in 1994 until its acquisition by
Genesis in February 2002. Mr. Reddy served as the Chief
Executive Officer of Athena Semiconductors, Inc., a wireless
communications business, from December 2002 to October 2005 and
as a member of its Board of Directors from January 2002 to
October 2005, when it was acquired by Broadcom Corp. From 1986
to 1995, Mr. Reddy held several design and program
management positions at Intel Corporation. Mr. Reddy also
serves on the Board of Directors of Sonoros Corp., a privately
held company. Mr. Reddy received an M.S. in Electrical
Engineering from the University of Wisconsin, Madison and a B.S.
in Electrical Engineering from the Indian Institute of
Technology.
Elias Antoun has served as President and Chief Executive
Officer of the Company and a member of our Board of Directors
since November 2004. Prior to his appointment, Mr. Antoun
served as the President and Chief Executive Officer of Pixim,
Inc., an imaging solution provider for the video surveillance
market, between March 2004 and November 2004. From February 2000
to August 2003, Mr. Antoun served as the President and
Chief Executive Officer of MediaQ, Inc., a mobile handheld
graphics IC company acquired by NVIDIA Corporation in August
2003. From January 1991 to February 2000, Mr. Antoun held a
variety of positions with LSI Logic Corporation, most recently
serving as Executive Vice President of the Consumer Products
Division from 1998 until his departure in January 2000.
Mr. Antoun served as a Director of HPL Technologies, Inc.
from August 2000 to December 2005, and as Chairman of the Board
of Directors of HPL Technologies, Inc. from July 2002 to
December 2005. Mr. Antoun received a B.S. in Electrical
Engineering from UCLA, and an M.B.A. from Stanford Graduate
School of Business.
The
Board of Directors, its Committees and Meetings
Board of Directors. The Board of Directors
held 26 meetings during the fiscal year ended March 31,
2007. Each director attended or participated telephonically in
75% or more of the aggregate of (i) the total number of the
meetings of the Board of Directors (held during the period for
which such director was a director) and (ii) the total
number of meetings of all committees on which such director
served (held during the period for which such director served as
a committee member) during the fiscal year ended March 31,
2007.
A majority of the directors on the Companys Board of
Directors are independent within the meaning of the NASDAQ Stock
Market, Inc. director independence standards, as currently in
effect. The Board of Directors has determined that each of its
current directors, except Elias Antoun, has no material
relationship with Genesis and is independent. In addition, the
independent members of the Board of Directors met numerous times
during the fiscal year ended March 31, 2007.
Our Board of Directors has standing Compensation, Audit,
Corporate Governance and Nominating Committees.
Compensation Committee. The Compensation
Committee reviews and evaluates the compensation and benefits of
our officers, reviews general policy matters relating to
compensation and benefits of our employees and makes
recommendations concerning these matters to the Board of
Directors. The Compensation Committee also administers our stock
option plans and stock purchase plan. The Compensation Committee
held 19 meetings during the fiscal year ended March 31,
2007.
Currently, our Compensation Committee consists of
Mr. Diamond, Mr. Chang and Mr. Reddy, each of
whom qualify as independent in accordance with the
published listing requirements of Nasdaq. Mr. Diamond
serves as chairman of this committee. The current Compensation
Committee charter is available at our Web site located at
www.gnss.com.
Audit Committee. Among other things, the Audit
Committee reviews the scope and timing of audit services and any
other services that our independent accountants are asked to
perform, the auditors report on our consolidated financial
statements following completion of their audit and our policies
and procedures with respect
38
to internal accounting and financial controls. The Audit
Committee also reviews and approves any related party
transactions. The Audit Committee approves, in advance, all
permissible non-audit services provided by the companys
independent accountants.
Currently, our Audit Committee consists of
Mr. Christoffersen, Mr. Castor and Mr. Kidd.
Mr. Kidd serves as chairman of this committee. The Audit
Committee held 15 meetings during the fiscal year ended
March 31, 2007. In addition to qualifying as
independent in accordance with the published listing
requirements of Nasdaq, each member of the Audit Committee
qualifies as independent under special standards
established by the SEC for members of audit committees. The
Audit Committee also includes at least one independent member
who is determined by the Board of Directors to meet the
qualifications of an audit committee financial
expert in accordance with SEC rules, including that the
person meets the relevant definition of an independent director.
The Board of Directors has determined that each of the current
Audit Committee members is independent and an audit committee
financial expert. Stockholders should understand that this
designation is a disclosure requirement of the SEC related to
the Audit Committee members experience and understanding
with respect to certain accounting and auditing matters. The
designation as an audit committee financial expert does not
impose upon an Audit Committee member any duties, obligations or
liability that are greater than are generally imposed on him as
a member of the Audit Committee and the Board of Directors, and
his designation as an audit committee financial expert pursuant
to this SEC requirement does not affect the duties, obligations
or liability of any other member of the Audit Committee or the
Board of Directors. The current Audit Committee charter is
available at our Web site located at www.gnss.com.
Nominating Committee. The Nominating Committee
is responsible for seeking, screening and recommending for
nomination candidates for election to the Board of Directors and
appointments to the Board of Directors to fill any vacancies. In
so doing, the Nominating Committee may evaluate, among other
things:
|
|
|
|
|
The current size, composition and needs of the Board of
Directors and its committees;
|
|
|
|
such factors as judgment, independence, character and integrity,
area of expertise, diversity of experience, length of service,
and potential conflicts of interest of candidates; and
|
|
|
|
such other factors as the Nominating Committee may consider
appropriate.
|
These factors, and any other qualifications considered useful by
the Nominating Committee, are reviewed in the context of an
assessment of the perceived needs of the Board of Directors at a
particular point in time. As a result, the priorities and
emphasis of the Nominating Committee and of the Board of
Directors may change from time to time to take into account
changes in business and other trends, and the portfolio of
skills and experience of current and prospective Board of
Directors members. Therefore, the Nominating Committee has not
established any specific minimum criteria or qualifications that
a nominee must possess. The current Nominating Committee charter
is available at our Web site located at www.gnss.com.
The Nominating Committee will evaluate candidates identified on
its own initiative as well as candidates referred to it by other
members of the Board of Directors, by our management, by
stockholders who submit names to the Nominating Committee, or by
other external sources. Since our last annual meeting in 2006,
we have not employed a search firm or paid fees to other third
parties in connection with seeking or evaluating Board of
Directors nominee candidates.
With regard to referrals from our stockholders, the Nominating
Committees policy is to consider recommendations for
candidates to the Board of Directors from stockholders holding
not less than 1% of our outstanding common stock continuously
for at least twelve months prior to the date of the submission
of the recommendation. Candidates suggested by stockholders are
evaluated using the same criteria as for other candidates. A
stockholder that desires to recommend a candidate for election
to the Board of Directors shall direct the recommendation in
written correspondence by letter to Genesis Microchip Inc.,
attention of the Companys Secretary, at our offices at
2525 Augustine Drive, Santa Clara, California 95054.
Such notice must include the candidates name, home and
business contact information, detailed biographical data,
relevant qualifications, a signed letter from the candidate
confirming willingness to serve, information regarding any
relationships between the candidate and Genesis within the last
three years, evidence of the required ownership of common stock
by the recommending stockholder, and to
39
the extent known by the stockholder, any relationships between
the candidate and competitors, customers, suppliers and any
other parties that might give rise to the appearance of a
potential conflict of interest. Any stockholder who wishes to
make a direct nomination for election to the Board of Directors
at an annual or special meeting for the election of directors
must comply with procedures set forth in our bylaws.
Currently, our Nominating Committee consists of
Mr. Diamond, Mr. Castor and Mr. Kidd, each of
whom is independent in accordance with the published
listing requirements of Nasdaq. Mr. Diamond serves as
chairman of this committee. The Nominating Committee held two
meetings during the fiscal year ended March 31, 2007.
The current Nominating Committee charter is available at our Web
site located at www.gnss.com.
Corporate Governance Committee. The Corporate
Governance Committee oversees the Companys disclosure
controls and procedures, except for the financial reporting
controls and procedures overseen by the Audit Committee, and
recommends to the Board of Directors the adoption of any
measures it deems advisable for the improvement of disclosure
controls and procedures. Currently, our Corporate Governance
Committee consists of Messrs. Christoffersen, Chang and
Reddy. Mr. Christoffersen serves as chairman of this
committee. The Corporate Governance Committee held two meetings
during the fiscal year ended March 31, 2007.
The current Corporate Governance Committee charter is available
at our Web site located at www.gnss.com.
Corporate
Governance.
We believe transparent, effective, and accountable corporate
governance practices are key elements of our relationship with
our stockholders. To help our stockholders understand our
commitment to this relationship and our governance practices,
several of our key governance initiatives are summarized below.
Corporate Governance Guidelines. Our Board of
Directors has adopted Corporate Governance Guidelines which
govern, among other things, Board member criteria (including
limits on the number of boards upon which directors may serve),
responsibilities, compensation and education, Board committee
composition and charters, management succession, and Board
self-evaluation. You can access these Corporate Governance
Guidelines, along with other materials such as committee
charters, on our website at www.gnss.com.
Code of Ethics. We have adopted a code of
ethics that applies to our principal executive officer and all
members of our finance department, including the principal
financial officer and principal accounting officer. This
Code of Ethics-Financial, as well as our Code
of Business Conduct and Ethics, which applies to all
employees generally, are posted on our Website. The Internet
address for our Website is
http://www.gnss.com,
and both codes may be found as follows:
1. From our main Web page, first click on
Investors,
2. Next, click on Corporate Governance.
3. Finally, click on Code of Business Conduct and
Ethics or Code of Ethics-Financial.
We intend to satisfy the disclosure requirement under
Item 5.05(c) of
Form 8-K
regarding certain amendments to, or waivers from, a provision of
this code of ethics by posting such information on our website,
at the address and location specified above, within four
business days of such amendment or waiver.
Director attendance at annual
meetings. Genesis does not have a formal policy
regarding the attendance of its directors at annual or special
meetings of stockholders, but the Company encourages directors
to attend such meetings. Of the two directors elected at the
September 13, 2006 annual meeting and the five continuing
directors who were not up for re-election at that meeting, all
seven directors attended that meeting.
Director continuing education. Pursuant to our
Corporate Governance Guidelines, Genesis encourages the
directors to attend appropriate continuing education classes
every two years. During the last two years, each member of our
Board of Directors attended a director education program
endorsed by Institutional Shareholder Services, except for
Mr. Chang.
40
EXECUTIVE
OFFICERS
The following table lists the names and positions held by each
of our executive officers as of March 31, 2007:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Elias Antoun
|
|
|
51
|
|
|
President, Chief Executive Officer
and Director
|
Michael Healy(1)
|
|
|
45
|
|
|
Chief Financial Officer and Senior
Vice President, Finance
|
Behrooz Yadegar(2)
|
|
|
47
|
|
|
Senior Vice President, Product
Development
|
Hildy Shandell(3)
|
|
|
51
|
|
|
Senior Vice President, Corporate
Development
|
Anders Frisk(4)
|
|
|
51
|
|
|
Executive Vice President
|
Ernest Lin
|
|
|
53
|
|
|
Senior Vice President, Worldwide
Sales
|
Jeffrey Lin(5)
|
|
|
34
|
|
|
General Counsel
|
Ava Hahn(6)
|
|
|
34
|
|
|
Associate General Counsel and
Secretary
|
|
|
|
(1) |
|
On May 16, 2007, Michael Healy terminated employment. |
|
(2) |
|
On May 16, 2006, Behrooz Yadegar joined the company. |
|
(3) |
|
On September 12, 2006, Hildy Shandell joined the company. |
|
(4) |
|
In June 2007, Anders Frisk resigned from the company and will
terminate employment on July 31, 2007. |
|
(5) |
|
On June 8, 2007, Jeffrey Lin was appointed Secretary of the
company. |
|
(6) |
|
In May 2007, Ava Hahn resigned from the company and will
terminate employment on June 12, 2007. |
Elias Antoun has served as President and Chief Executive
Officer since November 2004. Prior to his appointment,
Mr. Antoun served as the President and Chief Executive
Officer of Pixim, Inc., an imaging solution provider for the
video surveillance market, between March 2004 and November 2004.
From February 2000 to August 2003, Mr. Antoun served as the
President and Chief Executive Officer of MediaQ, Inc., a mobile
handheld graphics IC company acquired by NVIDIA Corporation in
August 2003. From January 1991 to February 2000, Mr. Antoun
held a variety of positions with LSI Logic Corporation, most
recently serving as Executive Vice President of the Consumer
Products Division from 1998 until his departure in January 2000.
Mr. Antoun served as a Director of HPL Technologies, Inc.
from August 2000 to December 2005, and as Chairman of the Board
of Directors of HPL Technologies, Inc. from July 2002 to
December 2005.
Michael Healy joined Genesis in February 2004 as Chief
Financial Officer and Senior Vice President of Finance, and
terminated employment in May 2007. Previously, Mr. Healy
served as Chief Financial Officer of Jamcracker, Inc., a
software and application service provider, from November 2002 to
February 2004. From September 1997 to January 2002,
Mr. Healy held senior level finance positions at Exodus
Communications, including Senior Vice President of Finance.
Prior to then, he held various senior financial management
positions at Apple Computer, and was an auditor at
Deloitte & Touche. Mr. Healy holds a
bachelors degree in accounting from Santa Clara
University and is a Certified Public Accountant. Mr. Healy
is a member of the American Institute of Certified Public
Accountants and the California Society of Certified Public
Accountants.
Behrooz Yadegar joined Genesis in May 2006 as Senior Vice
President, Product Development. Prior to joining Genesis,
Mr. Yadegar served as the Vice President of Engineering and
Operations for Cortina Systems Inc., a global communications
supplier of port connectivity solutions to the networking and
telecommunications sector, from March 2004 to April 2006. From
October 2000 to August 2003, Mr. Yadegar was the Senior
Vice President of Engineering and Operations at MediaQ, Inc.,
which was acquired by NVIDIA in 2003. Previously,
Mr. Yadegar held senior technical management positions at
Silicon Graphics, MIPS and Intel. Mr. Yadegar holds B.S.
and M.S. degrees in electrical engineering from the
University of Missouri.
Hildy Shandell joined Genesis Microchip in September 2006
as Senior Vice President of Corporate Development. Prior to
joining Genesis, Ms. Shandell was the Vice President of
Corporate Development at Broadcom Corporation, a broadband
communications semiconductor company, from September 2002 until
September 2006. From January 1999 until May 2002,
Ms. Shandell was with 3Dlabs Inc., a developer of graphics
semiconductors, where she was most recently Chief Operating
Officer. From January 1995 until January 1999, Ms. Shandell
was Of
41
Counsel with Skadden, Arps, Slate, Meagher & Flom.
From April 1994 until January 1999, Ms. Shandell also
served as managing director of The Renaissance Fund, a private
equity fund focused on high technology and infrastructure
investments related to Israel. Prior to that, Ms. Shandell
was a partner at Fulbright & Jaworski.
Ms. Shandell holds a B.A. degree in Sociology and
Government from Lehigh University and a J.D. from Temple
University School of Law.
Anders Frisk has served as Executive Vice President since
January 2003. Mr. Frisk joined Genesis in March 2000 as
Vice President, Marketing. Prior to then, he served as Director
of Technology Planning with Nokia from February 1998 to March
2000, and as PC Architecture Manager with Fujitsu ICL Computers
from April 1991 to January 1998. Mr. Frisk has served on
the board of the Video Electronics Standards Association, or
VESA, and chaired VESAs Monitor Committee for four years.
Mr. Frisk holds a masters degree in electrical
engineering from Stockholms Royal Institute of Technology.
Mr. Frisk has resigned from the company and will terminate
employment on July 31, 2007.
Ernest Lin has served as Senior Vice President, Worldwide
Sales since January 2005. Prior to joining Genesis, Mr. Lin
served as vice president of global sales at NeoMagic Corporation
from December 2001 to December 2004. Prior to then, Mr. Lin
served as executive vice president of business operations for
LinkUp System Corporation from September 1997 until its
acquisition by NeoMagic in December 2001. Additionally,
Mr. Lin was instrumental in building Cirrus Logics
business in the Asia Pacific region. During his 12 year
tenure at Cirrus Logic, he held several executive management,
sales and engineering positions, including vice president, Asia
Pacific Sales. Mr. Lin holds an MBA from Santa Clara
University, a Masters degree in computer science from the
University of Utah and a BSEE from the National Taiwan
University in Taipei, Taiwan.
Jeffrey Lin joined Genesis in September 2004 and has
served as General Counsel since August 2005. Mr. Lin was
appointed Secretary in June 2007. Prior to joining Genesis, from
June 1999 to August 2004, Mr. Lin was an associate with
Wilson Sonsini Goodrich & Rosati, P.C., where he
focused on technology transactions for private and public
companies. Prior to that, Mr. Lin was an attorney at the
Federal Trade Commission, where he worked on antitrust matters
in the microprocessor industry. Mr. Lin holds a B.S. from
the University of Michigan and a J.D. from UCLA School of Law.
Ava Hahn joined Genesis in August 2002 as Corporate
Counsel. From May 2003 to August 2005, she served as General
Counsel, and since October 2003, she has also served as
Secretary. In addition, Ms. Hahn was Assistant Secretary
from September 2002 to October 2003. From August 2000 to August
2002, Ms. Hahn was Director, Legal Affairs at LuxN, Inc.,
an optical networking company. Prior to then, from August 1997
to August 2000, Ms. Hahn was an associate attorney with
Wilson Sonsini Goodrich & Rosati, P.C.
Ms. Hahn holds a bachelors degree from the University
of California at Berkeley and a J.D. from Columbia Law School.
Ms. Hahn has resigned from the company and will terminate
employment on June 12, 2007.
|
|
Item 11.
|
EXECUTIVE
COMPENSATION
|
REPORT OF
THE COMPENSATION COMMITTEE
The Compensation Committee of the Company has reviewed and
discussed the following Compensation Discussion and Analysis
with management, and, based on such review and discussions, the
Compensation Committee recommended to the Board that the
Compensation Discussion and Analysis be included in this 2007
Annual Report on
Form 10-K.
Compensation Committee
Jeffrey Diamond (Chair)
Chieh Chang
Chandrashekar M. Reddy
42
COMPENSATION
DISCUSSION AND ANALYSIS
Executive
Compensation Program Objectives and Philosophy
The Compensation Committee of our Board of Directors oversees
the design and administration of our executive officer
compensation program. Our Compensation Committees
philosophy in structuring and administering our executive
officer compensation program is to maximize stockholder value
over time by closely aligning the interests of the executive
officers with those of our stockholders. To achieve this goal of
maximizing stockholder value over time, the primary objectives
of our executive officer compensation program are to:
|
|
|
|
|
Offer compensation opportunities that attract and retain
executives whose abilities are critical to our long-term success;
|
|
|
|
Motivate executives to perform at their highest level and reward
outstanding achievement;
|
|
|
|
Maintain a significant portion of the executives total
compensation at risk, tied to achievement of financial,
organizational and management performance goals; and
|
|
|
|
Encourage executives to manage from the perspective of owners
with an equity stake in Genesis.
|
Determination
of Compensation
Our Compensation Committee, in conjunction with our CEO and our
Vice President, Human Resources, reviews at least annually our
executive officers compensation levels to determine
whether they provide adequate incentives and motivation to our
executive officers. The Compensation Committee determines
executive compensation based on an evaluation of the
responsibilities, experience and performance levels of each
individual executive officer as well as an evaluation of our
overall effectiveness in attracting and retaining executives
under our current business circumstances. For example, as
further described in the Risk Factors section of
this 10-K on
page 10, Genesis has recently experienced significant
turnover in its senior management team. The Compensation
Committee considers executive retention and risks associated
with management turnover among other factors in determining
executive compensation. To help ensure that the levels of
executive compensation determined by the Compensation Committee
are effective in retaining and motivating our executive
officers, the Compensation Committee also reviews compensation
levels of comparable executive officers in other similarly
situated companies with which we compete for talent. Our
Compensation Committees most recent review occurred in
late 2006 and early 2007, when our Compensation Committee
retained an independent compensation consultant, Compensia, to
assist it in evaluating our compensation practices and
philosophy and to assist it in developing and implementing our
executive compensation program. We paid Compensia $164,587 in
fiscal 2007.
Our compensation consultant developed a competitive peer group
based on input from the company, and performed an analysis of
competitive performance and compensation levels. We define our
competitive market for executive talent to be publicly traded
fabless semiconductor companies headquartered in Northern
California or with similar revenue levels, organization
structures and numbers of employees. Comparable public companies
used in our analysis include the following: Electronics For
Imaging, OmniVision Technologies, Zoran, Silicon Storage
Technology, Standard Microsystems, PMC-Sierra, Applied Micro
Circuits, Sigmatel, PortalPlayer (now Nvidia), Semtech, Silicon
Image, Integrated Silicon Solution, Cirrus Logic, Pixelworks and
Trident Microsystems (together, the Peer Group).
Our Compensation Committee believes that reviewing Peer Group
compensation levels can provide useful data for purposes of
comparison. As a general guideline, the Compensation Committee
believes that compensation levels at or near the Peer Group
median should enable the Company to remain competitive in the
markets for which the Company competes for talent. Peer Group
compensation levels are among many factors we consider in
assessing the reasonableness of our compensation. However, the
Compensation Committee does not adhere to strict benchmark
targets in setting compensation levels. Rather, the Compensation
Committee sets compensation levels based on the skills,
experience, responsibilities and achievements of each executive
officer, taking into account the strategic objectives of the
Company, the compensation ranges and relative performance of the
Peer Group, and the recommendations of the CEO, except with
respect to his own position. For example, in instances where an
executive officer is uniquely key to our success, our
Compensation Committee may provide compensation in excess of
the
43
Peer Group median for comparable positions. Executives with
significant experience and responsibility or a record of
sustained high-performance may be paid more than the Peer Group
median for their position, while executives with less experience
or a shorter record of sustained high performance may be paid
less than the Peer Group median for their position. Our
Compensation Committees judgments with regard to market
levels of compensation were based on the advice and Peer Group
data provided by the compensation consultant, on industry
compensation surveys from Radford Group, and the Compensation
Committees experience with and knowledge of other
similarly situated companies.
Based on an assessment by our compensation consultant, the
Compensation Committee believes that average executive total
compensation in fiscal 2007, including bonuses for performance
in fiscal 2006 that were paid out in early fiscal 2007,
approximated the 50th percentile of the Peer Group median.
When bonus amounts for fiscal 2006 performance are replaced with
bonus amounts for fiscal 2007 (which amounts equal zero, as
further described below), average executive total compensation
for fiscal 2007 was below the Peer Group median.
Elements
of Executive Compensation
The principal elements of our executive compensation program are
base salary, potential annual cash bonus awards pursuant to our
executive bonus plan, and long-term equity incentives in the
form of stock options
and/or
restricted stock units (RSUs). We view the separate
components of compensation as related but distinct. The
Compensation Committee does not believe that significant
compensation derived from one component of compensation should
necessarily negate or offset compensation from other components.
We determine the appropriate level for each compensation
component as well as for total compensation based in part, but
not exclusively, on each executives responsibilities,
performance and experience levels, our specific recruiting and
retention goals, our view of internal equity and consistency,
competitiveness and performance relative to the Peer Group and
other considerations we deem relevant, such as rewarding
extraordinary performance.
Base
Salary
Base salaries are a necessary component of compensation in order
to attract and retain talent and are intended to recognize and
reward day-to-day performance. Base salaries for our executives
are established based on the scope of their responsibilities and
the experience and achievements of the executive, taking into
account competitive market compensation paid by other companies
for similar positions. Base salaries are reviewed annually, and
adjusted from time to time, typically in April along with all
other employees, to realign salaries with competitive market
levels after taking into account individual responsibilities,
performance and experience.
Executive
Bonus Plan
Our executive bonus plan provides at risk cash
compensation that is tied to annual performance and is intended
to reward both individual achievement and achievement of
corporate-level goals. We designed the bonus plan to focus our
management on achieving key corporate objectives, to motivate
certain desirable individual behaviors and to reward substantial
achievement of our key corporate financial objectives and
individual goals. Payment pursuant to the bonus plan is based
upon two components, a corporate financial component and an
individual performance objective component.
The corporate financial component is based on our financial
performance relative to the minimum financial targets under our
fiscal year 2007 operating plan. Specifically, these minimum
targets are (a) 90% of the operating plan revenue, and
(b) 90% of the operating plan non-GAAP operating income.
Both (a) and (b) must be achieved in order for a bonus
pool to be established under the plan. This component is
weighted 75% towards non-GAAP operating income and 25% towards
revenue achievement. For purposes of this calculation, non-GAAP
operating income may be adjusted for unusual items (such as
mergers and acquisitions) as determined by the CEO and Chief
Financial Officer, and as approved by the Board of Directors. An
eligible executive may earn a bonus up to the percentage of
his/her
salary as follows, for cash bonus amounts at 100% achievement of
performance targets: Elie Antoun, Chief Executive Officer, 50%
of base salary; Michael Healy, Chief Financial Officer, 25% of
base salary; Ernest Lin, 37.5% of base salary; Behrooz Yadegar,
25% of base salary; Anders Frisk, 25% of base salary; Hildy
Shandell, 25% of base salary.
44
The individual performance objectives are determined by our CEO
and Compensation Committee or, in the case of our CEO, by our
Compensation Committee, with input from the other members of our
Board of Directors. Our performance goals are both quantitative
and qualitative and are specific to each executives areas
of responsibility.
With respect to quantitative goals, no discretion may be
exercised because these goals are objective. With respect to
qualitative goals, a moderate amount of discretion may be
exercised because it is necessary to exercise discretion in
order to determine whether such goals are met. We believe that
our bonus target levels are difficult to achieve and that our
executives must perform at a high level devoting their full time
and attention in order to earn their respective bonuses.
Consistent with the at risk, pay-for-performance nature of the
executive bonus plan, the plan is funded only if the company
achieves at least 90% of corporate revenue and operating income
goals. Executive target bonus levels are set to deliver cash
compensation at or below market median levels for performance at
or below target; for performance above target levels, the bonus
opportunity accelerates so that total cash compensation earned
will generally reflect levels above market median.
In fiscal 2007, we did not achieve our corporate financial
goals, and as such the corporate bonus plan was not funded or
paid, except a payment of $28,500 to Hildy Shandell pursuant to
a guaranteed bonus provision in her offer letter.
Our Compensation Committee evaluates the effectiveness of our
executive bonus plan on at least an annual basis and may in the
future revise the program by, for example and without
limitation, implementing performance share awards in lieu of or
in combination with cash.
Long-Term
Equity Incentive Compensation
Our equity incentive compensation plans have been established to
provide our executive officers with incentives to help align
those employees long-term interests with the interests of
stockholders. The Compensation Committee believes that long-term
performance is achieved through a culture that encourages such
performance by our executive officers through the use of stock
and stock-based awards, because the increase in value of granted
awards is dependent on the companys longer-term
performance and stock price. We generally make these awards to
executives when they become an executive of the company, as well
as on an annual basis thereafter, typically in May. Equity award
amounts are intended to make the company competitive in the
market in attracting and retaining executives, while taking into
consideration total compensation levels and the companys
overall goals of linking pay to performance and managing the
dilution of existing stockholders interests that results
from equity awards.
Our equity awards currently consist of a combination of stock
option grants and RSUs, with awards weighted more towards stock
options as an employees responsibilities and ability to
impact the companys financial performance increases. In
general, executives will be awarded the majority of their
ongoing equity in the form of stock options. To the extent we
use RSUs for ongoing awards, they will typically comprise a
lower percent of total equity awards. Stock options are
attractive because they provide a relatively straightforward
incentive to increase stockholder value over the long term, and
also provide incentive for employees to continue their
employment with the company. RSU awards provide additional
incentive by providing employees with immediate stock ownership
upon vesting, which aligns their interests with those of our
stockholders. We believe that an RSU award program may consume
fewer shares than options in order to achieve similar incentive
levels because RSUs are immediately valuable to recipients, in
contrast to stock options, which may or may not ultimately
result in realizable value to recipients. Because of the lower
share consumption rate associated with RSUs, our use of RSUs may
lessen our equity overhang and reduce dilution for our
stockholders as well as reduce our equity compensation expenses
compared to an all stock option program. Our Compensation
Committee evaluates the effectiveness of our long-term equity
compensation program on at least an annual basis, and may in the
future revise our program by, for example and without
limitation, implementing an equity program with
performance-based vesting.
In fiscal 2007, the Compensation Committee implemented a policy
of awarding all equity grants on a fixed day of each month, in
order to ease administration of awards and to avoid any
appearance of setting the date of awards with the benefit of
hindsight. Beginning in November 2006, stock options are granted
with an exercise price equal to
45
the closing price of our common stock on the day of grant,
typically vest 25% after one year with the remainder vesting
monthly over the next three years, and generally will expire six
years after the date of grant. Prior to November 2006, our stock
option grants typically had an exercise price equal to the
closing price of our common stock on either the day of grant or
the day before the grant. Beginning in November 2006, our RSU
grants typically vest annually based upon continued employment
over a four-year period. Prior to November 2006, our RSU awards
typically vested either annually as described in the preceding
sentence, or 25% after one year with the remainder vesting
quarterly over the next three years. The vesting of certain of
our named executive officers stock options may be
accelerated in certain circumstances pursuant to the terms of
their agreements with the company. These terms are more fully
described below in Change of Control and Severance Benefits
and Potential Payments on Termination or Change of
Control below.
Change
of Control and Severance Benefits
We provide the opportunity for certain of our named executive
officers and certain other senior management to receive certain
compensation or benefits under severance
and/or
change of control provisions contained in their employment and
change of control severance agreements. Because we are a small
company in a very competitive and growing industry, where
longer-term compensation largely depends on future stock
appreciation, the Compensation Committee believes these benefits
are important to our ability to attract and retain an
appropriate caliber of talent in key positions. Our executive
officers may from time to time have competitive alternatives
that may appear to them to be more attractive
and/or less
risky than working at Genesis. The change of control benefits
also mitigate a potential disincentive for executives when they
are evaluating a potential change of control of Genesis,
particularly when the services of the executive officers may not
be required by the acquiring company. Severance benefits are
intended ease the consequences to an executive of an unexpected
termination of employment and help in avoiding distraction
during times of transition. Genesis benefits by requiring a
general release from separated executives receiving severance
benefits. Genesis may also request non-compete and
non-solicitation provisions in connection with individual
separation agreements. Our change of control agreements provide
assurance of limited severance and benefits in the event an
executive is terminated in connection with a change of control
of Genesis. The Compensation Committee believes that our change
of control agreements benefit Genesis and its stockholders by
avoiding the distraction and loss of key management personnel
that may occur in connection with rumored or actual fundamental
corporate changes. The Compensation Committees analysis
indicates that our severance and change of control provisions
are consistent with the provisions and benefit levels of the
Peer Group.
On a
case-by-case
basis, we may also extend option exercise periods for departing
executives in connection with severance and release of claims
agreements entered into at the time of severance. Please see the
table Potential Payments on Termination or Change of Control
on page 54.
Other
Compensation and Perquisites
We offer our executive officers participation in our defined
contribution 401(k) retirement plan, Employee Stock Purchase
Plan (ESPP), and group life, disability and health
insurance plans on the same basis as all of our employees, at
the same rates charged to other employees. However, executive
officers are not eligible to participate in our ESPP Loan
Program, which is available to all ESPP participants other than
executives. We previously provided our executives with a $600
per month car allowance in lieu of expense reimbursement for
certain business-related car travel expenses, but we
discontinued the car allowance in January 2007. We do not have
any deferred compensation programs for executives or employees.
46
Executive
Compensation Tables
The following tables presents compensation information for our
fiscal year ended March 31, 2007 paid to or accrued for our
Chief Executive Officer, Chief Financial Officer and each of our
five other most highly compensated executive officers. We refer
to these executive officers as our named executive
officers elsewhere in this
10-K.
FISCAL
YEAR 2007 SUMMARY COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
All Other
|
|
|
|
|
Name and Principal
|
|
|
|
|
|
|
|
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Compensation
|
|
|
Total
|
|
Position
|
|
Year
|
|
|
Salary ($)
|
|
|
Bonus ($)
|
|
|
($)(7)
|
|
|
($)(8)
|
|
|
($)
|
|
|
($)(9)
|
|
|
($)
|
|
|
Elias Antoun,
|
|
|
2007
|
|
|
|
364,001
|
|
|
|
0
|
|
|
|
11,564
|
|
|
|
1,488,567
|
|
|
|
0
|
|
|
|
23,723
|
|
|
|
1,887,855
|
|
President & CEO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Healy,
|
|
|
2007
|
|
|
|
241,384
|
|
|
|
0
|
|
|
|
9,406
|
|
|
|
790,324
|
|
|
|
0
|
|
|
|
24,043
|
|
|
|
1,065,157
|
|
formerly Sr. VP
Finance and CFO(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Behrooz Yadegar,
|
|
|
2007
|
|
|
|
229,174
|
|
|
|
75,000
|
(2)
|
|
|
86,759
|
|
|
|
119,878
|
|
|
|
0
|
|
|
|
20,128
|
|
|
|
530,939
|
|
Sr. VP Product Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hildy Shandell,
|
|
|
2007
|
|
|
|
144,002
|
|
|
|
100,000
|
(3)
|
|
|
166,571
|
|
|
|
64,550
|
|
|
|
28,500
|
(3)
|
|
|
9,561
|
|
|
|
513,184
|
|
Sr. VP Corporate Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raphael Mehrbians,
|
|
|
2007
|
|
|
|
168,807
|
|
|
|
0
|
|
|
|
10,510
|
|
|
|
418,969
|
|
|
|
0
|
|
|
|
185,258
|
|
|
|
783,544
|
|
formerly Sr. VP
Product Marketing(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tzoyao Chan,
|
|
|
2007
|
|
|
|
102,120
|
|
|
|
0
|
|
|
|
10,510
|
|
|
|
401,431
|
|
|
|
0
|
|
|
|
233,371
|
|
|
|
747,432
|
|
formerly Sr. VP
Product Development(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anders Frisk,
|
|
|
2007
|
|
|
|
275,834
|
|
|
|
0
|
|
|
|
8,294
|
|
|
|
476,065
|
|
|
|
0
|
|
|
|
24,377
|
|
|
|
784,570
|
|
Executive Vice President(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Mr. Healy terminated employment with the Company on
May 16, 2007. |
|
(2) |
|
Mr. Yadegar commenced employment on May 16, 2006 and
received a $75,000 sign-on bonus. |
|
(3) |
|
Ms. Shandell commenced employment on September 12,
2006 and, pursuant to her offer letter, received a $100,000
sign-on bonus and a guaranteed bonus of $28,500 under our
Executive Bonus Plan. The Other Compensation column
includes $5,658 in reimbursement for legal fees incurred in
connection with her offer letter. |
|
(4) |
|
Mr. Mehrbians terminated employment with the Company on
October 31, 2006. The Other Compensation column
includes $164,736 in severance pay and $8,667 in COBRA
reimbursement pursuant to Mr. Merhbianss separation
agreement. |
|
(5) |
|
Mr. Chan terminated employment with the Company on
July 31, 2006. The Other Compensation column
includes $208,472 in severance pay and $16,251 in COBRA
reimbursement pursuant to Mr. Chans separation
agreement. |
|
(6) |
|
Mr. Frisk resigned from the company in June 2007 and will
terminate employment on July 31, 2007. |
|
(7) |
|
The amounts in this column for Stock Awards indicate
the amount in dollars recognized for financial statement
reporting purposes for the fiscal year ended March 31, 2007
in accordance with FAS 123R disregarding forfeiture
assumptions of $21,170. See Note 9 of the Notes to
Consolidated Financial Statements for the assumptions used by
the Company in calculating these amounts. |
|
(8) |
|
The amounts in this column for Option Awards
indicate the amount in dollars recognized for financial
statement reporting purposes for the fiscal year ended
March 31, 2007 in accordance with FAS 123R |
47
|
|
|
|
|
disregarding forfeiture assumptions of $69,826. See Note 9
of the Notes to Consolidated Financial Statements for
assumptions used by the Company in calculating these amounts. |
|
(9) |
|
See All Other Compensation and
Perquisites tables. |
Executive compensation is set by our Compensation Committee, and
reviewed at least annually, based on an evaluation of the
responsibilities, experience and performance levels of each
individual executive officer. As discussed above, executive
compensation consists primarily of base salary, awards of
restricted stock units and stock options, and an executive bonus
plan. For fiscal 2007, we did not meet the minimum financial
target component of the executive bonus plan. As a result, the
executive bonus plan was not funded and no payments were made,
except for a payment of $28,500 to Ms. Shandell, who was
guaranteed a bonus under the plan pursuant to her offer letter.
FISCAL
YEAR 2007 ALL OTHER COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Perquisites
|
|
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
|
|
|
and Other
|
|
|
|
|
|
Contributions
|
|
|
Severance
|
|
|
|
|
|
|
|
|
|
Personal
|
|
|
Insurance
|
|
|
to Retirement and
|
|
|
Payments /
|
|
|
|
|
|
|
|
|
|
Benefits
|
|
|
Premiums
|
|
|
401(k) Plans
|
|
|
Accruals
|
|
|
|
|
Name
|
|
Year
|
|
|
($)(1)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Total ($)
|
|
|
Elias Antoun
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
15,023
|
|
|
|
3,000
|
|
|
|
0
|
|
|
|
23,723
|
|
Michael Healy(2)
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
15,343
|
|
|
|
3,000
|
|
|
|
0
|
|
|
|
24,043
|
|
Behrooz Yadegar
|
|
|
2007
|
|
|
|
5,100
|
|
|
|
15,028
|
|
|
|
0
|
|
|
|
0
|
|
|
|
20,128
|
|
Hildy Shandell(3)
|
|
|
2007
|
|
|
|
8,358
|
|
|
|
1,203
|
|
|
|
0
|
|
|
|
0
|
|
|
|
9,561
|
|
Raphael Mehrbians(2)
|
|
|
2007
|
|
|
|
4,200
|
|
|
|
6,497
|
|
|
|
1,158
|
|
|
|
173,403
|
|
|
|
185,258
|
|
Tzoyao Chan(2)
|
|
|
2007
|
|
|
|
2,400
|
|
|
|
5,024
|
|
|
|
1,224
|
|
|
|
224,723
|
|
|
|
233,371
|
|
Anders Frisk(4)
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
15,677
|
|
|
|
3,000
|
|
|
|
0
|
|
|
|
24,377
|
|
|
|
|
(1) |
|
Consists of car allowance, which was discontinued effective
January 23, 2007. |
|
(2) |
|
No longer employed by the company. |
|
(3) |
|
Consists of car allowance, which was discontinued effective
January 23, 2007, and reimbursement for legal fees incurred in
connection with negotiating Ms. Shandells offer of
employment. |
|
(4) |
|
Will terminate employment on July 31, 2007. |
All other compensation consists of insurance premiums and 401(k)
plan contributions, which are paid to executives at the same
rate as other eligible employees. For part of fiscal 2007, we
also paid a car allowance, which is reflected above.
FISCAL
YEAR 2007 PERQUISITES TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial
|
|
|
|
|
|
|
|
|
|
Car
|
|
|
Planning/
|
|
|
Total Perquisites and
|
|
Name
|
|
Fiscal Year
|
|
|
Allowance($)(1)
|
|
|
Legal Fees($)(2)
|
|
|
Other Personal Benefits($)
|
|
|
Elias Antoun
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
0
|
|
|
|
5,700
|
|
Michael Healy(3)
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
0
|
|
|
|
5,700
|
|
Behrooz Yadegar
|
|
|
2007
|
|
|
|
5,100
|
|
|
|
0
|
|
|
|
5,100
|
|
Hildy Shandell
|
|
|
2007
|
|
|
|
2,700
|
|
|
|
5,658
|
|
|
|
8,358
|
|
Raphael Mehrbians(3)
|
|
|
2007
|
|
|
|
4,200
|
|
|
|
0
|
|
|
|
4,200
|
|
Tzoyao Chan(3)
|
|
|
2007
|
|
|
|
2,400
|
|
|
|
0
|
|
|
|
2,400
|
|
Anders Frisk(4)
|
|
|
2007
|
|
|
|
5,700
|
|
|
|
0
|
|
|
|
5,700
|
|
|
|
|
(1) |
|
The car allowance was discontinued for all executives effective
January 23, 2007. |
|
(2) |
|
Paid pursuant to offer letter. |
|
(3) |
|
No longer employed by the company. |
|
(4) |
|
Will terminate employment on July 31, 2007. |
48
Perquisites consist of the now-discontinued car allowance, also
noted in All Other Compensation above, and
reimbursement of legal fees to Ms. Shandell pursuant to her
offer letter.
FISCAL
YEAR 2007 GRANTS OF PLAN-BASED AWARDS TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
All Other
|
|
|
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
|
|
|
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Awards:
|
|
|
Exercise or
|
|
|
|
|
|
Fair
|
|
|
|
|
|
|
|
|
|
Estimated Future Payouts Under
|
|
|
Estimated Future Payouts Under
|
|
|
Number of
|
|
|
Number of
|
|
|
Base
|
|
|
Closing
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Plan Awards(4)
|
|
|
Equity Incentive Plan Awards
|
|
|
Shares of
|
|
|
Securities
|
|
|
Price
|
|
|
Price on
|
|
|
Stock &
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maxi
|
|
|
|
|
|
|
|
|
Maxi
|
|
|
Stock or
|
|
|
Underlying
|
|
|
of Option
|
|
|
Grant
|
|
|
Option
|
|
|
|
Grant
|
|
|
Approval
|
|
|
Threshold
|
|
|
Target
|
|
|
mum
|
|
|
Threshold
|
|
|
Target
|
|
|
mum
|
|
|
Units
|
|
|
Options
|
|
|
Awards
|
|
|
Date
|
|
|
Awards
|
|
Name
|
|
Date
|
|
|
Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)(5)
|
|
|
(#)(6)
|
|
|
($ / Sh)
|
|
|
($ / Sh)
|
|
|
($)(8)
|
|
|
Elias Antoun
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
|
|
12.27
|
|
|
|
11.82
|
|
|
|
430,062
|
|
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,300
|
|
|
|
|
|
|
|
0
|
|
|
|
11.82
|
|
|
|
52,761
|
|
|
|
|
|
|
|
|
|
|
|
|
136,500
|
|
|
|
182,000
|
|
|
|
364,000
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Healy(1)
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
12.27
|
|
|
|
11.82
|
|
|
|
179,193
|
|
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,430
|
|
|
|
|
|
|
|
0
|
|
|
|
11.82
|
|
|
|
17,546
|
|
|
|
|
|
|
|
|
|
|
|
|
45,260
|
|
|
|
60,346
|
|
|
|
120,692
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Behrooz Yadegar
|
|
|
5/5/2006
|
|
|
|
5/5/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000
|
|
|
|
12.97
|
|
|
|
13.08
|
|
|
|
530,369
|
|
|
|
|
5/5/2006
|
|
|
|
5/5/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
0
|
|
|
|
13.08
|
|
|
|
389,100
|
|
|
|
|
|
|
|
|
|
|
|
|
42,970
|
|
|
|
57,294
|
|
|
|
114,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hildy Shandell(2)
|
|
|
10/27/2006
|
|
|
|
9/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,000
|
|
|
|
10.23
|
|
|
|
10.14
|
|
|
|
245,646
|
|
|
|
|
10/27/2006
|
|
|
|
9/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
0
|
|
|
|
10.14
|
|
|
|
600,500
|
|
|
|
|
|
|
|
|
|
|
|
|
48,751
|
|
|
|
65,001
|
|
|
|
130,002
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raphael Mehrbians(1)
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
12.27
|
|
|
|
11.82
|
|
|
|
179,193
|
|
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,430
|
|
|
|
|
|
|
|
0
|
|
|
|
11.82
|
|
|
|
17,546
|
|
|
|
|
|
|
|
|
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tzoyao Chan(1)
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
12.27
|
|
|
|
11.82
|
|
|
|
143,354
|
|
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,430
|
|
|
|
|
|
|
|
0
|
|
|
|
11.82
|
|
|
|
17,546
|
|
|
|
|
|
|
|
|
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anders Frisk(3)
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
12.27
|
|
|
|
11.82
|
|
|
|
143,354
|
|
|
|
|
5/30/2006
|
|
|
|
5/30/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,430
|
|
|
|
|
|
|
|
0
|
|
|
|
11.82
|
|
|
|
17,546
|
|
|
|
|
|
|
|
|
|
|
|
|
51,719
|
|
|
|
68,958
|
|
|
|
137,917
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
No longer employed by the company, and therefore not eligible to
receive a bonus. |
|
(2) |
|
Options were approved during a closed trading window under the
companys Insider Trading Policy, and were therefore not
granted until the trading window reopened. |
|
(3) |
|
Mr. Frisk will terminate employment on July 31, 2007. |
|
(4) |
|
Potential payments as calculated pursuant to the fiscal year
2007 Executive Bonus Plan. See Executive Bonus Plan
discussion on page 44. The plan was not funded because the
company did not achieve its minimum corporate revenue and
operating income goals. As a result, no bonus payment will be
made pursuant to the fiscal year 2007 Executive Bonus Plan,
except to Ms. Shandell, who has earned a $28,500 bonus
payment under said plan in accordance with her offer letter. |
|
(5) |
|
These restricted stock units vest over four years from the date
of grant, except for Ms. Shandells grant, which vests
over three and a half years from the date of grant. |
|
(6) |
|
These stock options vest over four years from the date of grant,
except for Ms. Shandells options, which vest over
three and a half years from the date of grant. |
|
(7) |
|
The exercise price is higher than the closing price on the date
of grant because the awards were priced in accordance with the
then-current policy of using the closing price of the day before
grant. The company currently prices awards at the closing price
on the date of grant. |
|
(8) |
|
Amount reflects the full grant date fair value of the awards as
of March 31, 2007, as computed in accordance with
FAS 123R. The assumptions used to calculate the amounts in
this column are set forth under Note 9 of the Notes to
Consolidated Financial Statements. |
In fiscal 2007, our plan-based awards consisted of stock options
and restricted stock units awarded to Mr. Yadegar and
Ms. Shandell in accordance with their offer letters, and
annual refresh awards to our other named executives,
as set forth above. Our executive bonus plan, which is our
non-equity incentive award plan, is a cash bonus plan discussed
in more detail under Executive Bonus Plan above.
49
FISCAL
YEAR 2007 OPTION EXERCISES AND STOCK VESTED TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of Shares
|
|
|
Value Realized
|
|
|
Number of Shares
|
|
|
Value Realized
|
|
|
|
Acquired on Exercise
|
|
|
on Exercise
|
|
|
Acquired on Vesting
|
|
|
on Vesting
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Elias Antoun
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
Michael Healy(1)
|
|
|
0
|
|
|
|
0
|
|
|
|
469
|
|
|
|
5,629
|
|
Behrooz Yadegar
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
Hildy Shandell
|
|
|
0
|
|
|
|
0
|
|
|
|
12,500
|
|
|
|
99,000
|
|
Raphael Mehrbians(1)
|
|
|
35,000
|
|
|
|
198,800
|
|
|
|
402
|
|
|
|
5,303
|
|
Tzoyao Chan(1)
|
|
|
104,284
|
|
|
|
209,767
|
|
|
|
322
|
|
|
|
4,221
|
|
Anders Frisk(2)
|
|
|
0
|
|
|
|
0
|
|
|
|
376
|
|
|
|
4,514
|
|
|
|
|
(1) |
|
No longer employed by the company. |
|
(2) |
|
Mr. Frisk will terminate employment on July 31, 2007. |
FISCAL
YEAR 2007 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Option
|
|
|
|
|
|
RSUs That
|
|
|
RSUs That
|
|
|
|
Options
|
|
|
Options
|
|
|
Exercise
|
|
|
Option
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
(#)
|
|
|
(#)
|
|
|
Price
|
|
|
Expiration
|
|
|
Vested
|
|
|
Vested
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
($)
|
|
|
Date
|
|
|
(#)
|
|
|
($)
|
|
|
Elias Antoun(4)(5)
|
|
|
291,667
|
|
|
|
208,333
|
|
|
|
16.895
|
|
|
|
11/29/2014
|
|
|
|
4,300
|
|
|
|
39,947
|
|
|
|
|
0
|
|
|
|
60,000
|
|
|
|
12.270
|
|
|
|
5/30/2012
|
|
|
|
|
|
|
|
|
|
Michael Healy(1)(4)(5)
|
|
|
154,167
|
|
|
|
45,833
|
|
|
|
18.830
|
|
|
|
2/4/2014
|
|
|
|
602
|
|
|
|
5,593
|
|
|
|
|
9,740
|
|
|
|
11,510
|
|
|
|
19.500
|
|
|
|
10/25/2011
|
|
|
|
1,430
|
|
|
|
13,285
|
|
|
|
|
0
|
|
|
|
25,000
|
|
|
|
12.270
|
|
|
|
5/30/2012
|
|
|
|
|
|
|
|
|
|
Behrooz Yadegar(4)(5)
|
|
|
0
|
|
|
|
70,000
|
|
|
|
12.970
|
|
|
|
5/5/2012
|
|
|
|
30,000
|
|
|
|
278,700
|
|
Hildy Shandell(6)
|
|
|
11,250
|
|
|
|
33,750
|
|
|
|
10.230
|
|
|
|
10/27/2012
|
|
|
|
37,500
|
|
|
|
348,375
|
|
Raphael Mehrbians(2)(4)(5)
|
|
|
9,031
|
|
|
|
0
|
|
|
|
19.500
|
|
|
|
12/31/2007
|
|
|
|
0
|
|
|
|
0
|
|
Tzoyao Chan(3)(4)(5)
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
Anders Frisk(4)(5)(7)
|
|
|
33,917
|
|
|
|
0
|
|
|
|
22.560
|
|
|
|
2/17/2010
|
|
|
|
481
|
|
|
|
4,468
|
|
|
|
|
10,834
|
|
|
|
0
|
|
|
|
22.560
|
|
|
|
2/17/2010
|
|
|
|
1,430
|
|
|
|
13,285
|
|
|
|
|
13,750
|
|
|
|
0
|
|
|
|
17.000
|
|
|
|
8/2/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
6,500
|
|
|
|
0
|
|
|
|
17.000
|
|
|
|
8/2/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
14,375
|
|
|
|
0
|
|
|
|
7.500
|
|
|
|
7/22/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
31,667
|
|
|
|
0
|
|
|
|
12.390
|
|
|
|
2/18/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
8,334
|
|
|
|
833
|
|
|
|
16.800
|
|
|
|
5/16/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
377
|
|
|
|
5,297
|
|
|
|
15.620
|
|
|
|
5/26/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
17,956
|
|
|
|
6,370
|
|
|
|
15.620
|
|
|
|
5/26/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
7,792
|
|
|
|
9,208
|
|
|
|
19.500
|
|
|
|
10/25/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
20,000
|
|
|
|
12.270
|
|
|
|
5/30/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Terminated employment May 18, 2007. |
|
(2) |
|
Terminated employment October 31, 2006. |
|
(3) |
|
Terminated employment July 31, 2006. |
50
|
|
|
(4) |
|
Options vest over four years from the date of grant, with 25%
vesting after one year, and monthly vesting thereafter. |
|
(5) |
|
Restricted stock units vest 25% after one year, with annual
vesting thereafter. |
|
(6) |
|
Pursuant to Ms. Shandells offer letter, options and
restricted stock units vest over three and a half years from the
date of grant, with 25% vesting after six months of employment
and the balance vesting monthly in equal amounts over the
following thirty-six months. |
|
(7) |
|
Will terminate employment on July 31, 2007. |
Change
of Control and Severance Benefits
Tier 1
Change of Control Agreement with CEO
On March 2, 2007, we entered into a change of control
severance agreement with our Chief Executive Officer, Elias
Antoun (CEO Agreement). The CEO Agreement will
provide certain benefits upon an involuntary termination of
Mr. Antouns employment following a change of control
of the company. The agreement has a two-year term. The agreement
generally provides that if, within 12 months after the
change of control of the company, Mr. Antouns
employment is involuntarily terminated or he resigns for good
reason (as defined in the CEO Agreement), and he signs a release
of claims, then he will be entitled to (i) a lump sum
severance payment equal to 12 months base salary,
(ii) an amount representing Mr. Antouns foregone
annual bonus and (iii) accelerated vesting of 50% of
Mr. Antouns then outstanding, unvested equity
compensation awards. The amount of Mr. Antouns
foregone bonus is calculated by multiplying 50% of his annual
base salary, as in effect on the date of his employment
termination, by a fraction with a numerator equal to the number
of days between the start of the companys fiscal year
during which the termination occurs and the termination date and
a denominator equal to 365. Further, we will reimburse
Mr. Antoun for the premiums paid for the continued coverage
of his (and any eligible dependents) under the Companys
medical, dental and vision plans at the same level of coverage
in effect on the termination date for 12 months, or until
Mr. Antoun becomes covered under similar plans.
Tier 1
Change of Control Agreement with CFO
On March 2, 2007, we entered into a change of control
severance agreement with our then Chief Financial Officer,
Michael Healy (CFO Agreement). The CFO Agreement is
identical to the CEO Agreement described above, except that
Mr. Healys foregone annual bonus is calculated by
multiplying 25% of his annual base salary, as in effect on the
date of his employment termination, by a fraction with a
numerator equal to the number of days between the start of the
companys fiscal year during which the termination occurs
and the termination date and a denominator equal to 365. The CFO
Agreement is no longer effective, since Mr. Healy
terminated employment in May 2007.
Tier 2
Change of Control Agreement with Other Executives
On March 2, 2007, Genesis Microchip Inc. entered into a
change of control severance agreements (the Tier 2
Agreement) with the following officers:
|
|
|
|
|
Behrooz Yadegar, Sr. VP, Product Development
|
|
|
|
Anders Frisk, Executive Vice President
|
|
|
|
Ernest Lin, Sr. VP, Worldwide Sales
|
|
|
|
Jeffrey Lin, General Counsel
|
|
|
|
Ava Hahn, former Associate General Counsel & Secretary
|
The Tier 2 Agreement provides for certain benefits upon an
involuntary termination of each officers employment
following a change of control of the company, at a reduced level
from the Tier 1 agreements for our CEO and CFO described
above. The Tier 2 Agreement has a two-year term, and
generally provides that if, within 12 months after the
change of control of the company, the officers employment
is involuntarily terminated or he or she resigns for good reason
and signs a release of claims, then that officer will be
entitled to a lump sum
51
severance payment equal to six months base salary and
accelerated vesting of 25% of the officers then
outstanding, unvested equity compensation awards. Further, we
will reimburse the officer for the premiums paid for the
continued coverage of
his/her (and
any eligible dependents) under the Companys medical,
dental and vision plans at the same level of coverage in effect
on the termination date for six months, or until the officer
becomes covered under similar plan. The Tier 2 Agreement
will be effective with respect to Mr. Frisk on
August 1, 2007. The Tier 2 Agreement will no longer be
effective with respect to Ms. Hahn when she terminates
employment on June 12, 2007.
In addition, on August 14, 2006, the Company entered into a
Amendment to Change of Control Severance Agreement with Anders
Frisk. Pursuant to this Amendment, in the event that
Mr. Frisks employment with the company terminates as
a result of an involuntarily termination prior to July 31,
2007, and Mr. Frisk signs and does not revoke a release of
claims, Mr. Frisk is entitled to severance benefits in the
form of base salary from the date of termination to
July 31, 2007, and the same level of company-paid health
coverage and benefits.
Change of
Control Agreement with Hildy Shandell
On September 12, 2006, we entered into a change of control
severance agreement with our Senior Vice President, Corporate
Development, Hildy Shandell (the Shandell
Agreement). The Shandell Agreement terminates upon the
earlier of (a) two (2) years after a change of control
of Genesis, or (b) the date that all obligations of the
parties under the Shandell Agreement have been satisfied,
provided that if there has not been a change of control as of
three (3) years after the effective date of the agreement,
it immediately terminates.
The Shandell Agreement provides that if Ms. Shandells
employment is involuntarily terminated within three months
before a change of control of the company (as defined in the
Shandell Agreement) or within 12 months following a change
of control, Ms. Shandell will be entitled to certain
severance benefits, including, but not limited to: (i) a
lump sum payment equal to 12 months base salary and any
applicable allowances as in effect as of the date of such
termination or, if greater, as in effect immediately prior to
the Change of Control; (ii) a lump sum payment equal to a
pro-rated amount of Ms. Shandells annual target bonus
for the year in which the termination occurs, or, if greater,
her annual target bonus as in effect immediately prior to a
change of control for the year in which the change of control
occurs (calculated in either case assuming 100% achievement of
individual and corporate plan objectives);
(iii) accelerated vesting for 50% of
Ms. Shandells unvested stock options, restricted
stock and other stock based awards, unless the plan under which
such awards were granted or the agreement evidencing such awards
provides for accelerated vesting of a greater percentage of such
awards; (iv) the right to exercise all vested stock options
prior to the change of control for a period of up to two years
following the termination date; and (v) Company-paid health
coverage for up to 12 months following the termination date.
Should Ms. Shandells employment with Genesis be
involuntarily terminated at any time during the period that is
after twelve months but before twenty-four months after a change
of control (the Second Year), then, subject to
Ms. Shandells signing and not revoking a general
release of claims, she will be entitled to certain severance
benefits, including, but not limited to: (i) a lump sum
payment equal to the number of full months remaining in the
Second Year as of the termination date multiplied by
Ms. Shandells monthly base salary and allowances as
in effect as of the termination date, or, if greater, as in
effect immediately prior to the change of control; (ii) a
lump sum payment equal to a pro-rated amount of
Ms. Shandells annual target bonus for the year in
which the termination occurs, or, if greater, her annual target
bonus as in effect immediately prior to a change of control for
the year in which the change of control occurs (calculated in
either case assuming 100% achievement of individual and
corporate plan objectives); (iii) all stock rights shall
accelerate and become vested and exercisable as to the number of
shares that would have otherwise vested during the
12 months following the termination date as if
Ms. Shandell had remained employed by Genesis (or its
successor) through such date, unless the plan under which such
awards were granted or the agreement evidencing such awards
provides for accelerated vesting of a greater percentage of such
awards; (iv) all awards of restricted stock, restricted
stock units and other similar awards that were issued prior to
the Change of Control shall vest as to 50% of the portion of
such awards that is unvested as of the termination date, unless
the plan under which such awards were granted or the agreement
evidencing such awards provides for accelerated vesting of a
greater percentage of such awards; (v) the right to
exercise all vested stock options for a period of up to two
years following the termination date; and (vi) Company-paid
health coverage following the termination date pro-rated to
reflect that number of months remaining in the Second Year as of
the date of termination.
52
Employment
Agreements
Offer
Letter with Behrooz Yadegar
On April 11, 2006, we entered into an offer letter with
Behrooz Yadegar, our Senior Vice President, Product Development.
The offer letter provides for the following: (i) an at-will
employment wherein either Genesis or Mr. Yadegar may
terminate his employment at any time, with or without reason,
(ii) an annual base salary of $250,008, (iii) a
sign-on bonus of $75,000, (iv) an award of stock options to
purchase 70,000 shares of Genesis common stock at an
exercise price equal to the fair market value of Genesis common
stock on the date of grant, 25% of which vest after one year of
employment, with the balance vesting monthly over the following
36 months, subject to Mr. Yadegars continued
employment on the applicable vesting dates, and (v) an
award of 30,000 restricted stock units, 25% of which vest after
one year of employment, with the balance vesting quarterly in
equal amounts over the following 12 quarters, subject to
Mr. Yadegars continued employment on the applicable
vesting dates. Pursuant to the terms of Mr. Yadegars
offer letter, Mr. Yadegar is eligible to participate in the
Corporate Bonus Plan for fiscal year 2007.
In addition, in the event that Genesis terminates
Mr. Yadegars employment within the first two years of
employment, for reasons other than for cause or
Mr. Yadegars death or disability, and such
termination is not associated with a change of control such that
he would not be entitled to receive any severance benefits under
the change of control severance agreement (discussed above under
Change of Control and Severance Benefits), if
any, then, subject to Mr. Yadegars signing and not
revoking a separation agreement and release of claims in a form
reasonably acceptable to Genesis, he will be entitled to the
following benefits: (1) severance payments equal to six
months of then-current monthly base salary, (2) a pro-rated
bonus, if applicable, (3) one-year vesting acceleration of
all unvested RSUs, if any, (4) one-year vesting
acceleration of all unvested options, if any, and
(5) reimbursement of six months of COBRA benefit
continuation.
The offer letter also provides that if Genesis decides to
implement change of control severance agreements for its
executive officers, Mr. Yadegar will be offered such an
agreement.
Offer
Letter with Hildy Shandell
On August 30, 2006, we entered into an offer letter with
Hildy Shandell, our Senior Vice President, Corporate
Development. The terms of Ms. Shandells offer letter
with the Company include, among other things, the following:
(i) an at-will employment wherein either Genesis or
Ms. Shandell may terminate her employment with the Company
at any time, with or without reason; (ii) a monthly gross
salary of $21,667; (iii) a sign-on bonus of $100,000;
(iv) an award of stock options to purchase
45,000 shares of Genesis common stock at an exercise price
equal to the fair market value of the Companys common
stock on the date of grant, 25% of which vest after six months
of employment, with the balance vesting monthly in equal amounts
over the following thirty-six months, subject to
Ms. Shandells continued employment on the applicable
vesting dates; and (v) an award of 50,000 restricted stock
units, 25% of which vest after six months of employment, with
the balance vesting quarterly in equal amounts over the
following twelve quarters, subject to Ms. Shandells
continued employment on the applicable vesting dates.
Pursuant to the terms of Ms. Shandells offer letter,
she is eligible to participate in the Corporate Bonus Plan for
fiscal year 2007. Genesis also reimbursed Ms. Shandell
$5,648 in legal fees incurred in connection with negotiating,
preparing and executing her offer letter.
In addition, in the event that Genesis terminates
Ms. Shandells employment within the first three years
of her employment, for reasons other than for cause or
Ms. Shandells death or disability, and such
termination is not associated with a change of control such that
she would not be entitled to receive any severance benefits
under the Shandell Agreement (discussed above under
Change of Control Severance Benefits),
then, subject to Ms. Shandells signing and not
revoking a separation agreement and release of claims in a form
reasonably acceptable to Genesis, she will be entitled to the
following benefits: (i) severance payments equal to
12 months of then-current monthly base salary; (ii) a
pro-rated bonus (calculated assuming 100% achievement of
individual and corporate plan objectives); (iii) one-year
vesting acceleration of all unvested restricted stock units, if
any; (iv) one-
53
year vesting acceleration of all unvested options, if any; and
(v) reimbursement of twelve months of COBRA benefit
continuation payments.
The following table summarizes the benefits payable to each
named executive officer pursuant to the arrangements described
above:
POTENTIAL
PAYMENTS ON TERMINATION OR CHANGE OF CONTROL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Benefits /
|
|
|
Equity
|
|
|
|
|
Name
|
|
Payment Trigger Event
|
|
Severance
|
|
|
Severance(1)
|
|
|
Perquisites
|
|
|
Acceleration
|
|
|
Total Value
|
|
|
Elias Antoun
|
|
Involuntary Termination Unrelated
to Change-of-Control
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
Involuntary Termination Related to
Change-of-Control
|
|
$
|
364,000
|
|
|
$
|
182,000
|
|
|
$
|
16,800
|
|
|
$
|
23,220
|
|
|
$
|
586,020
|
|
Michael Healy
|
|
Involuntary Termination Unrelated
to Change-of-Control
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
Involuntary Termination Related to
Change-of-Control
|
|
$
|
241,384
|
|
|
$
|
120,692
|
|
|
$
|
16,800
|
|
|
$
|
12,058
|
|
|
$
|
390,934
|
|
Behrooz Yadegar
|
|
Involuntary Termination Unrelated
to Change-of-Control
|
|
$
|
125,000
|
|
|
$
|
0
|
|
|
$
|
8,400
|
|
|
$
|
81,000
|
|
|
$
|
214,400
|
|
|
|
Involuntary Termination Related to
Change-of-Control
|
|
$
|
125,000
|
|
|
$
|
0
|
|
|
$
|
8,400
|
|
|
$
|
81,000
|
|
|
$
|
214,400
|
|
Hildy Shandell
|
|
Involuntary Termination Unrelated
to Change-of-Control
|
|
$
|
260,000
|
|
|
$
|
0
|
|
|
$
|
16,800
|
|
|
$
|
141,075
|
|
|
$
|
417,875
|
|
|
|
Involuntary Termination Related to
Change-of-Control
|
|
$
|
260,000
|
|
|
$
|
0
|
|
|
$
|
16,800
|
|
|
$
|
282,150
|
|
|
$
|
558,950
|
|
Anders Frisk
|
|
Involuntary Termination Unrelated
to Change-of-Control
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
Involuntary Termination Related to
Change-of-Control
|
|
$
|
137,917
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
137,917
|
|
|
|
|
(1) |
|
This is the maximum bonus amount payable pursuant to the Change
of Control agreements. The actual bonus amount paid, if any,
would be prorated based on number of days served in the fiscal
year. |
Our agreements do not provide for any payments upon voluntary
termination or termination for cause.
Tax
and Accounting Considerations
We account for equity compensation paid to our employees under
the rules of SFAS No. 123R, which requires us to
estimate and record compensation expense over the service period
of the award. All equity awards to our employees, including
executive officers, and to our directors have been granted and
reflected in our consolidated financial statements, based upon
the applicable accounting guidance, at fair market value on the
grant date in accordance with the valuation determined by our
board of directors. The Compensation Committee also considers
Section 162(m), Rule 280G and Section 409(A) of
the Internal Revenue Code in structuring our executive
compensation program.
We do not have a 10(b)5-1 trading program. Our Code of Business
Conduct prohibits trading in derivatives of our stock or trading
in our stock on material non-public information. As described in
more detail above, we currently grant our equity awards on
standardized dates, which is intended to avoid so-called
spring-loading or bullet-dodging, or
timing the grant of our equity awards to benefit from our
releases of material non-public information.
Compensation
of Directors
Directors who are not our employees receive $5,000 per quarter
as a retainer, $1,000 for each meeting of the Board of Directors
or committee thereof attended in person and $500 for each
meeting attended by teleconference. Non-employee chairmen of
committees receive an additional retainer of $1,250 per quarter
for serving as a committee chairman, other than the chairman of
the Audit Committee who receives an additional quarterly
retainer of $2,500. Directors who are our employees receive no
separate compensation for services rendered as a director. In
addition, all directors are reimbursed for reasonable expenses
incurred in order to attend meetings.
Upon first joining the Board of Directors, non-employee
directors receive options to purchase a total of
25,000 shares of our common stock, 15,000 of which are
automatically issued pursuant to the terms of our 1997
Non-Employee Stock Option Plan, and 10,000 of which are issued
under our 2000 Nonstatutory Stock Option Plan. Since the option
pool in our 1997 Non-Employee Stock Option Plan is depleted, we
grant the stock options described above from our 2000
Nonstatutory Stock Option Plan or our 2001 Nonstatutory Stock
Option Plan.
54
Grants are also made annually on the first day of the month
following our annual meeting of stockholders. Each non-employee
director receives an option to purchase 10,000 shares of
our common stock, plus additional options to purchase
2,500 shares of our common stock for each committee on
which the director serves. The options are granted with an
exercise price equal to the closing price of our stock on the
date of the grant and vest over twelve months. The automatic
annual option grants were made on October 1, 2006 at an
exercise price of $11.77 per share. No other stock option grants
were made to non-employee directors in fiscal 2007.
Non-employee directors may also be granted stock options under
the terms of our 2000 Nonstatutory Stock Option Plan or our 2001
Nonstatutory Stock Option Plan. Awards granted to our
non-employee directors will vest in full upon consummation of
any change of control transaction.
The following table summarizes the retainers and attendance fees
and the number of stock option grants that were made to our
non-employee directors, in their capacity as non-employee
directors, during fiscal 2007:
FISCAL
YEAR 2007 DIRECTOR COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Option Awards
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)
|
|
|
($)
|
|
|
Jon Castor(3)
|
|
|
54,500
|
|
|
|
188,171
|
|
|
|
0
|
|
|
|
242,671
|
|
Chieh Chang(4)
|
|
|
56,000
|
|
|
|
188,171
|
|
|
|
0
|
|
|
|
244,171
|
|
Tim Christoffersen(5)
|
|
|
57,000
|
|
|
|
136,716
|
|
|
|
0
|
|
|
|
193,716
|
|
Jeffrey Diamond(6)
|
|
|
72,000
|
|
|
|
136,716
|
|
|
|
0
|
|
|
|
208,716
|
|
Robert H. Kidd(7)
|
|
|
57,500
|
|
|
|
136,716
|
|
|
|
0
|
|
|
|
194,216
|
|
Chandrashekar M. Reddy(8)
|
|
|
59,250
|
|
|
|
119,434
|
|
|
|
0
|
|
|
|
178,684
|
|
|
|
|
(1) |
|
Shows amounts earned through March 31, 2007. |
|
(2) |
|
This column reflects the dollar amount of option awards
recognized in accordance with FAS 123R for financial
statement reporting purposes for the fiscal year ended
March 31, 2007 disregarding forfeiture assumptions of
$5,055. The assumptions used to calculate the numbers in this
column are set forth under Note 9 of the Notes to
Consolidated Financial Statements. |
|
(3) |
|
Mr. Castor held options to purchase 43,000 shares
outstanding at fiscal year end. The grant date fair value of the
options to purchase 15,000 shares of our common stock that
were granted to each non-employee director in fiscal 2007 was
$94,208, as computed in accordance with FAS 123R. |
|
(4) |
|
Mr. Chang held options to purchase 53,000 shares
outstanding at fiscal year end. The grant date fair value of the
options to purchase 15,000 shares of our common stock that
were granted to each non-employee director in fiscal 2007 was
$94,208, as computed in accordance with FAS 123R. |
|
(5) |
|
Mr. Christoffersen held options to purchase
65,500 shares outstanding at fiscal year end. The grant
date fair value of the options to purchase 15,000 shares of
our common stock that were granted to each non-employee director
in fiscal 2007 was $94,208, as computed in accordance with
FAS 123R. |
|
(6) |
|
Mr. Diamond held options to purchase 115,500 shares
outstanding at fiscal year end. The grant date fair value of the
options to purchase 15,000 shares of our common stock that
were granted to each non-employee director in fiscal 2007 was
$94,208, as computed in accordance with FAS 123R. |
|
(7) |
|
Mr. Kidd held options to purchase 70,500 shares
outstanding at fiscal year end. The grant date fair value of the
options to purchase 15,000 shares of our common stock that
were granted to each non-employee director in fiscal 2007 was
$94,208, as computed in accordance with FAS 123R. |
|
(8) |
|
Mr. Reddy held options to purchase 67,167 shares
outstanding at fiscal year end. The grant date fair value of the
options to purchase 15,000 shares of our common stock that
were granted to each non-employee director in fiscal 2007 was
$94,208, as computed in accordance with FAS 123R. |
55
Compensation
Committee Interlocks and Insider Participation
The members of our Compensation Committee during the fiscal year
ended March 31, 2007 were Messrs. Diamond, Chang and
Reddy. At no time since our formation have any of the members of
our Compensation Committee served as our officers or employees
or as officers or employees of any of our subsidiaries, except
for Mr. Diamond and Mr. Reddy as described in their
biographies on page 37. No interlocking relationship exists
between our Board of Directors or its Compensation Committee and
the board of directors or compensation committee of any other
company, nor did any interlocking relationships exist during the
past fiscal year.
|
|
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
Equity
Compensation Plan Information
The following table provides information as of March 31,
2007 about our common stock that may be issued upon the exercise
of options, warrants and rights under our 1997 Employee Stock
Purchase Plan described above as well as our eight stock option
plans: the 1987 Stock Option Plan, the 1997 Employee Stock
Option Plan, the 1997 Non-Employee Stock Option Plan, the 2000
Non-Statutory Stock Option Plan, the 2001 Non-Statutory Stock
Option Plan, the 1997 Paradise Stock Option Plan, the Sage Stock
Option Plan, and the 2003 Stock Plan.
The 1997 Paradise Stock Option Plan and the Sage Stock Option
Plan, under which we do not grant any new options, were assumed
upon our acquisitions of other companies. Our stockholders have
not formally approved our 2000 Non-Statutory Stock Option Plan,
although they approved an amendment to that plan at the
September 14, 2000 annual meeting. Our stockholders have
not approved our 2001 Non-Statutory Stock Option Plan or our
2003 Stock Plan. Our stockholders have approved all other plans.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
|
Number of
|
|
|
|
|
|
Available for
|
|
|
|
Securities to
|
|
|
|
|
|
Issuance Under
|
|
|
|
be Issued
|
|
|
Weighted-Average
|
|
|
Equity
|
|
|
|
Upon Exercise
|
|
|
Exercise Price of
|
|
|
Compensation
|
|
|
|
of Outstanding
|
|
|
Outstanding
|
|
|
Plans
|
|
|
|
Options,
|
|
|
Options,
|
|
|
(Excluding Securities
|
|
|
|
Warrants and
|
|
|
Warrants and
|
|
|
Reflected in
|
|
Plan Name and Type
|
|
Rights
|
|
|
Rights
|
|
|
the First Column)
|
|
|
Equity compensation plans
approved by stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
1997 Employee Stock Purchase Plan*
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
215,085
|
|
1987 Stock Option Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
1997 Employee Stock Option Plan(1)
|
|
|
2,100,310
|
|
|
|
13.71
|
|
|
|
1,855,849
|
|
1997 Non-Employee Stock Option Plan
|
|
|
160,480
|
|
|
|
14.25
|
|
|
|
69,675
|
|
Equity compensation plans not
formally approved by stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
2000 Non-Statutory Stock Option
Plan
|
|
|
2,664,685
|
|
|
|
15.22
|
|
|
|
1,475,278
|
|
2001 Non-Statutory Stock Option
Plan(1)
|
|
|
260,864
|
|
|
|
21.97
|
|
|
|
106,901
|
|
2003 Stock Plan(1)
|
|
|
865,000
|
|
|
|
17.15
|
|
|
|
118,750
|
|
Equity compensation plans
assumed on acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
1997 Paradise Stock Option Plan
|
|
|
557
|
|
|
|
0.66
|
|
|
|
|
|
Sage Stock Option Plan(1)
|
|
|
301,871
|
|
|
|
23.15
|
|
|
|
|
|
Total*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The number of securities to be issued upon exercise of
outstanding rights under the 1997 Employee Stock Purchase Plan
and the weighted average exercise price of those securities is
not determinable. The 1997 Employee Stock Purchase Plan provides
that shares of our common stock may be purchased at a per share
price equal to 85% of the fair market value of the common stock
on the beginning of the offering period or a purchase date
applicable to such offering period, whichever is lower. The
closing price per share of our common stock on |
56
|
|
|
|
|
the Nasdaq Global Market on December 29, 2006 (the last
trading day of the most recent offering period) was $10.14 |
|
(1) |
|
This plan explicitly permits repricing of options granted under
the plan. |
Summaries of the stock option plans not formally approved by our
stockholders are as follows:
2000
Non-Statutory Stock Option Plan
Purpose
The purposes of the plan are to attract and retain the best
available personnel for positions of substantial responsibility,
to provide additional incentive to employees and consultants and
to promote the success of our business.
Administration
The plan provides for administration by our Board of Directors
or a committee appointed by the Board of Directors and is
currently administered by the Compensation Committee of the
Board of Directors. All questions of interpretation or
application of the plan are determined by the Board of Directors
or its appointed committee, and its decisions are final and
binding upon all participants. Directors receive no additional
compensation for their services in connection with the
administration of the plan.
Eligibility
to Participate in the Plan
Nonstatutory stock options and stock appreciation rights may be
granted to our employees, consultants and directors, and to
employees and consultants of our parent or subsidiary companies.
Number
of Shares Covered by the Plan
The aggregate number of shares of common stock authorized for
issuance under the plan is 1,500,000 shares.
Awards
Permitted Under the Plan
The plan authorizes the granting of nonstatutory stock options
and stock appreciation rights only.
Terms
of Options
The plans administrator determines the exercise price of
options granted under the plan and the term of those options.
The options that are currently outstanding under the plan vest
and become exercisable over periods of from one to four years
beginning on the grant date. Payment of the exercise price may
be made by cash, check, promissory note, other shares of our
common stock, cashless exercise, any other form of consideration
permitted by applicable law or any combination of the foregoing
methods of payment. Options may be made exercisable only under
the conditions the Board of Directors or its appointed committee
may establish. If an optionees employment terminates for
any reason, the option remains exercisable for a period fixed by
the plan administrator up to the remainder of the options
term; if a period is not fixed by the plan administrator, the
exercise period is three (3) months, or twelve
(12) months in the case of death or disability.
Terms
of Stock Appreciation Rights
The plans administrator is able to grant stock
appreciation rights, which are the rights to receive the
appreciation in fair market value of common stock between the
exercise date and the date of grant. We can pay the appreciation
in either cash or shares of common stock. Stock appreciation
rights will become exercisable at the times and on the terms
established by the plan administrator, subject to the terms of
the plan. The plan administrator, subject to the terms of the
plan, has complete discretion to determine the terms and
conditions of stock appreciation rights granted under the plan,
provided, however, that the exercise price will not be less than
100% of the fair market value of a share on the date of grant.
57
Capital
Changes
In the event of any changes in our capitalization, such as stock
splits or stock dividends, resulting in an increase or decrease
in the number of shares of common stock, effected without
receipt of consideration by us, appropriate adjustment will be
made by us in the number of shares available for future grant
and in the number of shares subject to previously granted but
unexercised options.
Dissolution
or Liquidation
In the event of the proposed dissolution or liquidation of our
Company, the award holders will be notified of such event, and
the plan administrator may, in its discretion, permit each award
to fully vest and be exercisable until ten (10) days prior
to such event, at which time the awards will terminate.
Merger,
Asset Sale or Change of Control
With respect to options granted on or before October 16,
2001 (unless the optionees have consented otherwise), in the
event of a merger of our Company with or into another
corporation, or any other capital reorganization in which more
than fifty percent (50%) of the outstanding voting shares of the
Company are exchanged (other than a reorganization effected
solely for the purpose of changing the situs of the
Companys incorporation), each outstanding option under the
plan will fully vest and be exercisable for a period often
(10) days prior to the closing of such transaction, and the
unexercised options will terminate prior to the closing of such
transaction.
With respect to options granted after October 16, 2001 (as
well as certain options granted before such date, with the
consent of the optionees) and stock appreciation rights, in the
event of a merger or proposed sale of all or substantially all
of the assets of our Company, each outstanding award under the
plan will be assumed or an equivalent option substituted by the
successor corporation or a parent or subsidiary of the successor
corporation. In the event the successor corporation refuses to
assume or substitute outstanding awards, the plan administrator
will notify each optionee that his or her options will vest and
be exercisable for a period of twenty (20) days from the
date of such notice, and the unexercised awards will terminate
upon the expiration of such period. In addition, awards granted
to our non-employee directors will vest in full upon
consummation of any such transaction.
Nonassignability
Awards may not be assigned or transferred for any reason (other
than upon death), except that the plan administrator may permit
awards to be transferred during the optionees lifetime to
members of the optionees immediate family or to trusts,
LLCs or partnerships for the benefit of such persons.
Amendment
and Termination of the Plan
The plan provides that the Board of Directors may amend or
terminate the plan without stockholder approval, but no
amendment or termination of the plan or any award agreement may
adversely affect any award previously granted under the plan
without the written consent of the optionee.
Certain
United States Federal Income Tax Information
An optionee generally will not recognize any taxable income at
the time he or she is granted a non-statutory stock option with
an exercise price equal to the fair market value of the
underlying stock on the date of grant. However, upon its
exercise, the optionee will recognize ordinary income generally
measured as the excess of the then fair market value of the
shares purchased over the purchase price. Any taxable income
recognized in connection with an option exercise by one of our
employees is subject to tax withholding by us. Upon resale of
such shares by the optionee, any difference between the sales
price and the optionees purchase price, to the extent not
recognized as taxable income as described above, will be treated
as long-term or short-term capital gain or loss, depending on
the holding period.
No taxable income is reportable when a stock appreciation right
with an exercise price equal to the fair market value of the
underlying stock on the date of grant is granted to an optionee.
Upon exercise, the optionee will recognize ordinary income in an
amount equal to the amount of cash received and the fair market
value of any shares
58
received. Any additional gain or loss recognized upon any later
disposition of the shares would be capital gain or loss.
Generally, we will be entitled to a tax deduction in the same
amount as the ordinary income realized by the optionee with
respect to shares acquired upon exercise of an award.
The foregoing is only a summary of the effect of federal income
taxation upon the optionee and us with respect to the grant and
exercise of options and stock appreciation rights granted under
the plan and does not purport to be complete. In addition, the
summary does not discuss the tax consequences of an
optionees death or the income tax laws of any state or
foreign country in which the optionee may reside.
2001
Non-Statutory Stock Option Plan
Purpose
The purposes of the plan are to attract and retain the best
available personnel for positions of substantial responsibility,
to provide additional incentive to employees, directors and
consultants and to promote the success of our business.
Administration
The plan provides for administration by our Board of Directors
or a committee appointed by the Board of Directors and is
currently administered by the Compensation Committee of the
Board of Directors. All questions of interpretation or
application of the plan are determined by the Board of Directors
or its appointed committee, and its decisions are final and
binding upon all participants. Directors receive no additional
compensation for their services in connection with the
administration of the plan.
Eligibility
to Participate in the Plan
Nonstatutory stock options may be granted to our employees
including officers, consultants and directors.
Number
of Shares Covered by the Plan
The aggregate number of shares of common stock authorized for
issuance under the plan is 1,000,000 shares.
Awards
Permitted Under the Plan
The plan authorizes the granting of nonstatutory stock options
only.
Terms
of Options
The plans administrator determines the exercise price of
options granted under the plan and the term of those options.
The options that are currently outstanding under the plan vest
and become exercisable over periods of two to four years
beginning on the grant date. Payment of the exercise price may
be made by cash, check, promissory note, other shares of our
common stock, cashless exercise, a reduction in the amount of
any Company liability to the optionee, any other form of
consideration permitted by applicable law or any combination of
the foregoing methods of payment. Options may be made
exercisable only under the conditions the Board of Directors or
its appointed committee may establish. If an optionees
employment terminates for any reason, the option remains
exercisable for a period fixed by the plan administrator up to
the remainder of the options term; if a period is not
fixed by the plan administrator, the exercise period is three
(3) months, or twelve (12) months in the case of death
or disability.
Capital
Changes
In the event of any changes in our capitalization, such as stock
splits or stock dividends, resulting in an increase or decrease
in the number of shares of common stock, effected without
receipt of consideration by us, appropriate adjustment will be
made by us in the number of shares available for future grant
and in the number of shares subject to previously granted but
unexercised options.
59
Dissolution
or Liquidation
In the event of the proposed dissolution or liquidation of our
Company, the option holders will be notified of such event, and
the plan administrator may, in its discretion, permit each
option to fully vest and be exercisable until ten (10) days
prior to such event, at which time the options will terminate.
Merger,
Asset Sale or Change of Control
In the event of a merger or proposed sale of all or
substantially all of the assets of our Company, each outstanding
option under the plan will be assumed or an equivalent option
substituted by the successor corporation or a parent or
subsidiary of the successor corporation. In the event the
successor corporation refuses to assume or substitute
outstanding options, the plan administrator will notify each
optionee that his or her options will vest and be exercisable
for a period of fifteen (15) days from the date of such
notice, and the unexercised options will terminate upon the
expiration of such period. In addition, awards granted to our
non-employee directors will vest in full upon consummation of
any such transaction.
Nonassignability
Options may not be assigned or transferred for any reason (other
than upon death), except that the plan administrator may permit
options to be transferred during the optionees lifetime
upon such terms and conditions as the administrator deems
appropriate.
Amendment
and Termination of the Plan
The plan provides that the Board of Directors may amend or
terminate the plan without stockholder approval, but no
amendment or termination of the plan or any award agreement may
adversely affect any award previously granted under the plan
without the written consent of the optionee.
Certain
United States Federal Income Tax Information
An optionee generally will not recognize any taxable income at
the time he or she is granted a non-statutory stock option.
However, upon its exercise, the optionee will recognize ordinary
income generally measured as the excess of the then fair market
value of the shares purchased over the purchase price. Any
taxable income recognized in connection with an option exercise
by one of our employees is subject to tax withholding by us.
Upon resale of such shares by the optionee, any difference
between the sales price and the optionees purchase price,
to the extent not recognized as taxable income as described
above, will be treated as long-term or short-term capital gain
or loss, depending on the holding period.
Generally, we will be entitled to a tax deduction in the same
amount as the ordinary income realized by the optionee with
respect to shares acquired upon exercise of the nonstatutory
stock option.
The foregoing is only a summary of the effect of federal income
taxation upon the optionee and us with respect to the grant and
exercise of options granted under the plan and does not purport
to be complete. In addition, the summary does not discuss the
tax consequences of an optionees death or the income tax
laws of any state or foreign country in which the optionee may
reside.
2003
Stock Plan
In October 2003, the Board of Directors approved the 2003 Stock
Plan (the Plan). The Plan provides for the grant of
non-statutory stock options, stock purchase rights, restricted
stock, stock appreciation rights, performance shares, and
performance units, to newly hired employees as a material
inducement to their decision to enter into our employ.
Awards under the Plan may not be granted to individuals who are
former employees or directors of ours, except that a former
employee who is returning to our employ following a bona-fide
period of non-employment by us may receive awards under the
Plan. Our Board of Directors or a committee appointed by the
Board of Directors administers the Plan and controls its
operation (the Administrator). However, all awards
under the Plan must be approved by either a majority of our
independent directors, or approved by a committee comprised of a
majority of independent directors.
60
The Administrator determines, on a
grant-by-grant
basis, the term of each option, when options granted under the
Plan will vest and may be exercised, the exercise price of each
option, and the method of payment of the option exercise price.
After a participants termination of service with us, the
vested portion of his or her option will generally remain
exercisable for the period of time stated in the option
agreement. If a specified period of time is not stated in the
option agreement, the option will remain exercisable for three
months following a termination for reasons other than death or
disability, and for one year following a termination due to
death or disability, in each case subject to the original term
of the option. The Administrator also determines the terms and
conditions of restricted stock awards (shares that vest in
accordance with the terms and conditions established by the
Administrator), stock purchase rights (rights to purchase shares
of our common stock, and such shares are generally restricted
stock), stock appreciation rights (the right to receive the
appreciation in fair market value of our common stock between
the exercise date and the date of grant), and performance shares
and/or units
(awards that will result in a payment to a participant only if
the performance goals or other vesting criteria established by
the Administrator are achieved or the awards otherwise vest).
In the event we experience a change in control, each outstanding
option, stock purchase right and stock appreciation right will
be assumed or substituted for by the successor corporation (or a
parent or subsidiary of such successor corporation). If such
awards are not so assumed or substituted, the Administrator will
notify participants that their options, stock purchase rights,
and stock appreciation rights will be exercisable as to all of
the shares subject to the award for a period of time determined
by the Administrator in its sole discretion, and that the award
will terminate upon the expiration of such period. In addition,
in the event we experience any dividend or other distribution,
recapitalization, stock split, reverse stock split,
reorganization, merger, consolidation,
split-up,
spin-off, combination, repurchase, or exchange of shares or
other securities, or other change in our corporate structure
affecting the shares occurs, the Administrator, in order to
prevent diminution or enlargement of the benefits or potential
benefits intended to be made available under the Plan may make
appropriate adjustments to outstanding awards and to the shares
available for issuance under the Plan.
There are 1,000,000 shares of our common stock reserved
under the Plan, and as of March 31, 2007,
119,000 shares remain for future issuance. By its terms,
the Plan will automatically terminate in 2013, unless earlier
terminated by the Board of Directors.
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table contains information about the beneficial
ownership of our common stock as of June 1, 2007 for:
|
|
|
|
|
each of our current directors, as well as our Chief Executive
Officer, former Chief Financial Officer and our other five most
highly compensated executive officers during the fiscal year
ended March 31, 2007;
|
|
|
|
all of our current directors and named executive officers as a
group; and
|
|
|
|
all persons known by us to be beneficial owners of more than
five percent (5%) of our outstanding stock.
|
The number and percentage of shares beneficially owned is
determined in accordance with
Rule 13d-3
of the Securities and Exchange Act of 1934 and the information
is not necessarily indicative of beneficial ownership for any
other purpose. Under
Rule 13d-3,
beneficial ownership includes any shares over which the
individual or entity has voting power or investment power and
any shares that the individual has the right to acquire within
60 days of June 1, 2007 through the exercise of any
stock options or vested restricted stock units. Unless
indicated, each person or entity either has sole voting and
investment power over the shares shown as beneficially owned or
shares those powers with his spouse.
The number of options and restricted stock units exercisable
within sixty (60) days of June 1, 2007 is shown in the
first column of the table and is included in the total number of
shares of common stock beneficially owned shown in the second
column. The percentage of shares beneficially owned is computed
on the basis of 37,179,849 shares of common stock
outstanding on June 1, 2007. Unless otherwise indicated,
the principal address of each stockholder listed below is
c/o Genesis
Microchip Inc., 2525 Augustine Drive, Santa Clara,
California 95054.
61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
Shares of
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Total
|
|
|
|
|
|
|
Issuable
|
|
|
Number of
|
|
|
|
|
|
|
Pursuant to
|
|
|
Shares of
|
|
|
|
|
|
|
Options and
|
|
|
Common Stock
|
|
|
Percentage of
|
|
|
|
Restricted Stock
|
|
|
Beneficially
|
|
|
Outstanding
|
|
Name
|
|
Units
|
|
|
Owned
|
|
|
Common Stock
|
|
|
BlackRock, Inc.(1)
|
|
|
|
|
|
|
4,429,072
|
|
|
|
11.9
|
%
|
BlackRock Advisors LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
BlackRock Investment Management LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
BlackRock (Channel Islands) Ltd
|
|
|
|
|
|
|
|
|
|
|
|
|
BlackRock Japan Co. Ltd.
|
|
|
|
|
|
|
|
|
|
|
|
|
BlackRock Investment Management
(UK) Ltd.
|
|
|
|
|
|
|
|
|
|
|
|
|
Master Values Opportunities Trust
|
|
|
|
|
|
|
|
|
|
|
|
|
40 East
52nd
Street
|
|
|
|
|
|
|
|
|
|
|
|
|
New York, NY 10022
|
|
|
|
|
|
|
|
|
|
|
|
|
DeutscheBank AG(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
DeutscheBank Securities Inc.
|
|
|
|
|
|
|
2,691,499
|
|
|
|
7.2
|
%
|
Taunusanlage 12
|
|
|
|
|
|
|
|
|
|
|
|
|
D-60325 Frankfurt am Main
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal Republic of Germany
|
|
|
|
|
|
|
|
|
|
|
|
|
Citadel Limited Partnership(3)
|
|
|
|
|
|
|
2,238,573
|
|
|
|
6.0
|
%
|
Citadel Investment Group LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
Citadel Equity Fund Ltd.
|
|
|
|
|
|
|
|
|
|
|
|
|
Citadel Derivatives Group LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenneth Griffin
|
|
|
|
|
|
|
|
|
|
|
|
|
131 S. Dearborn Street,
32nd
Floor
|
|
|
|
|
|
|
|
|
|
|
|
|
Chicago, IL 60603
|
|
|
|
|
|
|
|
|
|
|
|
|
D.E. Shaw Valence Portfolios,
L.L.C.(4)
|
|
|
|
|
|
|
1,837,980
|
|
|
|
4.9
|
%
|
D.E. Shaw & Co., L.P.
|
|
|
|
|
|
|
|
|
|
|
|
|
David E. Shaw
|
|
|
|
|
|
|
|
|
|
|
|
|
120 W. 45th Street,
39th Floor
|
|
|
|
|
|
|
|
|
|
|
|
|
New York, NY 10036
|
|
|
|
|
|
|
|
|
|
|
|
|
Elias Antoun
|
|
|
350,833
|
|
|
|
369,934
|
|
|
|
|
*
|
Michael Healy(5)
|
|
|
173,125
|
|
|
|
178,326
|
|
|
|
|
*
|
Behrooz Yadegar
|
|
|
20,417
|
|
|
|
20,417
|
|
|
|
|
*
|
Hildy Shandell
|
|
|
15,000
|
|
|
|
24,525
|
|
|
|
|
*
|
Raphael Mehrbians(5)
|
|
|
9,031
|
|
|
|
11,773
|
|
|
|
|
*
|
Tzoyao Chan(5)
|
|
|
0
|
|
|
|
16,690
|
|
|
|
|
*
|
Anders Frisk(6)
|
|
|
142,542
|
|
|
|
145,815
|
|
|
|
|
*
|
Jon Castor
|
|
|
38,833
|
|
|
|
38,833
|
|
|
|
|
*
|
Chieh Chang
|
|
|
48,833
|
|
|
|
62,570
|
|
|
|
|
*
|
Tim Christoffersen
|
|
|
63,000
|
|
|
|
63,000
|
|
|
|
|
*
|
Jeffrey Diamond(7)
|
|
|
113,000
|
|
|
|
127,554
|
|
|
|
|
*
|
Robert H. Kidd
|
|
|
68,000
|
|
|
|
68,000
|
|
|
|
|
*
|
Chandrashekar M. Reddy
|
|
|
64,667
|
|
|
|
196,222
|
|
|
|
|
*
|
Directors and Named Executive
Officers as a group (13 persons)(5)(6)(7)
|
|
|
1,107,281
|
|
|
|
1,323,659
|
|
|
|
3.6
|
%
|
|
|
|
* |
|
Less than one percent (1%) |
|
(1) |
|
Based on information contained in a Schedule 13G filed
February 13, 2007. |
|
(2) |
|
Based on information contained in a Schedule 13G filed
February 1, 2007. |
62
|
|
|
(3) |
|
Based on information contained in a Schedule 13G filed
March 23, 2007. |
|
(4) |
|
Based on information contained in a Schedule 13G filed
February 14, 2007. |
|
(5) |
|
No longer employed by the company. |
|
(6) |
|
Includes 3,273 shares of common stock held by
Mr. Frisk. Mr. Frisk has resigned from the Company and
will terminate employment on July 31, 2007. |
|
(7) |
|
Includes 14,554 shares owned by Diamond Family Trust, a
trust established for the benefit of Mr. Diamond and his
family. |
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934
requires our officers, directors and any person who owns more
than ten percent (10%) of our shares of common stock to file
reports of ownership on Forms 3, 4 and 5 with the
Securities and Exchange Commission and with us. Based on our
review of copies of forms and written representations, we
believe that all of our officers, directors and greater than ten
percent (10%) stockholders complied with all filing requirements
applicable to them for the year ended March 31, 2007,
except as follows: (1) on May 3, 2006, a Form 4
was filed for Anders Frisk which omitted to state that
Mr. Frisk was the beneficial owner of 2,581 shares of
our common stock, which such omission was corrected in an
amendment to the Form 4 filed on July 17, 2006, and
(2) on May 30, 2006, Ava Hahn was granted an option to
purchase 5,000 shares of common stock, which such grant was
first reported on a Form 4 filed June 8, 2006.
|
|
ITEM 13.
|
CERTAIN
RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE
|
See the disclosure under the caption entitled Change of
Control Severance Agreements and Employment
Agreements, and Note 14 Related Party
Transactions.
Our Audit Committee Charter states that the Audit Committee is
responsible for reviewing and approving in advance, any proposed
related party transactions. In addition, our Code of Conduct and
Business Ethics prohibits conflicts of interest. The code does
not distinguish between potential conflict of interest
transactions involving directors or executive officers and those
involving other employees. It notes that all covered persons are
expected to avoid conflicts of interest. The code provides some
examples of activities that could involve conflicts of interest,
including aiding our competitors, involvement with any business
that does business with us or seeks to do so, owning a
significant financial interest in a competitor or a business
that does business with us or seeks to do so, soliciting or
accepting payments or other preferential treatment from any
person that does business with us or seeks to do so, taking
personal advantage of corporate opportunities and transacting
company business with a family member. Further, all related
party transactions must be approved in advance by our Audit
Committee. The code does not expressly set forth the standards
that would be applied in reviewing, approving or ratifying
transactions in which our directors, executive officers or
stockholders have a material interest. We expect that any such
transaction would be approved only if our Audit Committee
concluded in good faith that it was in our interest to proceed
with it.
Each of our non-employee Board members qualify as
independent in accordance with the published listing
requirements of the Nasdaq Global Market.
63
|
|
ITEM 14.
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
|
We have selected KPMG as our independent accountants for the
2008 fiscal year. KPMG or its predecessor firms have served as
our independent accountants since our inception in Canada in
1987. The approximate fees billed to us by KPMG for services
rendered with respect to fiscal years 2007 and 2006 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
Audit Fees
|
|
$
|
901,017
|
|
|
$
|
815,790
|
|
Audit-Related Fees
|
|
|
120,503
|
|
|
|
180,183
|
|
Tax Fees
|
|
|
341,246
|
|
|
|
333,483
|
|
All Other Fees
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Total Fees
|
|
$
|
1,362,766
|
|
|
$
|
1,329,456
|
|
Audit Fees. This category consists of fees
paid for professional services provided in connection with the
integrated audit of our financial statements and internal
controls over financial reporting, and review of our quarterly
financial statements and audit services provided in connection
with other statutory or regulatory filings, including filings
related to potential mergers and acquisitions.
Audit-Related Fees. This category consists of
fees paid primarily for advisory services, research on
accounting matters and due diligence related to mergers and
acquisitions, and are not reported above under Audit
Fees.
Tax Fees. This category consists of fees paid
primarily for professional services rendered by KPMG in
connection with tax advice related to specialized projects such
as the implementation of the American Jobs Creation Act,
acquisition activities and tax compliance, including technical
tax advice related to the preparation of tax returns.
The Audit Committee has determined that the provision of
non-audit services performed during fiscal 2006, including work
related to acquisition activities and for tax planning and
compliance purposes, is compatible with maintaining the
independence of KPMG.
The Audit Committee has established a policy governing our use
of KPMG for non-audit services. Under the policy, management may
use KPMG for non-audit services that are permitted under SEC
rules and regulations, provided that management obtains the
Audit Committees approval before such services are
rendered. In fiscal 2007, all fees identified above under the
captions Audit-Related Fees and Tax Fees
that were billed by KPMG were approved by the Audit Committee
pursuant to the Companys pre-approval policies and
procedures established by the Audit Committee.
64
PART IV
ITEM 15. EXHIBITS
AND FINANCIAL STATEMENT SCHEDULES:
(a) Documents filed with this report:
1. Consolidated Financial Statements. The following
consolidated financial statements and related auditors
report are incorporated in Item 8 of this report:
|
|
|
|
|
Report of Independent Registered Public Accounting firm.
|
|
|
|
Consolidated Balance Sheets at March 31, 2007 and 2006.
|
|
|
|
Consolidated Statements of Operations for the years ended
March 31, 2007, March 31, 2006 and March 31, 2005.
|
|
|
|
Consolidated Statements of Stockholders Equity for the
years ended March 31, 2007, March 31, 2006 and
March 31, 2005.
|
|
|
|
Consolidated Statements of Cash Flows for the years ended
March 31, 2007, March 31, 2006 and March 31, 2005.
|
|
|
|
Notes to Consolidated Financial Statements
|
2. Consolidated Financial Statement
Schedules. Consolidated financial statement
schedules have been omitted because they are not applicable or
are not required, or because the required information is
included in the Consolidated Financial Statements and Notes
thereto which are included herein.
3. Exhibits. The exhibits listed in the
Exhibit Index are filed as a part of this report.
65
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
GENESIS MICROCHIP INC.
Elias Antoun
Chief Executive Officer and Director
Linda Millage
Principal Accounting Officer
Date: June 12, 2007
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
signature appears below hereby constitutes and appoints Linda
Millage and Jeffrey Lin, and each of them individually, as his
attorney-in-fact, each with full power of substitution, for him
in any and all capacities to sign any and all amendments to this
Report on
Form 10-K,
and to file the same with, with exhibits thereto and other
documents in connection therewith, with the Securities and
Exchange Commission, hereby ratifying and confirming all that
said attorney-in-fact, or his or her substitute, may do or cause
to be done by virtue hereof.
This report has been signed by the following persons in the
capacities and on the dates indicated as required by the
Securities Exchange Act of 1934.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
/s/ Elias
Antoun
Elias
Antoun
|
|
President, Chief Executive Officer
and Director
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Jon
Castor
Jon
Castor
|
|
Director
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Chieh
Chang
Chieh
Chang
|
|
Director
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Tim
Christoffersen
Tim
Christoffersen
|
|
Director
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Jeffrey
Diamond
Jeffrey
Diamond
|
|
Chairman of the Board
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Robert
H. Kidd
Robert
H. Kidd
|
|
Director
|
|
June 12, 2007
|
|
|
|
|
|
/s/ Chandrashekar
M. Reddy
Chandrashekar
M. Reddy
|
|
Director
|
|
June 12, 2007
|
66
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Exhibit Description
|
|
|
2
|
.1(1)
|
|
Agreement and Plan of Merger and
Reorganization, dated as of September 27, 2001, by and between
Genesis Microchip Incorporated and Sage, Inc.
|
|
2
|
.2(1)
|
|
Share Exchange and Arrangement
Agreement and Plan of Arrangement by and among the Registrant,
Genesis Microchip Nova Scotia Corp., and Genesis Microchip
Incorporated.
|
|
2
|
.3(2)
|
|
Agreement and Plan of Merger,
dated as of March 17, 2003, among Genesis Microchip Inc.,
Display Acquisition Corporation and Pixelworks, Inc. (with Forms
of Voting Agreements).
|
|
3
|
.1(1)
|
|
Certificate of Incorporation of
the Registrant.
|
|
3
|
.2(3)
|
|
Amended and Restated Bylaws of the
Registrant.
|
|
3
|
.3(4)
|
|
Certificate of Designation of
Rights, Preferences and Privileges of Series A Participating
Preferred Stock of the Registrant.
|
|
4
|
.1(1)
|
|
Form of Common Stock Certificate
of the Registrant.
|
|
4
|
.2(4)
|
|
Preferred Stock Rights Agreement,
dated as of June 27, 2002, between the Registrant and Mellon
Investor Services, L.L.C., as amended on March 16, 2003.
|
|
10
|
.1(5)*
|
|
Offer Letter of Employment with
Anders Frisk, dated February 15, 2000.
|
|
10
|
.2(5)*
|
|
Separation Agreement and Release
with Chandrashekar Reddy.
|
|
10
|
.3(5)*
|
|
Consulting Agreement with
Chandrashekar Reddy.
|
|
10
|
.4(6)*
|
|
1987 Stock Option Plan.
|
|
10
|
.5
|
|
Intentionally omitted.
|
|
10
|
.6*
|
|
1997 Employee Stock Purchase Plan,
as last amended on August 24, 2005.
|
|
10
|
.7*
|
|
1997 Non-Employee Stock Option
Plan.
|
|
10
|
.8*
|
|
2000 Nonstatutory Stock Option
Plan.
|
|
10
|
.9*
|
|
2001 Nonstatutory Stock Option
Plan.
|
|
10
|
.10(6)*
|
|
Paradise Electronics, Inc. 1997
Employee Stock Option Plan.
|
|
10
|
.11(6)*
|
|
Sage, Inc. Second Amended and
Restated 1997 Stock Plan.
|
|
10
|
.12(6)*
|
|
2001 Employee Stock Purchase Loan
Plan (for non-officers).
|
|
10
|
.13(7)*
|
|
Offer Letter with Michael Healy.
|
|
10
|
.14(8)*
|
|
CFO Tier 1 Change of
Control Severance Agreement with Michael Healy.
|
|
10
|
.15(8)*
|
|
CEO Tier 1 Change of
Control Severance Agreement with Elias Antoun.
|
|
10
|
.15(8)*
|
|
Form of director and officer
indemnification agreement.
|
|
10
|
.16(9)*
|
|
2003 Stock Plan.
|
|
10
|
.17(10)*
|
|
Form of 2000 Nonstatutory Stock
Option Plan Stock Option Agreement with Nonemployee Directors.
|
|
10
|
.18(10)*
|
|
Form of 2000 Nonstatutory Stock
Option Plan International Stock Option Agreement.
|
|
10
|
.19(10)*
|
|
Form of 2000 Nonstatutory Stock
Option Plan Stock Option Agreement for China.
|
|
10
|
.20(11)*
|
|
Amendment No. 1 to Separation
Agreement and Release with Chandrashekar Reddy, dated November
10, 2004.
|
|
10
|
.21(12)*
|
|
Offer Letter of Employment with
Elias Antoun, dated November 10, 2004.
|
|
10
|
.22(13)*
|
|
1997 Employee Stock Option Plan,
as amended on September 19, 2005, and form of Notice of Grant of
Restricted Stock Units.
|
|
10
|
.24(14)*
|
|
Offer Letter with Behrooz Yadegar,
dated April 11, 2006.
|
|
10
|
.25(15)*
|
|
Fiscal Year 2007 Executive Bonus
Plan, dated June 10, 2006.
|
|
10
|
.26(16)*
|
|
Separation Agreement and Release
with Tzoyao Chan, dated July 27, 2006
|
|
10
|
.27(17)*
|
|
Offer Letter with Hildy Shandell,
dated August 30, 2006
|
|
10
|
.28(17)*
|
|
Change in Control Severance
Agreement with Hildy Shandell, dated September 12, 2006
|
67
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Exhibit Description
|
|
|
10
|
.29(18)
|
|
Lease Agreement and Lease Rider
Agreement with Transamerica Occidental Life Insurance Company,
dated September 18, 2006.
|
|
10
|
.30(19)*
|
|
Separation Agreement and Release
with Raphael Mehrbians, dated October 20, 2006.
|
|
10
|
.31(20)
|
|
Settlement and License Agreement
with Silicon Image, Inc., dated December 21, 2006.
|
|
10
|
.32(8)*
|
|
Tier 2 Change of
Control Agreement with Anders Frisk.
|
|
10
|
.33(8)*
|
|
Form of Tier 2 Change
of Control Severance Agreement.
|
|
21
|
|
|
Subsidiaries.
|
|
23
|
.1
|
|
Consent of Independent Registered
Accounting Firm.
|
|
24
|
.1
|
|
Power of Attorney (see
page 66).
|
|
31
|
.1
|
|
Certification of Chief Executive
Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) of the
Securities Exchange Act of 1934.
|
|
31
|
.2
|
|
Certification of Principal
Accounting Officer, as required by Rule 13a-14(a) or Rule
15d-14(a) of the Securities Exchange Act of 1934.
|
|
32
|
.1
|
|
Certification of Chief Executive
Officer and Principal Accounting Officer, as required by Section
1350 of Chapter 63 of Title 18 of the United States Code
(18 U.S.C. 1350).
|
|
|
|
(1) |
|
Incorporated by reference to the Registrants Registration
Statement on
Form S-4
(File
No. 333-72202)
filed with the Securities and Exchange Commission on
October 25, 2001, as amended. |
|
(2) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities and Exchange Commission on
March 20, 2003. |
|
(3) |
|
Incorporated by reference to the Registrants Annual Report
on
Form 10-K
filed with the Securities and Exchange Commission on
July 1, 2002, as amended. |
|
(4) |
|
Incorporated by reference to the Registrants Registration
Statement on
Form 8-A12G
filed with the Securities and Exchange Commission on
August 5, 2002, as amended by the Registrants
Statement on
Form 8-12G/A
filed with the Securities and Exchange Commission on
March 31, 2003. |
|
(5) |
|
Incorporated by reference to the Registrants Annual Report
on
Form 10-K
filed with the Securities Exchange Commission on June 20,
2003. |
|
(6) |
|
Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Securities Exchange Commission on
February 21, 2002. |
|
(7) |
|
Incorporated by reference to the Registrants Quarterly
Report on Form
10-Q filed
with the Securities Exchange Commission on February 13,
2004. |
|
(8) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities and Exchange Commission on
March 7, 2007. |
|
(9) |
|
Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Securities Exchange Commission on
October 15, 2003. |
|
(10) |
|
Incorporated by reference to the Registrants Quarterly
Report on Form
10-Q filed
with the Securities Exchange Commission on November 9, 2004. |
|
(11) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
November 15, 2004. |
|
(12) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
November 19, 2004. |
|
(13) |
|
Incorporated by reference to the Registrants Quarterly
Report on Form
10-Q filed
with the Securities Exchange Commission on November 8, 2005. |
|
(14) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on May 10,
2006. |
68
|
|
|
(15) |
|
Incorporated by reference to the Registrants Annual Report
on
Form 10-K
filed with the Securities Exchange Commission on June 14,
2006. |
|
(16) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on August 1,
2006. |
|
(17) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
September 18, 2006. |
|
(18) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
September 19, 2006. |
|
(19) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
October 23, 2006. |
|
(20) |
|
Incorporated by reference to the Registrants Current
Report on
Form 8-K
filed with the Securities Exchange Commission on
December 22, 2006. |
|
* |
|
Identifies a management contract or compensatory plan of
arrangement required to be filed as an exhibit to this report
pursuant to Item 14(c) of this report. |
69